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  1  
ABSTRACT 
Ghrelin and leptin, two important metabolic hormones involved in regulation of 
energy balance in the adult, have recently been shown to have a neurotrophic role 
during early life development in that they regulate neuronal connectivity within 
regions of the hypothalamus responsible for control of energy balance. Disturbances 
to the early life nutritional environment including overnutrition have been highly 
correlated with long-life metabolic problems, such as childhood obesity and its 
complications. (Throughout this thesis the term overnutrition refers to the neonatally 
overfed animal model due to litter manipulation and not as a form of malnutrition, 
which may elicit similar offspring phenotypes.) In addition to their metabolic roles, 
leptin and ghrelin appear to be important for early brain development, with leptin 
stimulating and ghrelin inhibiting the establishment of appetite regulatory circuitry. 
Recent research suggests that the neurodevelopmental actions of leptin and ghrelin are 
restricted to a crucial developmental period that occurs during the first two weeks 
after birth in rodents, which in humans this critical period encompasses the third 
trimester of pregnancy and approximately 1000 days after birth. However, the effects 
of overnutrition on the developing brain during this period and the mechanisms that 
underlie neurodevelopmental actions of leptin and ghrelin are currently unknown. It is 
also unclear whether overnutrition affects brain development in males and females to 
the same extent. The early developmental period is associated with enhanced neuronal 
plasticity, and disturbances during this critical time have the potential to program later 
life health outcomes. It is therefore important to shed further insight into the roles of 
leptin and ghrelin, to develop interventions that alleviate the incidence of childhood 
obesity and associated comorbidities.  
 
  2 
An animal model of childhood obesity in rats was used to investigate the short- and 
long-term effects of neonatal overfeeding on the leptin and ghrelin system. The 
animal model was achieved by manipulating litter sizes into control litters of 12 pups 
and small litters of 4 pups, the later representing the neonatal overfeeding 
environment. The reduction of litter size immediately after birth, led to a significant 
increase in dietary intake. Consequently, neonatally overfed pups experienced 
accelerated weight gain and disrupted circulating leptin and ghrelin levels in 
comparison to control counterparts. Using this model we examined the short- and 
long-term effects of neonatal overnutrition on the leptin and ghrelin systems in males 
and females. We investigated here the effects of neonatal overnutrition on 
hypothalamic orexigenic and anorexigenic neuronal fibre immunoreactivity and if 
these changes were mediated by leptin in male rats. We also investigated whether 
these effects could be normalised by a leptin antagonist. We found that neonatal 
overnutrition in males was associated with short-term central leptin resistance, altered 
orexigenic neuronal fibre immunoreactivity and no changes in anorexigenic 
immunoreactivity. We also found that short-term neonatal leptin antagonism did not 
reverse excess body weight or hyperleptinemia. Our findings suggest that factors 
other than leptin contribute to the obese phenotype. Most importantly, we found that 
in males the early life effects of neonatal overfeeding are partly resolved in adulthood, 
emphasising the importance of brain plasticity. Interestingly, neonatally overfed 
females, despite an obese phenotype characterised by hyperleptinemia and increased 
body weight compared to controls, did not show the same changes in the central 
feeding circuitry as observed in males. These findings are suggestive of sex 
differences in the effects of neonatal overfeeding and of differences in the ability of 
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the male and female central systems to respond to challenges in the early life 
nutritional environment.  
 
Similarly to leptin, ghrelin along with its appetite-stimulating role in adults is 
involved in the establishment of hypothalamic feeding pathways during neonatal 
development in rodents. Here was investigated long-term effect of neonatal 
overfeeding on the ghrelin system including the ability of both forms of ghrelin (acyl 
ghrelin and des-acyl ghrelin) to access the hypothalamus in male rats. We 
demonstrated that neonatal overfeeding affects the ghrelin system during early life by 
suppressing circulating ghrelin levels and increasing hypothalamic responsiveness to 
exogenous acyl but not des-acyl ghrelin. Neonatal overnutrition also affects the ability 
of acyl ghrelin to reach the hypothalamus. Importantly, the influences of neonatal 
overnutrition observed during early life were resolved in adulthood. In contrast to 
males, where neonatal overnutrition resulted in compromised hypothalamic ghrelin 
signalling, in females, the central ghrelin system and circulating ghrelin remained 
intact. However, neonatal overnutrition in females was associated with long-term 
alterations in the capacity for the pituitary gland to respond to ghrelin. 
 
Ghrelin has recently been shown to have additional properties to those involved in 
satiety signalling, including regulation of hypothalamic-pituitary-adrenal (HPA) axis 
responses to psychological stress, as well as being a potent anti-inflammatory agent. 
Here were investigated both forms of ghrelin (acyl and des-acyl ghrelin) and their 
anti-inflammatory activity hypothesising that this activity is mediated via the HPA 
axis. In experiments where male rats were concomitantly injected with acyl or des-
acyl ghrelin and lipopolysaccharide (LPS) acyl, but not des-acyl ghrelin, suppressed 
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the inflammatory cytokine response to LPS. Des-acyl ghrelin also had no effects on 
components of the HPA axis. Acyl ghrelin, despite stimulating neuronal activation in 
the paraventricular nucleus of the hypothalamus in vivo and stimulating 
adrenocorticotropic hormone release from the pituitary in vitro, did not affect the 
HPA axis response to LPS. These findings suggest acyl ghrelin’s anti-inflammatory 
effects are independent of its actions on the HPA axis and have implications for the 
potential use of this peptide for treatment of inflammatory conditions without 
compromising HPA axis activity. 
 
In conclusion, findings from this thesis indicate that metabolic hormones leptin and 
ghrelin have immense importance in the development of central centres of energy 
control and metabolism. Altered nutritional environment during early development 
affects both leptin and ghrelin systems in the rat, however it resolves to a certain 
extent in adulthood. Importantly, these central developmental changes mediated by 
leptin and ghrelin have a strong sex-specific factor. In this thesis we also added to the 
understanding of the mechanisms by which ghrelin exerts its anti-inflammatory 
properties, which is of great importance in development of therapeutic strategies for 
treatment of inflammatory conditions.   
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Childhood obesity 
Childhood obesity is one of the world’s greatest health challenges. The incidence of 
childhood obesity has been increasing during the last decades and there are over 42 
million children under the age of five who are overweight or obese (WHO, 2016). 
Childhood obesity is associated with a series of complications such as type 1 and 2 
diabetes, cardiovascular diseases, some types of cancers, hypertension, early puberty, 
steatohepatitis, sleep apnoea, asthma, musculoskeletal disorders as well as 
psychological problems, amongst other conditions (Figure 1.1. (Barton 2012; Kim, 
Despres, and Koh 2016)), making childhood obesity one of the leading causes of 
death in the United States of America and Europe (Mokdad et al. 2005; Park et al. 
2012). Although, in some countries such as United States of America, Western 
European countries, Japan and Australia included, levels of childhood obesity may 
have reached a plateau in the last 10 years, the prevalence of childhood obesity 
remains very high especially in the low and middle income countries. This represents 
a significant health issue particularly in the more vulnerable groups in the population 
(Ogden et al. 2014; de Onis, Blossner, and Borghi 2010). There is now strong 
evidence that childhood obesity leads to adult obesity and its related comorbidities 
(Kelsey et al. 2014).  
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Figure 1.1 Childhood obesity-related diseases.  
Childhood obesity poses a lifetime risk for other disease conditions including 
cardiovascular, metabolic, and problems with the central nervous system (CNS) 
during both childhood and adulthood. Modified from (Barton 2012). 
 
Similarly to other countries, in Australia percentages of obese children have increased 
dramatically in the last decades with around 20% of children under the age of five 
being overweight and around 5% of them classified as obese (Pearce et al. 2016). 
According to the Centers for Diseases Control and Prevention, a child is considered to 
be overweight between the 85-95th percentile and obese above the 95th percentile (de 
Onis et al. 2013). Based on survey analyses, the World Health Organisation (WHO) 
estimated that the prevalence of children under the age of five years old with a body 
mass index (BMI) of over the 98th percentile, increased from 4.2% in 1990 to 6.7% in 
2010, and is expected to increase to 9.1% by 2020 (Lakshman, Elks, and Ong 2012). 
These increased numbers of obese children result in increased health costs compared 
to those of normal healthy children of the same age (Brown et al. 2017). The 
prevalence of childhood obesity in many countries including Australia continues to 
rise, despite concerted efforts and recognition of the problem, making it a major focus 
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of research.  
 
The interaction of several factors including behavioural, environmental, physiological 
and hereditary has contributed to the increasing prevalence of obesity (Hruby and Hu 
2015). Twin studies, for instance, have estimated a heritability impact on BMI in 
children of between 40-70% (Farooqi and O'Rahilly 2000; Wardle et al. 2008). A 
number of mutations in the leptin receptor gene (LEPR), also known as OBR for 
obese gene, melanocortin 4 receptor (MC4R), as well as reduced methylation of the 
insulin-like growth factor 2 (IGF2) gene are associated with obesity (reviewed in 
(Willyard 2014)). However, the genetic contribution to disease risk has been shown to 
be smaller than the crucial role lifestyle plays in the development of obesity. Studies 
investigating the gene-lifestyle interactions in obesity have suggested that a healthy 
lifestyle may partially or totally eliminate the effects of genetic predisposition 
(Temelkova-Kurktschiev and Stefanov 2012).  
 
Perinatal programming of obesity – animal models  
As is predicted by the strong risk of obesity in children progressing to obesity in later 
life, early life events including the perinatal and postnatal environment can 
significantly contribute to the likelihood of an individual becoming obese later in life 
(Robillard and Segar 2006). A number of animal models of maternal overnutrition or 
under-nutrition during pregnancy or post-pregnancy have been used to study the early 
impact of the nutritional environment. One animal model that allows the study of 
effects of postnatal nutritional status in rodents is by manipulation of litter sizes. 
Larger than normal litter sizes with less access to maternal milk mimics an under-
nutritional environment, whereas a smaller than normal litter size with exposure to 
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excess maternal milk mimics an over-nutritional environment (Fiorotto et al. 1991). In 
rodents one of the main periods of developmental changes to brain pathways 
governing feeding and metabolism is the first two weeks after birth and any 
perturbations to the nutritional status during this time permanently affects their 
metabolic programming (Plagemann 2006). Essential metabolic hormones that 
regulate energy balance via their action in the hypothalamus are leptin, ghrelin, 
insulin and glucose, and during important developmental periods all of these 
hormones have their specific roles in modulating axonal innervation of important sites 
involved in metabolic control (Srinivasan et al. 2008).  
 
Insulin, for instance, inactivates orexigenic neuropeptide Y (NPY) and agouti related 
peptide (AgRP) neurons in the ARC (Benoit et al. 2002) and upregulates the 
anorexigenic proopiomelanocortin (POMC) in order to control energy intake (Qiu et 
al. 2014; Loh et al. 2017). Furthermore, insulin has a neurotrophic role during 
important periods of neurodevelopment (the first three weeks after birth). Plagemann 
and colleagues have shown that hypothalamic injection of insulin to rodents during 
the second or the eighth day of life is associated with long-term changes in weight 
regulation (Plagemann et al. 1992). Vogt and colleagues used an animal model of 
maternal high fat diet during lactation to establish the crucial role of insulin in 
formation of hypothalamic neuronal projections (Vogt et al. 2014). Human studies 
have shown that children from diabetic mothers experience impaired glucose 
tolerance and hyperinsulinemia, which further relates to adult obesity (Plagemann et 
al. 1997; Simerly 2008).  
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The focus of this thesis was on the roles of leptin and ghrelin during development. 
These hormones play an important role in regulation of hypothalamic development in 
the formation of neural circuits (Bouret, Draper, and Simerly 2004b). Leptin, in 
addition to its role in metabolic regulation, has shown to initiate the growth of 
neuronal growth and connectivity within regions of the hypothalamus related to 
feeding and metabolism (Bouret, Draper, and Simerly 2004b). Ghrelin in adulthood 
plays an important role in central control of energy expenditure by controlling 
feeding, adiposity and glucose metabolism (Tschop, Smiley, and Heiman 2000; Wren 
et al. 2001; Druce et al. 2005). In addition to this, ghrelin has an important role in 
programming feeding-related neurocircuitry during development, that of suppressing 
leptin-initiated neuronal outgrowth (Steculorum et al. 2015)  
 
Leptin levels in circulation positively correlate with fat deposition in adults. In 
neonates, naturally occurring increases in levels of leptin (known as the leptin surge) 
are crucial in initiating and supporting hypothalamic developmental changes during 
the first weeks of life in rodents (Ahima, Prabakaran, and Flier 1998). Once 
differentiated, neurons send axonal projections to target cells. Arcuate nucleus of the 
hypothalamus (ARC) neurons have relatively short projections limiting their 
connections within the hypothalamus. Comprehensive research has defined the timing 
of neuronal projections from the ARC towards other regions of the hypothalamus 
responsible for regulation of feeding. The paraventricular nucleus of the 
hypothalamus (PVN) is not innervated from ARC neurons until after postnatal day 
(P)10 (Bouret, Draper, and Simerly 2004a). At this age the leptin receptor is absent 
from PVN neurons and the timing of the appearance of its expression coincides with 
ARC axonal innervation of the PVN (reviewed in (Bouret 2017)). 
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Leptin and ghrelin are both important during these neuronal developmental periods, 
but how they are influenced by early life nutritional environment, the specific effects 
of this on females and if developmental perturbations to this circuitry are permanent 
have not been thoroughly studied. We defined here the role of these hormones in the 
early life overfeeding context. In these studies we consider the possibility that males 
and females respond differently to early life environmental insults. Additionally, the 
roles of different forms of ghrelin, acyl ghrelin (AG) and des-acyl ghrelin (DAG), 
have not been characterized during neonatal life, especially DAG due to the current 
lack of information on its receptor. The studies described in this thesis give insights 
into the role of DAG during development. 
 
The role of leptin in metabolism  
Leptin, discovered in 1994 (Zhang et al. 1994), is secreted mainly by adipocytes in 
white adipose tissue and is found in circulation in proportional amounts to fat stores 
in the organism (Considine et al. 1996). Leptin exerts its effect by binding to its 
receptors, which exist in several isoforms as a result of alternative splicing (LEPR a-
f). LEPR a, the short isoform of the leptin receptor is important in leptin transport 
across the blood-brain barrier (BBB) (Bjorbaek et al. 1998), whereas the long 
isoform, LEPR b, that is mainly expressed in the hypothalamus (the only isoform with 
the full length intracellular domain required for cell signaling) is important in 
mediating signal transduction (Elmquist et al. 1998; Friedman and Halaas 1998). 
Binding of leptin to its receptor activates a series of signal transduction pathways 
including the Janus kinase-signal transducers and activators of transcription 3 (JAK-
STAT3) pathway, important in regulation of energy homeostasis, mammalian target 
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of rapamycin (mTOR), adenosine monophosphate (AMP) activated protein kinase 
(AMPK) and mitogen activated protein kinase (MAPK) as reviewed in (Robertson, 
Leinninger, and Myers 2008). Leptin activates JAK, which leads to the 
phosphorylation of proteins of the JAK family (particularly STATs 1 and 3). In 
hypothalamic neurons, the STATs dimerize and translocate into the nucleus where 
they induce transcription of genes encoding proopiomelanocortin (POMC) and 
decrease transcription of genes encoding neuropeptide Y (NPY) and agouti related 
protein (AgRP) (reviewed in (Gurzov et al. 2016)), collectively resulting in the 
suppression of feeding behavior. 
 
Leptin has an important role in maintaining energy homeostasis via interactions with 
specific regions of the hypothalamus, particularly the ARC, but also the lateral 
hypothalamus (LH), ventromedial hypothalamus (VMH) and dorsomedial 
hypothalamus (DMH), which are all involved in central control of feeding and energy 
expenditure (Myers et al. 2009). In the hypothalamus leptin activates two major 
antagonizing groups of neurons: anorexigenic POMC / cocaine and amphetamine 
regulated transcript (CART) and orexigenic NPY / AgRP neurons (Cowley et al. 
2001; Morrison et al. 2005). These neurons then project to secondary neurons in the 
PVN, LH and VMH (reviewed in (Timper and Bruning 2017; Myers and Olson 2012; 
Waterson and Horvath 2015)).  
 
Leptin-deficient humans and animals develop obesity as a result of a combination of 
reduced energy expenditure and increased calorie intake as a result of aberrant 
signalling of these pathways and this often progresses to diabetes (St-Pierre and 
Tremblay 2012; D'Souza A et al. 2014). Leptin deficiency, furthermore, is associated 
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with infertility due to abnormal synthesis of gonadotropins and hormones related to 
gonadal development (Elias and Purohit 2013). Additionally, leptin deficient animals 
experience increased glucocorticoids levels, contributing to disrupted linear growth 
(reviewed in (Park and Ahima 2015)), and also differences in regulating body 
temperature compared to wild type animals (Fischer et al. 2016). These conditions are 
reversed with administration of exogenous leptin if given during the neonatal period. 
However, obesity in individuals that are not leptin deficient is associated with high 
circulating leptin levels indicating a malfunction at central levels of leptin signaling, 
known as leptin resistance.  
 
Two possible sites at which leptin resistance occurs are the BBB and the leptin 
intracellular signaling pathway. In order to reach the Lepr b receptor in the 
hypothalamus, peripheral leptin needs to pass through the BBB via a saturable 
transporter (Lopez 2016). In obesity, this transporter becomes saturated due to 
continuously high circulating leptin levels, resulting in a reduced capacity to respond 
to further increases in leptin, and thus leptin resistance (Crujeiras et al. 2015). In the 
early stages of obesity, leptin resistance is observed at the level of the BBB as well as 
in the ARC (Munzberg, Flier, and Bjorbaek 2004), whereas in advanced obesity leptin 
resistance occurs in the BBB, ARC as well as in other hypothalamic and extra-
hypothalamic regions such as ventral tegmental area (VTA) (Matheny et al. 2011). 
Obesity-induced leptin resistance at the BBB level can also be mediated by high 
levels of triglycerides. Triglycerides cross the BBB and induce central leptin 
resistance by blocking the ability of leptin to stimulate its receptors in the 
hypothalamus (Banks et al. 2017). Tanycytes, specialized glial cells at the median 
eminence, have an important role in regulating leptin transport through the BBB by 
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activating the extracellular signal-regulated kinase (ERK) pathway. In healthy 
subjects these cells successfully transport leptin towards the mediobasal 
hypothalamus (MBH), where it applies its anorexigenic effects. In diet-induced 
obesity these cells retain leptin, disrupting its entry to and action in the MBH (Balland 
et al. 2014; Gao, Tschop, and Luquet 2014). Megalin, a low-density lipoprotein 
receptor-related protein-2, is also thought to play an important role in leptin transport 
through the BBB. Animals that lack megalin in brain endothelial cells, experience 
hyperleptinemia, increased adiposity and decreased hypothalamic leptin signaling 
(Bartolome et al. 2017). The second contributor to leptin resistance may be a failure 
of leptin signaling pathways in specific neurons. The disruption of JAK-STAT3 
signaling has been shown to be a contributor to leptin resistance. In obesity, leptin has 
an impaired ability to induce STAT3 phosphorylation (reviewed in (Ladyman and 
Grattan 2013)). Leptin signaling is negatively regulated by suppressor of cytokine 
signaling 3 (SOCS3) and protein tyrosine phosphatase 1B (PTP1B), which are both 
increased during obesity. Leptin signaling is positively regulated by Src Homology 2 
adaptor protein 1 (SH2B1) and genetic deletion of this protein induces severe leptin 
resistance (Ren et al. 2005). 
 
Leptin in neurodevelopment  
Recent literature has brought to light an additional role of this hormone, one that 
occurs during neonatal neuronal development. At this time leptin regulates the growth 
of neuronal connectivity within specific regions of the hypothalamus related to 
feeding and metabolism (Bouret, Draper, and Simerly 2004b). At birth, a rodent’s 
hypothalamic connectivity is functionally immature. As mentioned above, the ARC 
signals feeding information via the DMH, LH, and PVN, and the pathways by which 
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these brain regions communicate do not become fully developed until after the second 
week of life; more specifically between day 12 and 14 in mice (Bouret, Draper, and 
Simerly 2004a) and between day 12 and 17 in rats (Bouret and Simerly 2006; Bouret 
2010); Figure 1.2). During the early neonatal period animals maximize caloric intake 
to ensure growth and survival. At this time, there is a marked increase in circulating 
leptin, originally described as a leptin surge, which occurs from P7 to P14 peaking at 
P10 in mice and P4 to P14 with again a peak at P10, in rats (Ahima, Prabakaran, and 
Flier 1998; Delahaye et al. 2008). During this period, the ARC does not transmit 
leptin signals to the other parts of the hypothalamus. Consistent with this finding, 
administration of leptin during neonatal life does not decrease food intake or body 
weight until after weaning (separation from the dam on postnatal day 21) (Bouret 
2013). Instead, this leptin surge acts on the brain to trigger the maturation of satiety 
communication pathways.  
 
Leptin’s importance in the development of neuronal projections has been studied in 
the leptin-deficient mice (ob/ ob), showing that leptin deficiency causes a significant 
delay in formation of projections from the ARC, especially towards the PVN (Bouret 
and Simerly 2004), with both orexigenic NPY/AgRP and anorexigenic POMC/CART 
projections being affected by leptin deficiency ((Proulx, Richard, and Walker 2002; 
Mistry, Swick, and Romsos 1999); Figure 1.2)). Moreover, leptin treatment in adult 
leptin-deficient mice is ineffective in reversing innervation deficiency, whereas 
supplementation during the neonatal period fully restores the density of ARC 
projections (reviewed in (Bouret et al. 2008)). These results suggest that leptin is a 
very important neurotrophic factor in controlling initiation and maturation of neuronal 
circuitry. 
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Figure 1.2 The main hypothalamic nuclei involved in feeding regulation and 
programming of hypothalamic feeding circuits.  
Neuropeptide Y (NPY), agouti related peptide (AgRP) and proopiomelanocortin 
(POMC) neurofibres projecting from arcuate nucleus of the hypothalamus (ARC) 
towards other hypothalamic nuclei including dorsomedial hypothalamus (DMH), 
ventromedial hypothalamus (VMH) paraventricular nucleus of the hypothalamus 
(PVN) and lateral hypothalamus (LH) and timing in postnatal days (P) of detection of 
these projections (Modified from (Bouret and Simerly 2006))  
 
In the absence of the leptin surge at the crucial time, these signaling pathways do not 
properly develop and the animal is permanently impaired in its ability to regulate 
body weight and adiposity (Bouret and Simerly 2007). Alterations to maternal diet 
during pregnancy or lactation can affect the magnitude and onset of this leptin surge, 
leading to long-term alterations in body weight regulation in the animal (Proulx, 
Richard, and Walker 2002). The mother’s milk is an important source of leptin for 
postnatal rodents. Pups suckled in small litters have greater access to mother’s milk 
and greater than normal amounts of leptin (reviewed in (Spencer 2013)). This early 
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access to excessive amounts of leptin may trigger the leptin surge prematurely, 
leading to permanent differences in how these pathways communicate (Bouret and 
Simerly 2004). In this thesis it is tested whether neonatal overfeeding affects the 
establishment and long-term maintenance of this connectivity by assessing 
hypothalamic NPY, AgRP and POMC fibre density and its functional outputs during 
development.  
 
The role of ghrelin in metabolism 
Ghrelin is a peptide hormone consisting of 28 amino acids and in adults is principally 
synthesised in P/D1-type cells in humans (Rindi et al. 2002) or X/A-like cells in 
rodents in the fundus of the stomach, which account for approximately 20-30% of the 
endocrine cell population of the oxyntic glands (Kojima et al. 1999; Date et al. 2000). 
In adults, ghrelin is also expressed in small amounts in duodenum, jejunum, ileum, 
colon, lung, heart, pancreas, kidney, testis, ovary and pituitary (Ghelardoni et al. 
2006). There are also reports of ghrelin being expressed in the hypothalamus but such 
findings are inconsistent and whether it is produced there in meaningful amounts is 
still not clear (Furness et al. 2011; Abizaid and Horvath 2012)). Ghrelin mediates 
growth hormone (GH) secretion from the pituitary but regulation of GH secretion is 
not dependent on ghrelin’s orexigenic role in the hypothalamus. 
 
The ghrelin gene is located on the short arm of chromosome 3 at position 25-26 and is 
a 7.2kb region consisting of six exons, four (exons 1-4) of which code for the 117 
amino acid peptide preproghrelin, which produces two mature peptides. Within this 
precursor peptide, part of exon 1 encodes for the preproghrelin signaling peptide; the 
remainder of exon-1, along with part of exon-2, codes for the 28 amino-acid-peptide 
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ghrelin; and the reminder of exon 2, with 3 and 4, codes for the C-terminal peptide C-
ghrelin, which contains the sequence for the 23 amino-acid peptide obestatin (Seim et 
al. 2007). In the stomach, ghrelin, derived from preproghrelin, is modified by 
acylation with octanoate (an eight-carbon fatty acid) (Kojima et al. 1999). This 
esterification process is mediated by an acyl-transferase named ghrelin O-
acyltransferase (GOAT), which is part of the membrane-bound O-acyltransferase 
(MBOAT) family (Gutierrez et al. 2008; Yang et al. 2008). The acylated form of 
ghrelin (acyl-ghrelin (AG)), acting via its receptor growth hormone secretagogue 
receptor (GHSR1a), was traditionally thought of as the active form with its effects on 
GH release and energy balance.  
 
Other data suggest that the non-octanoylated form (des-acyl ghrelin (DAG)) has its 
own roles, despite the fact that the receptor(s) through which DAG produces 
biological effects remain unknown. DAG induces short-term food intake when 
centrally administered, but, contrary to AG, it does not activate GHSR1a or NPY, so 
such effects may be orexin mediated (Toshinai et al. 2006). Other studies, however, 
have shown an ability of DAG to reduce food intake and stomach motility under 
fasting conditions (Chen et al. 2005). Human studies have pointed to a role for DAG 
in improving insulin sensitivity. Individuals undergoing an intensive long-term 
exercise intervention have increased levels of DAG and decreased fasting insulin 
(Cederberg et al. 2012). Also, insulin levels are negatively associated with plasma 
DAG levels in individuals with metabolic syndrome (Barazzoni et al. 2007). 
Furthermore, DAG exhibits cardio-protective effects (Li et al. 2006; Baldanzi et al. 
2002), it has vasodilator properties (Ku et al. 2015), and it has recently been shown to 
be involved in activation of the hypothalamic-pituitary-adrenal (HPA) axis responses 
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to stress (Stark et al. 2016b). Therefore, ghrelin exists in circulation in two active 
forms, AG and DAG.  
 
The pathways through which circulating gastric ghrelin signals the hypothalamus, are 
not clearly understood. It is suggested that ghrelin transmits orexigenic signals from 
the stomach to the brain through a vagal pathway. The majority of afferent nerve 
fibres comprising the vagus nerve are connections to the nucleus tractus solitarius 
(NTS), which is one of the main brain regions where feeding related signals from 
gastro-enteric system are integrated (Emond, Schwartz, and Moran 2001). Peripheral 
ghrelin signaling that travels to the NTS via the vagus nerve activates the 
noradrenergic ARC receptors and consequently induces feeding (Date et al. 2006). 
Blockage of vagal afferent pathways or vagotomy (severance of the vagus nerve) 
leads to an insensitivity to the orexigenic effects of ghrelin and suppression of 
ghrelin-induced feeding, including in humans (le Roux et al. 2005). Pharmacokinetic 
studies in mice have shown that ghrelin crosses the BBB by saturable transport. 
Human acyl-ghrelin can cross the BBB, although mouse acyl-ghrelin has a decreased 
ability to do so. This ability is altered by factors such as obesity, serum triglyceride 
levels and fasting (Banks et al. 2002).  
 
Reaching the brain from the periphery, ghrelin activates hypothalamic NPY/AgRP 
neurons, which highly express GHSR1a, to stimulate release of NPY and AgRP, 
leading to an increase in food intake (Kamegai et al. 2001). One of the mechanism by 
which ghrelin activates NPY and AgRP neurons is by increasing intracellular calcium 
via pathways depending on phospholipase C and adenylate cyclase-protein kinase-A 
(Kohno et al. 2007; Coiro et al. 2006). Both routes of ghrelin administration, 
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intracerebroventricular (ICV) or peripheral, induce feeding via activation of NPY and 
AgRP neurons. Administration of ghrelin ICV in mice activates the main 
hypothalamic appetite centres including ARC, PVN, DMH and LH (Lawrence et al. 
2002) and ghrelin-induced feeding is completely abolished in mice lacking both NPY 
and AgRP (Jensen-Seaman et al. 2004). Peripherally injected ghrelin would still exert 
its orexigenic effects by activating hypothalamic NPY and AgRP neurons, however to 
do this it requires intact ARC (Cabral et al. 2014). NPY and AgRP fibres arising from 
the ARC further innervate other hypothalamic appetite centres to convey food related 
signals (Cowley et al. 2003).  
  
Ghrelin is one of the only peripherally produced feeding signals that stimulates food 
intake. Ghrelin levels are high in times of fasting and this is associated with increased 
hunger, with levels decreasing following absorption of nutrients. An increase in 
plasma ghrelin indicates negative energy balance and consequently stimulates feeding 
and low energy expenditure (Cummings et al. 2001). Ghrelin levels are inversely 
correlated with body mass index BMI. As such, human and animal studies have 
shown that ghrelin levels are decreased in the obese compared to normal body weight 
controls (Haqq et al. 2003; Wadden et al. 2012; Uchida et al. 2014).  
 
Obesity is usually associated with ghrelin resistance, which is explained by a reduced 
NPY/AgRP responsiveness to circulating ghrelin in order to reduce further food 
intake (Briggs et al. 2010), however why this occurs is unclear. It is hypothesised that 
ghrelin resistance is the body’s mechanism of ensuring sufficient energy reserves 
during times of food scarcity (Zigman, Bouret, and Andrews 2016). In support of this 
hypothesis, ghrelin knockout mice have reduced body weight regain after a calorie-
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restricted diet (Briggs et al. 2013). Contrary to its orexigenic effects, circulating 
ghrelin levels after a meal do not decrease in obese humans (English et al. 2002; 
Tschop et al. 2001). Furthermore, obesity in mice is associated with impairments in 
ghrelin transport through the BBB and reduced hypothalamic sensitivity to ghrelin, 
consequently leading to central ghrelin resistance (Banks, Burney, and Robinson 
2008; Briggs et al. 2010). In addition, weight loss is associated with an increase in 
plasma ghrelin levels, with consequent further stimulation of hunger, making it 
difficult to maintain a calorie-restricted diet (Cummings et al. 2002).  
 
Ghrelin in early life neurodevelopment in rodents  
In the rat embryo, ghrelin is expressed as early as the morula stage and continues to 
be expressed in the fetus (Nakahara et al. 2006; Kawamura et al. 2003). In human and 
rodent fetuses, pancreas is the main source of ghrelin, with low levels of ghrelin 
detected in the fetal stomach (Wierup et al. 2002; Chanoine and Wong 2004). 
However, stomach ghrelin increases to reach adult levels by 3-5 weeks after birth 
(Hayashida et al. 2002; Torsello et al. 2003) and pancreatic ghrelin levels decrease 
from birth to weaning becoming almost undetectable in adulthood (Wierup et al. 
2002).  
 
Ghrelin may play a role in development as early as the embryonic stage. It stimulates 
blastocyst development and its receptor, GHSR1a, is also detected in mouse embryos 
as early as the morula stage. In addition, ghrelin is expressed in the uterus and is 
secreted in uterine fluid at levels that are affected by maternal nutrition. As such, 
increased fasting ghrelin levels in the mother are reflected in increased ghrelin levels 
in the fetus (Kawamura et al. 2003). Postnatally, exogenous ghrelin does not 
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significantly promote milk intake nor body weight in the first 2-3 weeks in rats and 
mice (Piao et al. 2008). A possible explanation for this lack of response is that the 
neonatal brain is relatively insensitive to ghrelin and this lack of effect may represent 
ghrelin resistance. However, GHSR1a is found in the nuclei of neurons known to 
regulate feeding, including the ARC, and acute peripheral ghrelin treatment activates 
ARC neurons during early postnatal life (Steculorum et al. 2015). Further supporting 
a functional role of ghrelin in the postnatal rodent ARC, the mRNA levels of POMC 
and NPY mRNA in the ARC are decreased and increased, respectively, following 
acute ghrelin injection to mouse pups at P10 (Steculorum and Bouret 2011). Given 
that ghrelin receptors are present and functional in the developing hypothalamus, 
these results support the hypothesis that ghrelin in early life has different function 
from that in adulthood. A number of in vitro studies have shown that the exposure of 
cultured hypothalamic cells to ghrelin markedly increases cell proliferation and these 
effects are greater when the cells are taken from E17 embryos instead of P2 pups 
(Inoue et al. 2010). Both the AG and DAG forms of ghrelin promote cell proliferation 
and neurogenesis, with AG exerting greater proliferative effects than DAG (Sato et al. 
2006).  
 
As suggested by Steculorum and colleagues, ghrelin may also act as a brake to leptin-
induced axonal growth in the postnatal period, in order to stop the overgrowth and 
maintain optimal functioning of hypothalamic circuitry in appetite regulation 
(Steculorum et al. 2015). Thus, leptin initiates axonal growth during the leptin surge, 
and ghrelin terminates the development of ARC projections (Steculorum et al. 2015). 
Based on the above results, it is suggested that an exacerbated leptin surge and 
disruption of ghrelin’s normal elevation during postnatal life can lead to long-term 
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metabolic problems. Despite a large number of studies in this area, there are 
considerable gaps in our knowledge in how the nutritional environment during 
development affects long-term metabolism and what are the specific roles of leptin 
and ghrelin during development. Further studies are also needed to investigate the 
developmental effects of neonatal ghrelin and leptin in extra-hypothalamic brain 
regions such as the pituitary gland. Since ghrelin and leptin receptors are expressed in 
these regions it remains possible that these hormones are involved in cognitive or 
HPA axis functions and behavioral regulation (Llorente et al. 2009). Such suggestions 
need to be verified and the site(s) of action for the developmental effects of ghrelin 
and leptin need to be further investigated.  
 
The role of ghrelin in reproduction, regulation of HPA axis and inflammation  
Ghrelin has recently been shown to have an important role in reproduction (reviewed 
in (Sominsky, Hodgson, et al. 2017)). As a metabolic hormone, ghrelin directly or 
indirectly affects the hypothalamic-pituitary-gonadal (HPG) axis by acting as an 
inhibitory agent (Lebrethon et al. 2007). It informs the hypothalamus when there is 
insufficient energy and consequently disrupts or delays fertility (Martini et al. 2006). 
The hypothalamus is responsible for the release of gonadotropin releasing hormone 
(GnRH) from GnRH neurons located at the anterior hypothalamic area, from where 
they project to the median eminence and stimulate the pituitary gland to release 
luteinizing hormone and follicle stimulating hormone (FSH). The pituitary hormones 
then further regulate gonadal steroidogenesis. Absence or inappropriate release of 
these hormones at any level of the HPG axis is associated with fertility issues 
(reviewed in (Acevedo-Rodriguez et al. 2018)). Both male and female rats, have 
shown a disruption of HPG axis functioning in the presence of high levels of ghrelin 
  24 
(Dupont et al. 2010). Excess ghrelin suppresses luteinizing hormone pulse frequency 
and testosterone secretion (Wang et al. 2011), in both men and women (Lanfranco et 
al. 2008; Kluge et al. 2012) preventing reproduction until sufficient energy is 
available. This suppressive effect of ghrelin on luteinizing hormone pulsatility is 
associated with increased circulating cortisol levels (Vulliemoz et al. 2004), indicative 
of ghrelin’s interactive role between both HPG and HPA axes (Sominsky, Hodgson, 
et al. 2017). 
 
Recent research, including from our group, has indeed shown that ghrelin along with 
its role in regulating metabolism and reproduction has an important role in the HPA 
axis regulation in response to stress. During acute physical or psychological stress, 
cells in the PVN secrete corticotropin-releasing hormone (CRH), which acts on the 
anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) release. Increased 
circulating ACTH levels stimulate the adrenal cortex to synthesise and secrete 
glucocorticoids, which then initiate a series of events to aid the organism to cope with 
the stress (Nicolaides et al. 2015). Ghrelin activates the HPA axis at all levels. At the 
hypothalamus ghrelin activates CRH neurons in the PVN and increases circulating 
glucocorticoid levels without affecting GHSR1a on these neurons, suggestive of 
ghrelin’s indirect effect on the apex of the HPA axis (Cabral et al. 2012; Spencer et al. 
2012). Our group has shown that ghrelin stimulates the HPA axis at the level of the 
pituitary by targeting the GHSR1a to facilitate ACTH release (Spencer et al. 2012). 
Ghrelin can also directly activate pituitary ACTH cells (Stevanovic et al. 2007). In 
humans, ghrelin administration increases ACTH and cortisol release from the adrenal 
gland (Arvat et al. 2001; Takaya et al. 2000; Locatelli et al. 2010). Similarly, ghrelin 
also stimulates increases in circulating ACTH and corticosterone in rodents (Spencer 
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et al. 2012). Under normal conditions the absence of ghrelin (i.e. in ghrelin knockout 
animals) has no effect on adrenal responses to exogenous ACTH and normal PVN 
responses to dexamethasone (agent that mimics glucocorticoid release). However, in 
response to acute stress these animals have exacerbated PVN neuronal activation and 
reduced glucocorticoid secretion from adrenals compared to wild types (Spencer et al. 
2012). Despite some limited knowledge of the role ghrelin plays in the regulation of 
stress responsivity, it remains unknown how nutritional environment during neonatal 
period affects ghrelin’s ability to regulate the HPA axis and whether this is different 
between males and females. 
 
It is important to note that the role of ghrelin as an anti-inflammatory agent has 
recently received great interest. A number of studies have pointed out a potential role 
for ghrelin in pro-inflammatory disease states in humans and animal models including 
sepsis (Maruna et al. 2005), pancreatitis (Kerem et al. 2007), Crohn’s disease (a form 
of inflammatory bowel disease) (Ghomraoui et al. 2017), colitis (Tiaka et al. 2011) 
and rheumatoid arthritis (Koca et al. 2008). The presence of the ghrelin receptor on 
peripheral blood mononuclear cells (PBMC) such as in human lymphocytes (T- and 
B-cells) (Gnanapavan et al. 2002; Dixit et al. 2004) and human and rodent immune 
organs such as thymus and bone marrow (Hattori 2009; Taub, Murphy, and Longo 
2010) suggests that ghrelin may at least partly activate these cells and organs. Indeed, 
Dixit and colleagues have shown that ghrelin suppresses expression of 
proinflammatory cytokines such as interleukin 1 beta (IL-1β), IL-6 and tumor 
necrosis factor alpha (TNF) by human T-lymphocytes and monocytes (Dixit et al. 
2004). The anti-inflammatory role of ghrelin has also been observed in a mouse 
model of colitis where ghrelin administration significantly suppressed a number of 
  26 
inflammatory cytokines including: TNF and several pro-inflammatory interleukins.  
Also, increased anti-inflammatory IL-10 levels in colonic mucosa were associated 
with significant improvement in survival rate (Gonzalez-Rey, Chorny, and Delgado 
2006). One of the suggested mechanisms by which ghrelin exerts its anti-
inflammatory effects is via the vagus nerve, as is seen in animal models of traumatic 
brain injury, where ghrelin administration suppresses circulating TNF and IL-6 
(Bansal et al. 2012). Other suggested mechanisms are via inhibition of high-mobility 
group box 1 (HMGB1) secretion from macrophages. HMGB1 is an important protein 
involved in a number of inflammatory conditions including sepsis. Ghrelin 
significantly inhibits secretion of this protein from macrophages by blocking its 
cytoplasmic translocation (Chorny et al. 2008).  The mechanisms via which ghrelin 
achieves these anti-inflammatory effects however, remain to be further elucidated.  
 
Sex differences in developmental programming of metabolism and stress 
Males and females respond differently to metabolic and stressful situations, making 
sex differences an important, and often under-investigated area of study. For instance, 
fat distribution in women is mainly located in the gluteal and femoral region, whereas 
in men the highest proportion of body fat is accumulated in the abdominal area 
(Karastergiou et al. 2012; Fuente-Martin et al. 2013). A number of studies have 
shown that there is a high correlation between obesity and mood disorders (Doyle et 
al. 2007; Scott et al. 2008) and obese women are more likely to develop emotional 
disorders than obese men (Barry and Petry 2008). We have previously seen that 
neonatal overfeeding in females, alongside an obesigenic phenotype, is associated 
with unique changes in female HPA axis. Females, but not males, have exacerbated 
PVN responses to psychological stress accompanied by increased open arm 
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exploration in the elevated plus maze (Spencer and Tilbrook 2009), potentially related 
to an impaired ability of the female pituitary gland to respond to ghrelin. These 
disorders are not only affected by overfeeding, but also by underfeeding in rodents, 
which also differentially affects males and females (Fuente-Martin et al. 2012; Mela 
et al. 2012; Granado et al. 2014).  
 
Important contributors to stress responses and related disorders include the metabolic 
hormones leptin and ghrelin. As previously mentioned, the leptin surge that initiates 
at approximately P4 and P7 in mice and rats is crucial not only for optimal 
neurodevelopmental function, but also for optimal development of the endocrine 
system (Ahima, Prabakaran, and Flier 1998). The absence or disruption of the leptin 
surge is related to long-term altered HPA axis activity. For instance, rats overfed 
during early life develop hyperleptinemia and show an accelerated maturation of the 
HPA axis compared to normally fed counterparts (Boullu-Ciocca et al. 2005). When 
challenged with physical or psychological stress, these neonatally overfed animals 
display exacerbated HPA axis responses to the challenge (reviewed in (Spencer 
2013)). Other studies have demonstrated that chronic leptin treatment in early life is 
followed by suppressed CRH and increased glucocorticoid receptor expression from 
the PVN (Oates, Woodside, and Walker 2000; Proulx et al. 2001). Very little is 
known about the relationship between stress and metabolic hormones leptin and 
ghrelin during development with regard to sex and nutritional status. However, both 
stress and obesity induce sex-dependent susceptibilities to metabolic disorders 
(Murphy and Loria 2017). In girls and women circulating ghrelin levels differ from 
those in boys and men, such that females have higher total and acyl-ghrelin in 
comparison to males (Hagobian and Braun 2010; Espelund et al. 2005; Ostergard et 
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al. 2003; Soriano-Guillen et al. 2016). Initially, Lutter and colleagues (Lutter et al. 
2008) and later Meyer and Harmatz (Meyer et al. 2014; Harmatz et al. 2017) showed 
that exposure to chronic stress increases circulating ghrelin levels. On the other hand, 
alterations in ghrelin levels can affect behaviour and mood, with recent studies 
showing an anxiolytic and anxiogenic role of ghrelin in regulating anxiety-related 
behaviours in response to acute stress (Spencer et al. 2015; Spencer et al. 2012). 
Ghrelin thus promotes anxiety at low concentrations and suppresses anxiety and stress 
at higher concentrations (Spencer et al. 2012). It is proposed that increased levels of 
ghrelin during stress may be required to prevent excess anxiety and therefore to 
facilitate food-seeking. However, the mechanism by which ghrelin modulates anxiety-
related behaviours in males and females is not fully studied. Despite the clear sex 
differences in many parameters, the majority of current research uses males, mainly to 
avoid the possible influences of the female hormonal cycle. However, it is critical to 
consider both sexes in order to better understand the effects of sex-dependent 
metabolic and stress-related disorders.  
 
In the current work I will address four major aims to assess the roles of leptin and 
ghrelin in developmental programming of obesity and in adult stress and 
inflammation.  
 
Aim 1: To determine the impact of early life overfeeding on the hypothalamic 
circuitry and the long-term role of leptin in hypothalamic programing in male Wistar 
rats.  
To test this aim I will examine the metabolic effects of neonatal overfeeding on body 
weight and circulating leptin. I will also examine central effects of neonatal 
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overfeeding on hypothalamic responsiveness to exogenous leptin and leptin-mediated 
NPY/AgRP and POMC neurons and whether these effects could be normalised by 
neonatal leptin antagonism. It has been previously shown that neonatal overfeeding 
amongst other effects is associated with altered levels of circulating leptin. This, and 
leptin’s neurotrophic effects during neurodevelopment, led us to hypothesise that 
altered leptin levels would be associated with long-term disrupted connectivity within 
hypothalamic regions responsible in controlling metabolism. 
This chapter has been published in the Journal of Endocrinology in 2017, entitled 
“Hypothalamic effects of neonatal diet: reversible and only partially leptin 
dependent”. (Sominsky, Ziko, et al. 2017) 
 
Aim 2:  To examine the effects of neonatal overfeeding on the ghrelin system, 
including acyl and des-acyl ghrelin accessibility to the hypothalamus in male Wistar 
rats. 
To test this aim I will examine whether low circulating ghrelin levels in the neonatally 
overfed rats affected the hypothalamic responsiveness to exogenous ghrelin and 
hypothalamic responsiveness to fluorescently labeled acyl and des-acyl ghrelin. It has 
been previously shown that neonatal overfeeding is associated with altered ghrelin 
levels, however it is not clear whether this alterations are associated with long-term 
disruptions on the central or peripheral ghrelin system. 
This chapter has been published in Neuropharmacology in 2016, entitled “Early life 
disruption to the ghrelin system with over-eating is resolved in adulthood in male 
rats”(Sominsky, Ziko, Nguyen, et al. 2016). (Co-authors Sominsky L. and Ziko I. 
have equally contributed to this publication). 
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Aim 3: To define the role of early life overfeeding on the peripheral and central leptin 
systems in female Wistar rats.  
As the previous studies had shown that neonatal overfeeding in males, along with an 
obesigenic phenotype, were associated with a disruption of hypothalamic orexigenic 
NPY/AgRP circuitry. We hypothesised in this aim that the same outcomes would 
occur in females. 
This chapter has been published in Frontiers in Endocrinology 2017, entitled 
“Hyperleptinemia in neonatally overfed female rats does not dysregulate feeding 
circuitry” (Ziko et al. 2017). 
 
Aim 4:  To examine the effects of neonatal overfeeding on the ghrelin system in 
female Wistar rats long-term.   
Previous studies have demonstrated that ghrelin affects the activity of the HPA axis at 
the pituitary level via activation of its receptor. I hypothesised that neonatal 
overfeeding in females would compromise the pituitary ghrelin system, further 
affecting HPA axis responses to stress.  
This chapter has been published in PLOS One 2017, entitled “Neonatal overfeeding 
disrupts pituitary ghrelin signaling in female rats long-term; implications for the 
stress response” (Sominsky, Ziko, and Spencer 2017). 
 
Aim 5: To examine the contribution of different forms of ghrelin on the anti-
inflammatory responses to an immune challenge. I hypothesised that ghrelin’s anti-
inflammatory activity is mediated via the HPA axis, and acylated and des-acylated 
ghrelin would differently contribute to cytokine suppression in response to an immune 
challenge.  
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This chapter has been published in Brain, Behaviour, and Immunity 2018 entitled 
“Acylated ghrelin suppresses the cytokine response to lipopolysaccharide and does so 
independently of the hypothalamic-pituitary-adrenal axis” (Ziko et al. 2018). 
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Introduction 
The early life nutritional environment affects long-term regulation of body weight 
with both under- and over-nutrition leading to metabolic problems. An unintended 
experiment in humans arose from the Dutch famine, which occurred in the winter of 
1944-45. This tragedy has shown us that the fetus in the mother’s uterus can adapt 
and survive after a minimal and poor nutritional diet, however the challenge imposed 
by the poor nutrition perinatally exposes the offspring to metabolic problems, 
including the inability to control their eating, a preference for high calorie foods, as 
well as a reduction in physical activity later in life (Roseboom, de Rooij, and Painter 
2006; Ravelli, Stein, and Susser 1976). Reflecting these data, the “thrifty gene 
hypothesis” was proposed as early as 1962 by James V Neel, according to which, 
genes that predispose to obesity have a selective advantage in populations that have 
continuously experienced starvation (Neel 1962). 
 
Overnutrition during important developmental periods has also been associated with 
metabolic mal-programming and offspring predisposition to chronic conditions in 
adulthood, such as type two diabetes and increased susceptibility to obesity (reviewed 
in (Carolan-Olah, Duarte-Gardea, and Lechuga 2015; Tarry-Adkins and Ozanne 
2017)). Prenatal under-nutrition followed by postnatal overnutrition in animal models 
is highly associated with obesity and leptin resistance as a result of catch-up growth 
(Dellschaft et al. 2015; Vickers and Sloboda 2012; Sebert et al. 2009). The 
combination can result in significant alterations in neuropeptide Y (NPY), agouti 
related peptide (AgRP) and proopiomelanocortin (POMC) within the hypothalamus 
(Ikenasio-Thorpe et al. 2007).  
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Environmental factors can thus influence the way our metabolism responds to 
nutritional challenges especially when insults happen during important developmental 
periods. As early as 1979 Dobbing and Sands found that major brain growth spurts 
happen at around birth in humans and around postnatal day (P)7 in rats, based on the 
increasing weight of the brain (Dobbing and Sands 1979). This important 
developmental period has been extensively studied ever since. In 1998, Ahima and 
colleagues found that circulating leptin levels are highly increased around P7-P10 in 
mice irrespective of food intake or fat mass, reinforcing the idea that leptin may have 
a developmental role (Ahima, Prabakaran, and Flier 1998). Bouret and Simerly 
thereafter found that this leptin surge coincided with the maturation of neuronal 
projections innervating the hypothalamus and established the particular importance of 
leptin as a trophic factor in formation of these projections (Bouret, Draper, and 
Simerly 2004b).  
 
As previously mentioned in the main introduction of this thesis (Section 1.3: The role 
of leptin in metabolism), leptin in adult males centrally regulates metabolism by 
activation of anorexigenic neurons and inactivation of orexigenic neurons in the 
arcuate nucleus of the hypothalamus (ARC). The leptin surge in neonates, however, 
initiates neuronal maturation, and disruption or exacerbation of this leptin surge (as 
shown with the neonatal overfeeding animal model (Stefanidis and Spencer 2012)) 
may lead to permanent disruption of connections and long-term obesity (Bouret, 
Draper, and Simerly 2004a, 2004b). We observed in our animal model of childhood 
obesity that the hyperleptinemia and body weight increase with neonatal overfeeding 
are maintained throughout the animal’s life (Stefanidis and Spencer 2012). Davidowa 
and colleagues have shown that this hyperleptinemia is associated with reduced ARC 
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responsiveness to leptin, indicative of leptin resistance (Davidowa and Plagemann 
2000). Results from the same group have also shown that neonatal overfeeding 
induces POMC hypermethylation within the hypothalamus (Plagemann et al. 2009). 
A limited number of studies have observed that neonatal overfeeding induces an 
increase in NPY and AgRP gene expression (Lopez et al. 2005) and also suppresses 
NPY responsiveness to ghrelin (Collden et al. 2015). However, it still remains 
unknown how the neonatal over-nutritional environment affects the NPY/AgRP 
wiring and POMC expression in the hypothalamus in the short or long-term, and these 
factors are examined here. We also inspected the early life overnutrition effects on 
hypothalamic responsiveness to leptin and the ability of a leptin antagonist to re-
establish hypothalamic circuitry under neonatal overfeeding conditions.  
 
Materials and methods  
2.1.1 Animals  
All our timed pregnant Wistar rats were obtained from the Animal Resources Centre, 
WA, Australia. The rats were delivered to our facility between E14 and E16. On 
arrival at the RMIT University Animal Facility, they were housed at 22°C on a 12 hr 
light/darkness cycle (07:00–19:00 hr) and provided with standard pelleted rat chow 
and water ad libitum. All procedures were conducted in accordance with the National 
Health and Medical Research Council Australia Code of Practice for the Care of 
Experimental Animals and RMIT University Animal Ethics Committee approval.  
 
2.1.2 Litter size manipulation 
On the day of birth (P0) pups were removed from their dams and numbers were 
recorded. After sex identification, pups were reallocated to litters of 4 (2 males and 2 
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females) called small litter (SL), representing the neonatally overfed model. Sex was 
determined by a larger genital papilla and longer anogenital distance in male pups 
than in female pups. The control litter (CL) consisted of 12 pups (6 males and 6 
females). Care was taken that none of the dams obtained their own pups and the 
procedure was conducted quickly (within 5-10 min) so that pups maintained their 
body temperature. Excess pups were culled or utilized for other research projects. Our 
group has previously shown that this litter size manipulation results in SL pups being 
significantly heavier as early as P7 and they remain heavier throughout their lives 
(Spencer & Tilbrook, 2009; Ziko et al., 2014). Following pup reallocation, the litters 
were weighed as whole litters on P0 (all litters) and P7 (litters culled on P14) and 
individually on the day of the experiment. The pups were otherwise left undisturbed 
with mothers, except for the usual animal husbandry, until experimentation. Only 
male animals were examined in this chapter. All experimental groups were derived 
from three or more litters, using a maximum of two pups from the same litter for an 
experimental treatment to control for maternal effects (Spencer and Meyer 2017).  
 
 
2.1.3 Brain collection  
Neonatally overfed and control animals on P7, P14 and ~P70 were deeply 
anaesthetised with Lethabarb (150 mg/kg sodium pentobarbitone, i.p.) then 
decapitated. Another cohort of animals at P12 and ~P70 were deeply anaesthetised 
with Lethabarb then perfused transcardially with phosphate buffered saline (PBS; 
4°C, pH 7.4) followed by 4% PFA in PBS (4°C, pH 7.4). All brains were removed 
and placed in 4% paraformaldehyde (PFA) in (PBS) for 24 hr then into 20% sucrose 
in PBS at 4°C. Brains were sectioned at 30 μm (adults) or 40 μm (neonates) and 
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stored at 4°C in PBS containing 0.02% sodium azide until further processed for 
immunohistochemistry. 
2.1.4 Immunohistochemistry  
Hypothalamic sections were immunolabelled for a variety of markers as summarised 
in Table 2.1. Samples from different treatment groups were randomly selected and 
processed in batches. To block endogenous peroxidases phospho signal transducer 
and activator of transcription 3 (pSTAT3) sections were incubated with hydrogen 
peroxide (H2O2) in PBS for 15 min. After the primary and secondary antibody 
incubation as detailed in Table 2.1., pSTAT3 sections were then incubated with 
avidin-biotin horseradish peroxidase (HRP) complex (ABC; 45 min; Vector Elite Kit; 
Vector), followed by incubation with diaminobenzidine (DAB), intensified with 1% 
cobalt chloride and 1% nickel sulphate for 10 min. Then 0.05% H2O2 was added to 
the DAB solution to visualise HRP activity. The reaction was stopped when the 
contrast between specific labelling and background was optimal. The sections were 
then mounted on gel-coated slides, dried, dehydrated in a series of increasing 
concentrations of alcohols then cleared in histolene and coverslipped. After blocking 
non-specific protein binding with 3% bovine serum albumin (BSA) in 0.1 M PBS 
with Triton X-100, sections were incubated with NPY, AgRP and POMC primary and 
secondary antibodies as detailed in Table 2.1. Next, sections were counterstained with 
4’,6-diamidino-2-phenylindole (DAPI) for 15 min then mounted on slides with 
DAKO anti-fading solution. Slides were kept in the dark at 4°C until visualised.  
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Table 2.1 Primary and secondary antibodies used in immunohistochemistry 
 
Antigen Primary Antibody Secondary 
Antibody  
Incubation 
Time/Temperature 
Signal transducer 
and activator of 
transcription 3 
(pSTAT3) 
Anti-rabbit 
pSTAT3 (Abcam) 
[1: 5000] 
Biotinylated anti-
rabbit (Vector 
Laboratories, 
Burlingame, CA, 
USA 
[1:500] 
1’ AB: overnight, 4°C 
2’ AB: 1.5 h, Room 
Temperature 
Neuropeptide Y 
(NPY) 
Anti-rabbit NPY 
(Sigma-Aldrich)  
[1:1000] 
Alexa-fluor 488 
goat anti-rabbit 
(Thermo 
Scientific)  
[1:500] 
1’ AB: overnight, 4°C 
2’ AB: 2 h, Room 
Temperature 
Agouti related 
protein (AgRP) 
Anti-goat AgRP 
(Neuromics Inc., 
MN, USA) 
[1:500] 
Alexa-fluor 594 
rabbit anti-goat 
(Thermo 
Scientific)  
[1:200] 
1’ AB: 42 h, Room 
Temperature 
2’ AB: 12 h, Room 
Temperature 
Proopiomelanocortin 
(POMC)  
Anti-rabbit POMC 
(Phoenix 
Pharmaceuticals, 
Burlingame, CA, 
USA) 
[1:5000] 
Alexa-fluor 488 
goat anti-rabbit 
(Thermo 
Scientific)  
[1:500] neonate  
[1:200] adult 
1’ AB: overnight, 4°C 
 
2’ AB: 1h, 
Room 
Temperature 
 
 
An experimenter blinded to treatment groups assessed hypothalamic sections for 
numbers of pSTAT3 positive cells in the ARC and ventromedial hypothalamus 
(VMH). The summed counts of positive cells throughout three sections 120 μm apart 
between 2.76 and 3.48 caudal to bregma were taken according to the Paxinos and 
Watson Rat Brain Atlas (Paxinos and Watson 2009). pSTAT3 immunohistochemistry 
and cell counts were performed by Ms Thai Xinh Nguyen as part of her Honours 
project from sections generated by me and under my supervision. NPY, AgRP and 
  39 
POMC photomicrographs were taken on an upright Nikon Eclipse 90i confocal laser 
microscope using 561 nm lasers (605/75 filter set) for AgRP labeling, 488 nm (513/30 
filter set) for NPY and AgRP and 408 nm laser for DAPI. Images were viewed under 
the 20x magnification lens under Galvano scanner using a 512 x 512 pixels scan size. 
A thresholding method was used with NIS Elements Advanced Research Software in 
order to analyse NPY and AgRP fibre density. After background subtraction, the 
upper and lower threshold limits were defined based on the signal intensity values 
from the control group of animals. NPY and AgRP labelling of the cell bodies was 
only observed in the neonatal ARC and not in the neonatal PVN or adult ARC or 
PVN. The perikaryon labelling of NPY and AgRP was excluded from the neonatal 
ARC analysis as follows. The thresholds for each of the channels were separately 
defined and the program subtracted the DAPI layer from the NPY or AgRP threshold 
layer generating a new layer with the cell bodies excluded. A region of interest 
constant for all the samples was then analysed for fibre density from this layer. 
POMC-positive cells were manually counted using Image J (National Institutes of 
Health) in four brain sections with the summed counts from all brain sections taken as 
our graphed result.  
 
The specificities of the antibodies used in our study have been previously validated by 
manufacturers and other researchers in pre-absorption and Western blotting 
experiments and further supported in our own validation experiments by incubation of 
experimental tissue without a primary or without a secondary antibody. Negligible 
positive labelling was seen in these negative controls. Positive labelling was 
confirmed in the brain regions of interest. More specifically, the NPY antibody 
(N9528) has been validated by the manufacturer and used in (Garcia et al. 2011; 
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Kobelt et al. 2008; Konieczna et al. 2013; Pekala et al. 2011). The AgRP antibody 
(GT15023) has been validated by the manufacturer and used by (Betley et al. 2015; 
Cao et al. 2011; Garfield et al. 2015; Kim et al. 2016; Kobelt et al. 2008; Li et al. 
2012; Shibata et al. 2016). The POMC antibody (H-029-30) specificity has been 
confirmed by (Wittmann, Hrabovszky, and Lechan 2013) and used by (Cheng, Chu, 
and Chow 2011; Evans et al. 2007; Gotoh et al. 2006; Pandit et al. 2016; Reyes et al. 
2006; Singru et al. 2012; Tavares, Maldonado, and Minano 2013; Zhan et al. 2013). 
The pSTAT3 antibody (ab76315) has been previously validated by the manufacturer 
by Western blotting in HeLa cell lysate and used in the following publications (Desai 
et al. 2007; Mao et al. 2016; McGuckin et al. 2013).  
 
2.1.5 Effects of neonatal overfeeding on hypothalamic gene expression  
Quantitative real-time PCR (qRT-PCR) was used to assess neonatal overfeeding 
effects on hypothalamic gene expression of the leptin receptor (Lepr) in the ARC and 
hypothalamus from the animals described above (see Table 2.2 for primer details). 
Brains were immediately removed and the hypothalamus was isolated with razor 
blade from the fresh brain. Initially a coronal cut was made anterior to the optic 
chiasm and another coronal cut was made 4mm caudal to the first cut. Then the slice 
was placed with its posterior surface upside and two lateral cuts were made above the 
optic tracts. Finally, a horizontal cut above the third ventricle finalised the 
hypothalamic dissection. This isolation technique was adapted by (Reyes et al. 2003) 
and it can also be found at (Udvari et al. 2017). The arcuate nucleus was dissected at 
the base of the hypothalamus using a small dissecting knife. The brain was dissected 
into the ARC and hypothalamus that does not contain the ARC. These samples were 
immediately snap-frozen in liquid nitrogen and stored at -80 °C until use. RNA was 
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purified using QIAzol reagents and RNeasy Mini Kits (QIAGEN, Valencia, CA, 
USA). The RNA concentration was determined by spectrophotometer measurements 
at 260nm and 280nm (NanoDrop 2000/2000c, Thermo Scientific, Waltham, MA, 
USA). 1 μg RNA was transcribed to cDNA using iScript cDNA synthesis kits 
(QIAGEN) according to the manufacturer’s instructions. A qRT-PCR Taqman Gene 
Expression Assay (Applied Biosystems, Mulgrave, VIC, Australia) was performed on 
a Rotor-Gene Q instrument (Qiagen GmbH) and the relative quantitative measure of 
the target gene expression was compared with an endogenous control, 18s. RNA 
expression was determined using the double delta (C(t)) equation 2-ΔΔC(t), where 
threshold cycle (C(t)) values were the values at which fluorescence was first detected 
significantly above background, as previously described. Minus reverse-transcriptase 
(-RT), with omitted reverse transcriptase reactions, and no template controls (NTC), 
with omitted primer reactions, were run simultaneously with the samples in order to 
verify that no genomic DNA contamination was present. The mean C(t) value of our -
RT test samples for 18s was more than ten cycles different from the mean C(t) value 
of our test samples, indicative of a 2-fold difference in the initial template amount, 
therefore allowing us to assume 100% efficiency and the presence of negligible 
genomic DNA. NTC were undetermined (>40 C(t)), suggesting there was no genomic 
DNA contamination. Data are presented as fold increase relative to P7 CLs (neonates) 
or adult CLs (adults). We initially tested both of the housekeeping genes 18S and β-
actin, and based on the analysis of variability, β-actin was chosen as an endogenous 
control due to its stability in the neonatal hypothalamus. We can confidently confirm 
the reliability of our reference gene in this study. 
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Table 2.2 Primer details for qRT-PCR 
 
Primer name NCBI Reference Sequence TaqMan Assay ID Product size 
18s X03205.1 4319413E 187 
Lepr NM_012596 Rn01433205_ml 94 
 
 
2.1.6 Effects of neonatal overfeeding on food intake and hypothalamic 
responsiveness to exogenous leptin  
To assess whether neonatal overfeeding affected the ability of the hypothalamus to 
control feeding and body weight after an exogenous stimulus with leptin (3 mg/kg of 
leptin i.p. (PeproTech, Rocky Hill, NJ, USA)) nocturnal, diurnal and 24 hr food intake 
were measured. In order to assess neonatal overfeeding acute (neonatal) and long-
term (adulthood) effects on hypothalamic responsiveness to exogenous leptin P12 and 
~P70 CL and SL animals were injected with 1 mg/kg i.p. leptin (PeproTech, Rocky 
Hill, NJ, USA) or 0.9% sterile saline and pSTAT3 immunoreactive cells in the ARC 
and VMH were assessed. ~P70 animals were given 7 days of normalisation before a 
second injection of 1 mg/kg leptin. Body weight measurements were also conducted 
before and 45 min post injection. All of the experiments were conducted between 
09:00 and 13:00 hr to avoid potential effects of circadian rhythms on any of the 
parameters measured. 
 
2.1.7 Leptin ELISA  
Leptin concentrations were determined using a standard commercially available rat-
specific leptin ELISA, following the manufacturer’s instructions (Millipore, Ballerica, 
MA, USA). Leptin ELISAs were conducted by Dr Luba Sominsky from samples 
generated by me. Intra-assay variability was 1.9-2.5% CV, inter-assay variability 3.0-
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3.9% CV, and lower limit of detection 0.04 ng/mL. All compared samples were 
assayed in duplicate and processed in the same assay.  
 
2.1.8 Leptin antagonist  
Super rat leptin antagonist (SRLA) (SLAN-4; Protein Laboratories Rehovot Lt. 
Rehovot, Israel) used in this study was prepared similarly to super mice leptin 
antagonist (SMLA) described in (Shpilman et al. 2011). SRLA is a polypeptide chain 
containing 146 amino acids, with mutations D23L, L39A/D40A/F41A, resulting in a 
powerful antagonist with high affinity for the leptin receptor. To assess whether 
antagonising the exacerbated leptin surge at its onset (~P4) would ameliorate the 
disruption in NPY/AgRP neuronal fibre density, body weight, and circulating leptin 
levels long-term in our neonatally overfed animals compared to controls, 5 mg/kg 
leptin antagonist (i.p.) or saline was injected daily to a cohort of CL and SL animals 
from P4 to P7. These animals were allowed to grow into adulthood (~ P70) and body 
weight and circulating leptin were assessed. We also assessed POMC positive cells as 
well as hypothalamic NPY/AgRP fibre density as described above.  
 
2.1.9 Statistical analysis 
Statistical analyses were performed separately based on age. For neonates, pre-
weaning body weights, leptin receptor expression and hypothalamic responses to 
leptin were compared using multifactorial analyses of variance (ANOVA)s (using 
SPSS software) with age (P7/P14) and litter size manipulation (CL/SL) as between 
factors. For neonatal NPY, AgRP, POMC and pSTAT3 immunoreactivity, and for the 
adults Student’s unpaired t-tests (one variable) or two-way ANOVAs (more than one 
variable) were used, also including treatment factors where appropriate (saline/leptin 
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or saline/SRLA). Where significant interactions were found, Tukey post hoc tests 
were performed. Data are presented as the mean ± SEM. Statistical significance was 
assumed when p ≤ 0.05. All data were tested for homogeneity of variance and 
normality, using the Levene’s test for Equality of Variance and the Shapiro-Wilks 
test, respectively, complemented by the assessment of skewness and kurtosis. These 
assessments and all other statistical analyses were conducted using SPSS. Outliers 
were determined using the Grubbs’ test (α = 0.05) in GraphPad Prism. 
 
 
 Results 
2.1.10 Neonatal overfeeding effects on the peripheral and central leptin 
systems 
Our group has previously shown that overfeeding during early life is associated with 
increased body weight (Smith and Spencer 2012; Spencer and Tilbrook 2009; 
Stefanidis and Spencer 2012). Here it is shown again that neonatally overfed male 
pups have significantly increased body weight at P14 compared to normally fed pups 
of the same age (F(2,28) = 20.75, p < 0.001; n = 8; Figure 2.1 A). This increase in body 
weight is associated with a significant increase in circulating leptin levels at P14 as 
previously described (Stefanidis and Spencer 2012). While there were no differences 
in the expression of the receptor in the hypothalamus excluding the ARC, in the ARC, 
there was a significant increase in the leptin receptor mRNA expression at P14 
compared to P7 (significant effect of age: F(1,23) = 51.37, p < 0.001; n = 6-8; Figure 
2.1 C).  
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To test the effects of neonatal overfeeding on the hypothalamic responsiveness to 
exogenous leptin, P12 pups were given a leptin injection and measured leptin’s ability 
to activate pSTAT3 cells in the ARC and VMH. Leptin significantly increased 
numbers of pSTAT3 positive cells in both ARC (significant effect of leptin: F(1,15) = 
8.54, p = 0.011; n = 3-6; Figure 2.1 D, F) and VMH (significant effect of leptin: F(1,15) 
= 18.82, p = 0.001; n = 3-6; Figure 2.1 E) of normally fed pups, but failed to do so in 
the overfed ones, indicative of central leptin resistance.  
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Figure 2.1 Neonatal overfeeding effects on the peripheral and central leptin 
systems.  
(A) Pre-weaning body weights of rats raised in control (CL) and small (SL) litters (n 
= 8). (B) Hypothalamic and (C) arcuate nucleus of the hypothalamus (ARC) leptin 
receptor expression (n = 6 - 8). (D) Neuronal activation in response to leptin injection 
at P12; numbers of phosphorylated signal transducer and activator of transcription 
(pSTAT3) positive cells in the ventromedial hypothalamus (VMH) (n = 3 - 6) and (E) 
in the ARC (n = 3 - 6). (F) Representative photomicrographs showing leptin-induced 
pSTAT3 positive cells in the ARC of CL and SL rats (n = 3 - 6). Data are mean ± 
SEM. * p < 0.05. Scale bars = 200 μm. 
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2.1.11 Neonatal overfeeding affects hypothalamic orexigenic NPY and 
AgRP, but not the anorexigenic POMC  
To determine whether the effects of neonatal overfeeding on circulating leptin levels 
and body weight were associated with modification of key hypothalamic 
neuropeptides such as anorexigenic POMC and orexigenic NPY and AgRP, numbers 
of POMC-positive cells and NPY/AgRP fibre density in the ARC and PVN of overfed 
and normally fed pups at P12 were measured. Neonatal overfeeding had no effects on 
ARC POMC positive cells (Figure 2.2 B, E), however it significantly increased both 
NPY (t(10) = 2.33, p = 0.042; n = 6 per group Figure 2.2 D, G) and AgRP (t(9) = 5.18, p 
= 0.001; n = 5-6 per group Figure 2.2 C, F) fibre density when compared to controls. 
In the PVN neonatal overfeeding did not affect AgRP fibre density (Figure 2.2 I, K) 
and in contrast to the ARC it suppressed NPY fibre density in comparison to controls 
(t(10) = 2.3, p = 0.044; n = 6 per group Figure 2.2 J, L).  
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Figure 2.2 Neonatal overfeeding affects the hypothalamic neuropeptide Y (NPY) 
and agouti related peptide (AgRP) fibre density, but not proopiomelanocortin 
(POMC) immunoreactivity.  
(A, H) schematic diagram illustrating the region of interest analysed for NPY, AgRP 
and POMC. (B) NPY (n = 6), (C) AgRP (n = 6) and (D) POMC immunolabeling in 
the arcuate nucleus (ARC) (n = 6). Representative photomicrographs of (E) NPY (n = 
6), (F) AgRP (n = 6) and (G) POMC labeling in the ARC of control (CL) and small 
litter (SL) animals on postnatal day (P)12 (n = 5 - 6). (I) NPY and (J) AgRP labelling 
in the paraventricular nucleus of the hypothalamus (PVN). Representative 
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photomicrographs showing NPY (K) and AgRP (L) labelling the PVN. Data are mean 
± SEM. * p < 0.05. Scale bars = 100 μm. 
 
2.1.12 Neonatal overfeeding effects on the leptin system long-term 
To determine the long-term peripheral and central effects of neonatal overfeeding on 
the leptin system leptin parameters were measured in adult animals that were overfed 
during the first weeks of their life and compared them to control animals. Neonatally 
overfed animals remained overweight despite weaning them onto a normal diet (t(21) = 
2.24, p = 0.036; n = 11-12; Figure 2.3 A). Previous data from our group (Stefanidis 
and Spencer 2012) have shown that, similar to body weight, neonatal overfeeding 
affects circulating leptin levels long-term. Therefore, hypothalamic gene expression 
of the leptin receptor was measured. We observed that adult animals that were 
overfed during neonatal life had similar levels of Lepr expression in the hypothalamus 
compared to controls (Figure 2.3 B). Since we observed that neonatal overfeeding 
was associated with a disruption of neonatal NPY and AgRP neurons in the ARC and 
PVN, we assessed whether these changes were maintained until adulthood. Neonatal 
overfeeding did not affect ARC (Figure 2.3 D) or PVN (Figure 2.3 G) AgRP fibre 
density in adult rats. Neonatal overfeeding not only did not induce an increase in adult 
ARC NPY fibre density, but it significantly suppressed it (t(10) = 2.32, p = 0.043; 
Figure 2.3 C). No effects of neonatal overfeeding on the adult PVN NPY fibre density 
(Figure 2.3 F) or ARC POMC positive cells (Figure 2.3 E) were seen. Overall, the 
above results indicate that neonatal overfeeding effects on NPY/AgRP fibre density 
observed during neonatal life are resolved by adulthood.  
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Figure 2.3 Long-term effects of neonatal overfeeding on the leptin system.  
(A) Body weight of adult control (n = 11 – 12) (CL) and small litter (SL) animals. (B) 
Leptin receptor expression in the hypothalamus (n = 6 - 10). (C) Neuropeptide Y 
(NPY) (n = 6), (D) agouti related peptide (AgRP) (n = 5 - 6) and (E) 
proopiomelanocortin (POMC) immunolabeling in the arcuate nucleus (ARC) (n = 5). 
Representative photomicrographs of (H) NPY, (I) AgRP and (J) POMC labeling in 
the ARC. Representative photomicrographs of (K) NPY and (L) AgRP labelling in 
the PVN. Data are mean ± SEM. * p < 0.05. Scale bars = 100 μm. 
 
0
5
10
15
20
N
PY
 d
en
si
ty
(a
re
a 
fra
ct
io
n 
%
) 
0
350
350
400
450
500
B
od
y 
w
ei
gh
t (
g)
 
0
2
4
6
8
10
A
G
R
P 
de
ns
ity
(a
re
a 
fra
ct
io
n 
%
) 
0.0
0.5
1.0
1.5
2.0
Le
pr
 m
R
N
A 
(fo
ld
 c
ha
ng
e)
B - hypothalamus D – ARC AgRP 
H – ARC NPY 
* 
A 
F – PVN NPY 
CL   SL   CL   SL   
K – PVN NPY L – PVN AgRP 
CL   SL   CL   SL   
I – ARC AgRP J – ARC POMC 
CL   SL   
0
10
20
30
40
N
PY
 d
en
si
ty
(a
re
a 
fra
ct
io
n 
%
) 
* 
C – ARC NPY 
0
5
10
15
20
A
G
R
P 
de
ns
ity
(a
re
a 
fr
ac
tio
n 
%
) 
G – PVN AgRP 
80
100
120
140
160
180
N
um
be
r o
f 
PO
M
C
 p
os
iti
ve
 c
el
ls
 
E – ARC POMC 
    CL             SL             CL              SL             CL             SL         
    CL             SL             CL             SL             CL             SL         
    CL             SL         
  51 
 
Given the neonatal leptin resistance in the ARC with neonatal overfeeding, it would 
be expected a long-term hypothalamic inability to respond to exogenous leptin. There 
was an overall suppression of nocturnal (significant effect of leptin: F(1,46) = 3.97, p = 
0.052; Figure 2.4 A) and 24 hr (main effects of leptin: F(1,46) = 4.42, p = 0.041; Figure 
2.4 C) food intake with exogenous leptin. However, no effects of exogenous leptin on 
diurnal food intake (Figure 2.4 B), or any effects of litter size manipulation were 
observed. Similarly, neonatal overfeeding had no effect on hypothalamic 
responsiveness to leptin in adulthood, as seen in similar numbers of pSTAT3 positive 
cells in the ARC of both CL and SL animals (significant effect of leptin: F(1,18) = 4.92, 
p = 0.040; Figure 2.4 D and E). These results overall indicate that leptin resistance 
observed during neonatal life with neonatal overfeeding does not persists into 
adulthood. 
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Figure 2.4 Neonatal overfeeding effects on long-term leptin responsiveness.  
Nocturnal (A) (n = 8 - 17), diurnal (B) and 24 hr (n = 8 - 17) (C) food intake after 
exogenous leptin in control (CL) and small litter (SL) animals (n = 8 - 17). (D) 
Numbers of phosphorylated signal transducer and activator of transcription (pSTAT3) 
positive cells in the arcuate nucleus of the hypothalamus (ARC) (n = 5 - 6). (E) 
Representative photomicrographs showing leptin-induced pSTAT3 positive cells in 
the ARC of CL and SL rats. Data are mean ± SEM. * p < 0.05. Scale bars = 100 μm. 
 
2.1.13 Short- and long-term effects of early-life leptin antagonist  
The neonatal leptin antagonist was not able to normalise neonatal body weight at P21 
(main effect of litter size: F(1,18)= 34.50, p < 0.001; n = 5-6, Figure 2.5 A) or 
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adulthood (main effect of litter size: F(1,18)= 9.54, p = 0.006; n = 5-6, Figure 2.5 B) in 
animals that were overfed during their neonatal life. The leptin antagonist also failed 
to normalise circulating leptin (main effect of litter size: F(1,15)= 11.13, p = 0.005; n = 
5-6, Figure 2.5 C). Neonatal leptin antagonist was also not able to affect POMC 
positive cells in the ARC (Figure 2.5 D). It significantly suppressed AgRP fibre 
density in the ARC irrespective of litter size (main effect of leptin antagonist: F(1,19)= 
6.82, p = 0.017; n = 5-6, Figure 2.5 F), however it did not affect ARC NPY fibre 
density (main effect of litter size: F(1,19)= 5.31, p = 0.033; n = 5-6, Figure 2.5 E) or 
PVN NPY and AgRP fibre density (Figure 2.5 G and H). These leptin antagonist data 
suggest that there are possibly metabolic factors other than hyperleptinemia affecting 
long-term body weight in the neonatally overfed rat.  
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Figure 2.5 Long-term effects of a leptin antagonist on neonatal overfeeding-
induced changes in the leptin system.  
Body weight on (A) postnatal day 21 (n = 5 - 6) and (B) adulthood in control (CL) 
and small litter (SL) animals given leptin antagonist as neonates (n = 5 - 6). (C) 
Circulating leptin levels (n = 5 - 6). (D) Numbers of proopiomelanocortin (POMC) 
positive cells in the arcuate nucleus of the hypothalamus (ARC) (n = 5 - 6). 
Neuropeptide Y (NPY) immunolabeling in the ARC (n = 5 - 6) (E) and 
paraventricular nucleus of the hypothalamus (PVN) (n = 6) (G). Agouti related 
peptide (AgRP) immunolabeling in the ARC (n = 5 - 6) (F) and PVN (n = 6) (H). 
Data are mean ± SEM. * # p < 0.05. * indicates post hoc effects (* in B, C, and E 
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indicates main effect of litter size and no post hoc group differences. # in F indicates 
main effect of leptin antagonist and no post hoc group differences). 
 
 
Discussion 
Here, for the first time, it is observed that neonatal overfeeding along with an increase 
in body weight and an exacerbated leptin surge was associated with an acute 
(neonatal) disruption of the NPY and AgRP fibre density in the ARC and PVN as 
well as acute hypothalamic leptin resistance. These changes being specific to the early 
life period and being resolved by adulthood emphasise the brain’s plasticity and 
ability to adapt to environmental changes. Encouraging evidence from this study 
shows that in adulthood, the neonatally overfed animals not only have recovered into 
optimal NPY/AgRP fibre density, but they show significant reduction in ARC NPY 
fibre density when compared to their control counterparts. Alongside these changes, 
neonatally overfed adults show recovered hypothalamic leptin resistance despite 
maintaining elevated leptin levels (Stefanidis and Spencer 2012). Antagonising leptin 
activity during neurodevelopment in neonatally overfed pups, despite the inability to 
ameliorate body weight or hyperleptinemia, led to suppressed ARC NPY fibre density 
in CL animals to levels similar to those seen in SL.  
 
POMC in the ARC is critical in maintaining energy homeostasis and the inability of 
leptin to optimally activate POMC neurons leads to obesity. It is demonstrated here 
that overfed pups with hyperleptinemia do not show the expected increase in 
hypothalamic POMC immunoreactivity or gene expression. Similarly, a study by 
Plagemann and colleagues’ (Plagemann et al. 2009) showed that neonatal overfeeding 
was associated with no differences in hypothalamic POMC gene and protein 
expression, despite hyperleptinemia which is expected to lead to increased POMC 
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expression (Elias et al. 1999). The results from Plagemann are inversely correlated to 
POMC promoter methylation (epigenetic modification resulting in transcriptional 
repression) leading to lack of upregulation in POMC gene expression in a setting of 
hyperleptinemia. These and our results may reflect an altered capacity of the system 
to respond to different energy balance conditions.  
 
Work from Ahima and colleagues has highlighted the importance of the leptin surge 
during the first weeks of development in rodents (Ahima, Prabakaran, and Flier 
1998). Others (Schmidt et al. 2001; Lopez et al. 2007) and our group (Stefanidis and 
Spencer 2012) have shown that neonatal overfeeding is associated with an 
exacerbation of this leptin surge during the neonatal period and persistent 
hyperleptinemia throughout life. The leptin surge, as explained by Bouret and 
colleagues (Bouret, Draper, and Simerly 2004b; Bouret and Simerly 2007) is not 
involved in feeding during this P7-P10 neurodevelopmental window, but it is crucial 
in maturation of hypothalamic wiring that controls feeding in the long-term. 
Therefore it is expected that an exacerbated leptin surge would be associated with an 
increase in NPY/AgRP fibre density. Indeed, here we observed that both ARC NPY 
and AgRP fibre density are increased with neonatal overfeeding. We also observed a 
decrease in PVN NPY, but not AgRP in neonatally overfed pups. While NPY and 
AgRP are highly co-localised (99%) in the ARC (Hahn et al. 1998), they do not co-
localise to the same degree in the PVN. The PVN, apart from ARC-derived neurons is 
innervated by (~50%) NPY fibres derived elsewhere (Sawchenko et al. 1985). 
Furthermore, NPY and AgRP neurons of the PVN differently respond to certain 
stimuli (Kas et al. 2005).  
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Overweight and obesity are associated with leptin resistance, here we examined 
whether neonatal overfeeding affected hypothalamic responsiveness to exogenous 
leptin at P12. We observed that despite no changes in the gene expression of the 
hypothalamic leptin receptor, neonatal overfeeding suppressed the ARC and VMH 
neurons’ ability to respond to exogenous leptin determined as the number of neurons 
positive for pSTAT3 in response to this stimulus. This finding is consistent with other 
studies showing that neonatal overfeeding leads to acute leptin resistance (Glavas et 
al. 2010; Bouret et al. 2008). 
 
It has been shown in a number of studies that neonatally overfed adults maintain 
increased body weight and hyperleptinemia despite being fed a normal diet after 
weaning (Lopez et al. 2007; Schmidt et al. 2001; Stefanidis and Spencer 2012). This 
hyperleptinemia is usually associated with long-term leptin resistance (Glavas et al. 
2010). However, here we saw that despite this increased body weight and 
hyperleptinemia, neonatal leptin resistance observed in ARC and VMH in response to 
overfeeding is resolved by adulthood. A study from Lopez and colleagues further 
supports our finding (Lopez et al. 2007). It is important to mention our observation 
here of a reduction in NPY fibre density in adult rats that were overfed during early 
life. This is likely indicative of an adaptation to the neonatal overfeeding with a 
compensatory response in this orexigenic circuitry. In this regard, previous studies 
have shown that NPY and AgRP are particularly able to adapt to the effects of 
overfeeding in genetic models of impaired leptin signalling (Bouret et al. 2012), 
neonatal overfeeding (Lopez et al. 2007) and diet-induced obesity (Ziotopoulou et al. 
2000), with a compensatory response to conditions of positive energy balance.  
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Despite a resolution of the central effects of neonatal overfeeding adulthood, these 
adult neonatally overfed rats remain overweight and maintain hyperleptinemia 
throughout life. We therefore hypothesised that a leptin antagonist introduced at the 
initiation of the leptin surge would ameliorate the long-term effects related to the 
neonatal overfeeding. The naturally occurring leptin surge initiates at around P4 and 
peaks at around P7 – P10 (Delahaye et al. 2008). At P14 there is a greater than ten-
fold increase in leptin levels in SL animals compared to controls, as previously shown 
(Stefanidis and Spencer 2012), indicating that neonatal overfeeding exacerbates or 
disrupts this naturally occurring leptin surge.  It is observed that while the leptin 
antagonist did not normalise body weight or hyperleptinemia in adult animals that 
were overfed in early life, it reduced AgRP density in both overfed and control 
animals. This outcome may depend on the dosage and timing of administration of the 
leptin antagonist. Previous studies have administered the same leptin antagonist for a 
slightly prolonged period of time compared to the study reported here (P2 - P13) 
(Attig et al. 2008; Benoit et al. 2013), but this regimen was associated with leptin 
resistance and negative effects on development and maturation of many organs (Attig 
et al. 2011). A study from our group using the same leptin antagonist dose and 
injection regime showed that the antagonist was able to reverse hyperleptinemia and 
rescue the decline of primordial follicles caused by neonatal overfeeding in female 
rats (Sominsky, 2016).  
The low animal numbers in some of the groups are explained by tissue loss and 
exclusion of statistical outliers (Grubb’s test; no more than one per group). The 
criteria of outlier exclusions are described below. The exclusion of outliers, however, 
has not compromised the effect sizes. For instance, for data depicted on Fig. 2.1 D, F 
we have seen that although the control group consisted of n = 3, these data show a 
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strong and significant interaction between the effects of litter size and drug (F(1,15) = 
8.54, p = 0.011), with a partial ETA squared of 0.363 and observed power of 0.78, 
indicating that these data explain over 36% of the overall variance (effects and error), 
with a power of 78% to detect these effects. Similarly, pStat3 expression in the VMH 
was not affected by any outlier exclusion, so that a strong and significant effect of 
leptin (F(1,15) = 18.82, p = 0.001) was seen, with a partial ETA squared of 0.56 and 
observed power of 0.982, indicating that these data explain over 56% of the overall 
variance, with a power of 98% to detect these effects. Original studies from the 
Spencer group where the neonatal overfeeding model was first described (Stefanidis 
and Spencer 2012; Clarke, Stefanidis, and Spencer 2012), provided extensive 
observations of changes in body composition. I have referred to this study where this 
was necessary.    
Overall our results suggest that neonatal overfeeding along with a permanent increase 
in body weight and hyperleptinemia acutely alters central leptin systems related to 
metabolic control, with most of this disrupted functionality being resolved by 
adulthood. Attenuating the effects of hyperleptinemia at this time with a leptin 
antagonist failed to reverse the acute or long-term weight gain and hypothalamic 
effects suggestive of contributions of other factors in the effects of neonatal 
overfeeding on satiety pathways.  
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Introduction  
Developmental programming of homeostatic feeding behaviour occurs during the first 
weeks of development in rodents and is integrated within the hypothalamus. As 
previously discussed in this thesis (Chapter 1, Introduction: “Leptin in development”), 
the main nuclei that regulate energy intake and expenditure within the hypothalamus 
are the arcuate nucleus of the hypothalamus (ARC), the paraventricular nucleus of the 
hypothalamus (PVN), the ventromedial nucleus of hypothalamus (VMH), 
dorsomedial nucleus of the hypothalamus (DMH) and the lateral hypothalamus (LH) 
(Gao and Horvath 2008). These nuclei are important integration sites for a number of 
peripheral hormones such as insulin, leptin and ghrelin, as well as nutrients such as 
glucose and free fatty acids (reviewed in (Bouret 2017)). In the previous chapter we 
discussed the role of leptin in developmental programming. The role of insulin is also 
very well established. Unlike the roles of insulin (Plagemann et al. 1997) (previously 
explained under Chapter 1,  “Perinatal programming of obesity – animal models”) 
and leptin (Chapter 2), little is known of the role of ghrelin in developmental 
programming of the hypothalamus. The main focus here is on the role of ghrelin in 
particular, as one of the most important metabolic hormones that, not only regulates 
homeostatic food intake, but may also act as a neurotrophic factor in 
neurodevelopment.  
 
Ghrelin is mainly secreted from the fundus of the stomach where ghrelin O-acyl 
transferase (GOAT) acylates ghrelin on the third serine residue (Goitein et al. 2012). 
This acylated form of ghrelin is crucial for ghrelin’s biological function via its growth 
hormone secretagogue receptor (GHSR). The two different forms of circulating 
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ghrelin: acyl ghrelin and des-acyl ghrelin, have separate contributions to physiology. 
Des-acyl ghrelin does not have any effect on GHSR function, however it is known to 
antagonise acyl ghrelin’s effects on feeding (as reviewed on (Delhanty, Neggers, and 
van der Lely 2012)). Des-acyl ghrelin is also able to stimulate proliferation of rat 
spinal cord and hypothalamic fetal cells, suggesting its involvement in neurogenesis 
and neurodevelopment (Inoue et al. 2010; Sato et al. 2006). 
 
In adulthood acyl ghrelin plays an important role in central control of energy 
expenditure by controlling feeding, adiposity and glucose metabolism. Adult humans 
and rodents injected acutely with ghrelin, increase their food intake and body weight 
(Tschop, Smiley, and Heiman 2000; Wren et al. 2001; Druce et al. 2005). Aside from 
ghrelin’s role in regulating feeding and metabolism in the adult, evidence from 
Bouret’s group has demonstrated an important role of ghrelin in programming 
feeding-related neurocircuitry during development, that of suppressing leptin-initiated 
neuronal outgrowth (Steculorum et al. 2015). Ghrelin significantly suppresses neurite 
projections from neonatal ARC explants in vitro. In vivo, anti-ghrelin compounds 
stimulate an increased density of neuronal projections initiating from the ARC and 
migrating towards the PVN (Steculorum et al. 2015) further supporting ghrelin’s 
function in suppressing excessive axon development. This exclusive maturation of 
hypothalamic pathways occurs during very precise developmental periods of time - 
during the first postnatal weeks after birth in rodents. During this time, the leptin 
surge that initiates at P4 and peaks at P7-P10 is followed by a gradual increase of 
circulating ghrelin levels that curtails leptin’s neurotrophic effects on axonal growth 
and prevents over-growth of these projections (Steculorum et al. 2015).  
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Overnutrition during postnatal life may contribute to the onset of obesity and 
metabolic-related diseases later in life (Cruz et al. 2005; Taveras et al. 2011). For 
instance, in an animal model of childhood obesity where rat pups are over-nourished 
during the first weeks of development, there is an increase in body weight, which is 
maintained throughout life (Clarke et al. 2013; Ziko et al. 2014; Collden et al. 2015). 
Limited research has shown that neonatal overfeeding suppresses circulating total and 
acyl ghrelin levels, which leads to a lack of central responsiveness to exogenous 
ghrelin (Collden et al. 2015). There is also some limited evidence for a role of des-
acyl ghrelin during development, at least during the very early phases. Des-acyl 
ghrelin is able to stimulate proliferation of rat spinal cord and hypothalamic fetal 
cells, suggesting its involvement in neurogenesis and neurodevelopment (Inoue et al. 
2010; Sato et al. 2006). However, the role of desacyl in later development has not yet 
been investigated, and acyl-ghrelin’s contribution to hypothalamic programming in 
the rat is similarly unknown. 
 
Here we hypothesised that neonatal overfeeding would affect the ghrelin system 
acutely (during postnatal development) and long-term (until adulthood) and that acyl 
and des-acyl ghrelin might be differentially affected. To test this hypothesis we 
examined early life overfeeding’s effects on the peripheral and central ghrelin systems 
including acyl and des-acyl ghrelin’s ability to access the hypothalamus. Our results 
showed that neonatal overfeeding acutely affected the ghrelin system by reducing 
circulating ghrelin, increasing hypothalamic Ghsr expression and hypothalamic 
responsiveness to exogenous acyl but not des-acyl ghrelin. Interestingly, while acyl 
ghrelin’s ability to access the ARC was not affected by neonatal overfeeding, acyl 
ghrelin’s ability to reach the PVN was attenuated. Importantly, however, these acute 
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effects of neonatal overfeeding on ghrelin’s ability to signal the brain were resolved 
by adulthood. 
 
Materials and methods  
3.1.1 Animals  
As described in Chapter 2, we obtained timed pregnant Wistar rats from the Animal 
Resources Centre, WA, Australia. On arrival at the RMIT University Animal Facility, 
we housed them at 22°C on a 12 hr light/dark cycle (07:00–19:00 hr) and provided 
them with standard pelleted rat chow and water ad libitum. We conducted all 
procedures in accordance with the National Health and Medical Research Council 
Australia Code of Practice for the Care of Experimental Animals and RMIT 
University Animal Ethics Committee approval.  
 
3.1.2 Litter size manipulation   
Litter size manipulation was performed as previously described in Chapter 2 
(Materials and Methods: “Litter size manipulation”) to create the neonatally overfed 
animal model. Only male animals were used in this study, which were culled at 
postnatal day (P) 7, 12, 14 and at ~P70. Females were kept for use in other 
experiments (as described in Chapter 4). The adult animals, after separation into same 
sex littermate pairs at weaning (P21), were left undisturbed until experimentation. 
 
3.1.3 Neonatal overfeeding effects on circulating ghrelin  
On the day of experimentation ~P70, a cohort of rats were deeply anesthetized with 
Lethabarb (150 mg/kg sodium pentobarbitone, i.p.). P70 is a period of young 
adulthood in rats; ~4 weeks past the attainment of reproductive maturity. Animals at 
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P7 or P14 were decapitated and trunk blood was collected for later assessment of 
serum ghrelin. To accurately measure plasma acyl and des-acyl ghrelin, blood 
collection tubes that contained no anticoagulant were treated with Pefabloc (Roche 
Applied Science) to achieve a final concentration of 1 mg/mL. Blood was left to clot 
at room temperature for 30 min then centrifuged at 2500 g for 15 min at 4 °C ± 2 °C. 
The collected serum was transferred into a fresh tube then acidified with HCl to a 
final concentration of 0.05 N. The samples were mixed, aliquoted, and stored at -20 
°C avoiding freeze-thaw cycles. Serum acyl and des-acyl ghrelin concentrations were 
determined using a standard ghrelin enzyme-linked immunoassay (ELISA) for total 
and acyl ghrelin (Millipore, Billerica, MA, USA) following the manufacturer’s 
instructions. The intra-assay variability was 0.3-7% and 0.7-1.3% CV, inter-assay 
variability 1-10% and 1.8-4.5% CV, and lower limit of detection 0.8 pg/mL and 0.04 
ng/mL for acyl and total ghrelin respectively. Samples were assayed in duplicate and 
were randomized across two plates. Acyl ghrelin concentrations were subtracted from 
total ghrelin concentrations to derive a value for serum desacyl ghrelin (Hosoda et al. 
2004).  
 
3.1.4 Neonatal overfeeding effects on hypothalamic gene expression  
To assess changes in expression of genes involved in ghrelin central pathways brains 
were collected and were then dissected into ARC and hypothalamus not containing 
the ARC. Samples were immediately snap-frozen into liquid nitrogen and stored at -
80 °C until use. RNA was purified and qRT-PCR was performed. The specific primer 
details are shown in Table 3.1. A relative quantitative measure of the target gene 
expression, compared with endogenous control 18s mRNA expression, was analysed 
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as fully described in Chapter 2 (Materials and Methods: “Effects of neonatal 
overfeeding on hypothalamic gene expression”). 
 
Table 3.1 Primer details for qRT-PCR 
 
Primer name NCBI Reference Sequence TaqMan Assay ID Product size 
18s X03205.1 4319413E 187 
Agrp NM_033650.1 Rn01431703_g1 67 
Ghsr NM_032075.3 Rn00821417_m1 61 
Mboat4 NM_001107317.2 Rn02079102_s1 93 
Npy NM_012614.2 Rn00561681_m1 63 
Pomc NM_139326.2 Rn00595020_m1 92 
 
 
3.1.5 Weight assessment in response to exogenous ghrelin  
Weight changes in response to 1 mg/kg i.p. acyl ghrelin, des-acyl ghrelin (or saline) in 
CL and SL neonatal and adult animals were assessed. Body weight was taken 
immediately before and 2 hr after injection for all animals, food intake was assessed 
at this time in adults only. 2 hr post-injection all animals were deeply anaesthetised 
with 150 mg/kg sodium pentobarbitone (i.p.) then transcardially perfused as described 
in Chapter 2 (Materials and methods: “Brain collection”).  
 
3.1.6 Neonatal overfeeding effects on neuronal activation in response to 
ghrelin c-Fos immunohistochemistry 
Sections through the hypothalamus were immunolabelled for c-Fos. Randomly 
selected sections from each treatment group (a single one in five series of 30 μm 
sections from each animal) were processed at the same time in batches. Briefly, 
sections were pre-treated with H2O2, treated with blocking solution and then 
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incubated in primary antibody (overnight; 4 °C; 1:10 000; rabbit; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). This was followed by secondary antibody (1.5 
hr; 1:500, biotinylated anti-rabbit; Vector Laboratories, Burlingame, CA, USA) and 
an avidin-biotin horseradish peroxidase (HRP) complex (ABC; 45 min; Vector Elite 
kit; Vector). The tissue was then incubated in diaminobenzidine (DAB) intensified 
with nickel to visualize the HRP activity. The reaction was stopped when the contrast 
between specific cellular and non-specific background labelling was optimal. Air-
dried brain sections were dehydrated in a series of alcohols, cleared in histolene and 
coverslipped. Hypothalamic sections were assessed by an experimenter blinded to 
treatment groups for the numbers of c-Fos-positive cells in the ARC and PVN. Four 
sections 120 μm apart between 2.76 and 3.48 mm caudal to the bregma per animal 
were analysed and the summed counts of the four sections was taken as our sampled 
result.  
 
3.1.7 Fluorescently labelled ghrelin  
To determine if the ability of ghrelin to reach the brain was affected by neonatal 
overfeeding P12 pups were injected subcutaneously with 1 mg/kg (x 2, 90 min apart) 
of Cyanine5 (Cy5)-labelled acyl or desacyl ghrelin dissolved in saline (0.9% NaCl). 
The Cy5 fluorescently labelled ghrelins were synthesized as previously detailed 
(Douglas et al. 2014; McGirr et al. 2011) and provided by Dr. Leonard Luyt from the 
Department of Chemistry, The University of Western Ontario, Canada. Brains were 
collected 2 hr after the first injection via decapitation, were immersion-fixed in 4% 
paraformaldehyde for 24 hr and incubated in 20% sucrose in PBS until processed for 
fluorescence microscopy. 40 μm brain sections were mounted on slides with DAKO 
mounting medium and constantly protected from light. Fluorescence images were 
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acquired on an A1R+ confocal laser scanning microscope (Nikon, Tokyo, Japan) 
using 640 nm excitation and detection using a 700 ± 37.5 band-pass filter. Through-
focus series (z-stacks) of ARC and PVN images were taken under 40 x magnification 
lenses (photoactivation, perfect focus system), under a Galvano scanner, spectral 
image of 512 x 512 pixels, 2 μm z-stacks. Negative controls that did not have 
injections of fluorescently labelled ghrelin had no signal under the same conditions. 
To estimate the total number of Cy5 fluorescently labelled acyl and desacyl ghrelin-
positive cells in the ARC and PVN, cell numbers and intensity signal were quantified. 
Fluorescently labelled acyl and desacyl ghrelin-positive cell numbers were manually 
counted using Image J (National Institutes of Health, Bethesda, MD, USA) in four 
brain sections per animal covering the bregma levels -1.44 mm to -3.60 mm 
throughout all the z-stacks and total cell numbers were summed. NIS Elements 
Advanced Research Software (Nikon, Tokyo, Japan) was used to estimate 
fluorescence signal intensity in the ARC and PVN. The fluorescence signal from 
blood vessels was manually excluded from the intensity analysis based on shape. 
Finally, the mean fluorescence intensity was quantified per cell throughout the whole 
ARC and PVN.  
 
3.1.8 Data Analysis 
Neonatal and adult changes were analysed separately. For neonates weights, serum 
ghrelin, gene expression, fluorescently labelled cells and hypothalamic responses to 
ghrelin were compared using multi-factorial analyses of variance (ANOVA)s with 
neonatal nutritional environment (CL/SL) and age (P7/12/14) as between factors. 
Treatment was also included where appropriate (saline/acyl/desacyl ghrelin). Where 
significant interactions were found, Tukey post hoc tests were performed. For the 
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adults Student’s unpaired t-tests or two-way ANOVAs were used. Data are presented 
as the mean ± SEM. Statistical significance was assumed when p ≤ 0.05. All data 
were tested for homogeneity of variance and normality, using the Levene’s test for 
Equality of Variance and the Shapiro-Wilks test, respectively, complemented by the 
assessment of skewness and kurtosis. These assessments and all other statistical 
analyses were conducted using SPSS. Outliers were determined using the Grubbs’ test 
(α = 0.05) in GraphPad Prism. 
 
Results  
3.1.9 Neonatal overfeeding effects on circulating ghrelin 
Neonatal overfeeding significantly reduced serum ghrelin at P7 (significant effect of 
litter size: F(1,28) = 8.2, p = 0.008 and age: F(1,28) = 14.56, p = 0.001; Figure 3.1 A), 
specifically due to a decrease in des-acyl ghrelin levels (significant effect of litter 
size: F(1,28)  = 9.17, p = 0.005 and age: F(1,28) = 17.72, p < 0.001; Figure 3.1 B, C). 
Significant increase in the AG /DAG ratio at P7 (significant litter size by age 
interaction: F(1,28) = 4.90, p = 0.035; Figure 3.1 D) was also observed. By P14 
however, ghrelin levels and AG/DAG ratio were no longer different between groups.  
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Figure 3.1 Neonatal overfeeding effects on circulating ghrelin.  
(A) Total ghrelin serum concentration (n = 8), (B) acyl ghrelin (n = 8) (AG) 
concentration and (C) des-acyl ghrelin (DAG) concentration in the control (CL) and 
small litter (SL) rats on postnatal day (P) 7 and 14 (n = 8). (D) Ratio of ghrelin at P7 
and P14 in CL and SL animals (n = 8). Data are mean ± SEM. * p < 0.05. 
 
3.1.10 Effects of neonatal overfeeding on the hypothalamus 
To test neonatal overfeeding effects on the hypothalamus mRNA expression of a 
number of genes (as described in Table 3.1) was measured. In the ARC, neonatal 
overfeeding significantly increased Ghsr expression at P7 (significant effect of litter 
size: F(1,25) = 9.003, p = 0.006 and age: F(1,25) = 11.52, p = 0.002; Figure 3.2 A) and 
also significantly increased Mboat4 (Goat) expression at P7 (significant litter size by 
age interaction: F(1,25) = 5.127, p = 0.032; Figure 3.2 B), indicating a potential for 
neonatal overfeeding to enhance hypothalamic responsiveness to endogenous ghrelin. 
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Similarly to circulating ghrelin levels, ARC gene expression of Ghsr and Mboat4 was 
normalised by P14. No effects of neonatal overfeeding were observed on Ghsr 
(Figure 3.2 C) or Mboat4 (Figure 3.2 D) expression in the hypothalamus not 
containing the ARC. Apart from an increase on Agrp (main effect of age: F(1,25) = 
26.15, p < 0.001, Figure 3.2 F) and an increase on Pomc (main effect of age: F(1,25) = 
15.16, p = 0.001 Figure 3.2 G) expression in the ARC, neonatal overfeeding was not 
associated with any changes in Npy, Agrp or Pomc gene expression in this region or 
in the hypothalamus not containing the ARC.  
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Figure 3.2 Hypothalamic gene expression in response to neonatal overfeeding.  
Growth hormone secretagogue receptor (Ghsr) gene expression in the arcuate nucleus 
of the hypothalamus (ARC) (n = 6 - 8) (A) and the hypothalamus not contain the 
ARC (HY) (n = 5 - 7) (C) of control (CL) and small litter (SL) animals at postnatal 
day (P) 7 and 14. Ghrelin O-acyl transferase (Goat) expression in the ARC (n = 6 - 8) 
(B) and HY (n = 4 - 7) (D). Gene expression of neuropeptide Y (Npy) (n = 6 - 8) (E), 
agouti related protein (Agrp) (F), proopiomelanocortin (Pomc) (G) in the ARC and 
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HY Npy (n = 6 - 8) (H), Agrp (n = 6 - 8) (I) and Pomc (n = 5 - 7) (J). Data are mean ± 
SEM. * p < 0.05. 
 
3.1.11 Effects of neonatal overfeeding on hypothalamic responsiveness to 
exogenous ghrelin  
Overfeeding-induced changes in the availability of ghrelin associated with increased 
Ghsr expression in the ARC, and hence a potential for increased responsiveness to 
ghrelin, prompted us to test whether neonatal overfeeding also affected hypothalamic 
ability to respond to an exogenous stimulus. Exogenous acyl ghrelin significantly 
increased neuronal activation in the ARC of P12 pups compared to controls 
(significant effect of litter size: F(1,28) = 5.88, p = 0.02; and drug F(2,28) = 7.51, p = 
0.002; Figure 3.3 A). Similarly, acyl ghrelin stimulated an increase in neuronal 
activation in the PVN of SL pups compared to CLs (significant litter size by drug 
interaction: F(2,30) = 3.55, p = 0.041; Figure 3.3 B). However, exogenous ghrelin did 
not affect body weight (as a neonatal proxy for food intake) (Figure 3.3 C). No effect 
of neonatal overfeeding after exogenous des-acyl ghrelin was observed on neuronal 
activation or body weight. 
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Figure 3.3 Effects of neonatal overfeeding on the weight change and 
hypothalamic responsiveness after exogenous ghrelin.  
c-Fos positive cells in the arcuate nucleus of the hypothalamus (ARC) (n = 4 - 7) (A) 
and paraventricular nucleus of the hypothalamus (PVN) (n = 5 - 7) (B) of control 
(CL) and small litter (SL) rats on postnatal day (P) 12. (C) Body weight change 2h 
after 1 mg/kg acyl ghrelin (AG), des-acyl ghrelin (DAG) or saline injection (n = 5 - 
7). Data are mean ± SEM. * p < 0.05. 
 
3.1.12 Neonatal overfeeding effects on ghrelin’s accessibility to the 
hypothalamus 
We observed here that neonatal overfeeding exacerbates hypothalamic responsiveness 
to exogenous ghrelin. The possibility that neonatal overfeeding affects the blood brain 
barrier (BBB) permeability as a potential mechanism for this effect by assessing 
numbers and intensity of cells labeled by fluorescently-labeled acyl and des-acyl 
ghrelin in the ARC and PVN was tested. Neonatal overfeeding had no effects on the 
ability of acyl or des-acyl ghrelin to reach the ARC, since there were similar numbers 
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of positive cells (Figure 3.4 A-D, I, J) and intensity of labelling per cell (Figure 3.4 E-
H) in the CL and SL animals at P12. In the PVN, however, there were fewer 
fluorescently labeled acyl ghrelin cells in SL animals compared to CLs (t (11) = 2.22, p 
= 0.049, Figure 3.4 K, O) and lower fluorescence intensity per cell (t (11) = 4.59, p = 
0.0008, Figure 3.4 L). No effects of neonatal overfeeding were observed on the 
fluorescently labeled des-acyl ghrelin positive cells or intensity per cell in PVN 
(Figure 3.4 M, N, P).  
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Figure 3.4 Neonatal overfeeding effects on peripheral ghrelin’s ability to access 
the hypothalamus.  
(A, B) Number of fluorescently labeled acyl ghrelin (AG) positive cells in the arcuate 
nucleus of the hypothalamus (ARC) of control (CL) and small litter (SL) animals on 
postnatal day (P) 12 (n = 6 - 8). (C, D) Number of fluorescently labeled des-acyl 
ghrelin (DAG) positive cells in the ARC of CL and SL animals on P12 (n = 5 - 7). (E, 
F) Intensity per cell of AG positive cells in the ARC (n = 6 - 8). (G, H) intensity per 
cell of DAG positive cells in the ARC (n = 6 - 7). (I) Photomicrographs of AG 
positive cells and (J) DAG positive cells in the ARC. (K) Number, (L) intensity (n = 6 
- 7) and (O) photomicrographs of AG positive cells in the paraventricular nucleus of 
the hypothalamus (PVN). (M) Number, (N) intensity (n = 6 - 7) and (P) 
photomicrographs of AG positive cells in the PVN. Scale bars = 50 μm. Data are 
mean ± SEM. * p < 0.05. 
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3.1.13 Long-term effects of neonatal overfeeding on the ghrelin system  
Optimal functioning of the ghrelin system during the early life developmental period 
is important for long-term metabolism (Steculorum et al. 2015). Therefore, we tested 
here whether changes in the ghrelin system with neonatal overfeeding were reflected 
in adulthood. Our group has previously shown that neonatally overfed rats remain 
significantly heavier than controls as adults (Smith and Spencer 2012; Spencer and 
Tilbrook 2009). Despite a permanent weight change with neonatal overfeeding and 
suppressed des-acyl ghrelin levels on P7, circulating ghrelin levels in adulthood were 
no longer different between groups (Figure 3.5 A). Similarly, hypothalamic Ghsr 
expression in adulthood was not different between groups (Figure 3.5 B). However, 
Mboat mRNA expression was significantly increased in the neonatally overfed adult 
animals relative to controls (t (12) = 2.70, p = 0.019, Figure 3.5 C). Interestingly, 
hypothalamic Npy mRNA expression was suppressed in the neonatally overfed adults 
(t (11) = 2.21, p = 0.049, Figure 3.5 D), without any effects on the hypothalamic Agrp 
and Pomc gene expression (Figure 3.5 E, F).  
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Figure 3.5 Neonatal overfeeding effects on adult ghrelin system.  
(A) Circulating total, acyl ghrelin (AG) and des-acyl ghrelin (DAG) in control (CL) 
and adult animals overfed (SL) during neonatal life (n = 6 - 7). Hypothalamic growth 
hormone secretagogue receptor (Ghsr), (B) ghrelin O-acyl transferase (Goat) Mboat 
(n = 6 - 8), (D) neuropeptide Y (Npy) (n = 6 - 7), (E) agouti related peptide (Agrp) (n 
= 6 - 8) and proopiomelanocortin (Pomc) gene expression (n = 6 - 8). Data are mean ± 
SEM. * p < 0.05. 
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on weight (Figure 3.6 A) or food intake (Figure 3.6 B). Acyl but not des-acyl ghrelin 
mediated an increase in c-Fos positive cells in the ARC, but without any effect of 
neonatal overfeeding (significant effect of ghrelin: F(2,27) = 26.31, p < 0.001, Figure 
3.6 C). In the PVN, there was no effect of neonatal overfeeding on Fos expression, 
but only an effect of drug (F(2,29) = 25.44, p < 0.001, Figure 3.6 D) and, interestingly 
an effect of des-acyl along with acyl ghrelin in increasing c-Fos positive cells 
compared to controls (Figure 3.6 D).  
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Figure 3.6 Neonatal overfeeding effects on body weight change and hypothalamic 
responsiveness to exogenous (1mg/kg) acyl ghrelin (AG), des-acyl ghrelin (DAG) 
or saline in adulthood.  
(A) Body weight change (n = 5 - 7) and (B) food intake 2 hr after injection in control 
(CL) and small litter (SL) adult animals (n = 5 - 6). (C) Arcuate nucleus of the 
hypothalamus (ARC)  (n = 5 - 6) and (D) paraventricular nucleus of the hypothalamus 
(PVN) c-Fos positive cells (n = 5 - 6). Photomicrographs of (E) ARC and (F) and 
PVN. Scale bars = 100 μm. Data are mean ± SEM. * p < 0.05. 
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Discussion  
Ghrelin, traditionally known for its role in appetite stimulation and energy balance 
(Tschop, Smiley, and Heiman 2000), has recently been implicated in other roles, 
including neurodevelopment (Collden et al. 2015). It has been thought likely that acyl 
ghrelin acts as a brake to the leptin surge-initiated growth of neuronal connectivity 
within regions of the hypothalamus that regulate feeding and metabolism (Steculorum 
et al. 2015). Des-acyl ghrelin, on the other hand, has not been studied extensively due 
to lack of knowledge about the receptor through which it acts. In the present study we 
show that postnatal overnutrition (during the first three weeks after birth) in the rat 
alters endogenous ghrelin’s ability to act on the hypothalamus during an important 
developmental period. Neonatal overfeeding suppresses des-acyl ghrelin levels during 
the first week after birth, increases the ratio between acyl ghrelin and des-acyl ghrelin, 
increases hypothalamic expression of ghrelin (Ghsr) and the enzyme that breaks down 
ghrelin into its active form (Goat) and, more importantly, decreases accumulation of 
acyl ghrelin in the PVN, which may be due to decreased ability to reach the PVN. 
 
We, and others have previously shown that early life overnutrition is associated with 
long-term weight gain (Cai et al. 2016; Clarke et al. 2013; Lopez et al. 2007; 
Stefanidis and Spencer 2012; Ziko et al. 2014; Glavas et al. 2010). Here we aimed to 
understand whether the permanent body weight change associated with neonatal 
overnutrition was a consequence of an acute or long-term disruption to the ghrelin 
system. Our results indicate that neonatal overfeeding has pronounced effects on 
suppressing circulating ghrelin levels during the first week of development. A similar 
reduction of acyl ghrelin levels has been reported in neonatally overfed mice (Collden 
et al. 2015; Soares et al. 2012). It is important to note that these studies have not 
considered whether des-acyl ghrelin measurements have been affected by early life 
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overnutrition. It is also important to consider the differences between species in 
regards to ghrelin des-acylation by the responsible enzymes, such as 
butyrylcholinesterase in humans and carboxylesterase in rodents (De Vriese et al. 
2004). Furthermore, carboxylesterase blood levels, differ greatly between mice and 
rats (Rudakova, Boltneva, and Makhaeva 2011). 
 
Similarly to what observed here, decreased des-acyl ghrelin levels, unchanged levels 
of acyl ghrelin and a higher acyl ghrelin to des-acyl ghrelin ratio are reported in obese 
individuals (Delhanty et al. 2013; St-Pierre et al. 2007; Longo et al. 2008; Pacifico et 
al. 2009). An increase in the acyl ghrelin to des-acyl ghrelin ratio may explain the 
increased sensitivity to acyl ghrelin’s effects, such as increased hypothalamic gene 
expression of Ghsr and Goat, that was observed in our study. Additionally our 
neonatally overfed pups exhibited exacerbated hypothalamic responses to exogenous 
acyl ghrelin, but not des-acyl ghrelin. Given the suppressive effect of des-acyl ghrelin 
on acyl ghrelin’s functions (Delhanty et al. 2013; Ozcan et al. 2014) the reduced des-
acyl ghrelin levels seen in neonatally overfed animals could attenuate acyl ghrelin’s 
usual “brake” on hypothalamic neurite outgrowth and lead to acyl ghrelin-mediated 
hyper-activation of hypothalamic neuronal growth.  
 
We showed here that there was no effect of neonatal overfeeding on the ability of 
ghrelin to access the hypothalamus based on the similar numbers of fluorescently 
labeled acyl or des-acyl ghrelin-positive cells seen in the ARC. However, neonatal 
overfeeding affected PVN accessibility of circulating, fluorescently-labeled acyl 
ghrelin as shown by the reduced positive cell numbers and intensity per cell in this 
region of the hypothalamus. These results contrasted with the observation of an 
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exacerbated neuronal activation in the PVN by the same acyl ghrelin dose in 
neonatally overfed pups compared to normally fed counterparts. A potential 
explanation for this discrepancy is that the PVN can be remotely activated, for 
example by ARC and DMH glutamatergic neuronal projections (Ziegler and Herman 
2000; Csaki et al. 2000). Furthermore, the PVN is innervated by different populations 
of neurons and despite the fact that the ghrelin receptor is expressed in PVN neurons, 
these neurons are a different population from those activated by stress (Spencer et al. 
2012). In support of these findings, Cabral and colleagues have shown that 
corticotropin releasing factor (CRF) neurons not containing Ghsr show increased 
neuronal activation in colchicine treated animals, although indirectly activated by 
ghrelin (Cabral et al. 2012).  
 
Taken together our results suggest that neonatal overfeeding exacerbates 
hypothalamic sensitivity to endogenous acyl ghrelin, possibly due to the lack of des-
acyl ghrelin’s antagonising effects on acyl ghrelin. Importantly, these neuroendocrine 
defects are restricted to the early life developmental period without life-long effects. 
The only long-term effect with neonatal overfeeding observed in our study was an 
increased expression of hypothalamic Mboat4, however this was not sufficient to 
affect circulating ghrelin levels or hypothalamic responsiveness to exogenous ghrelin. 
Mboat4 can be locally produced and regulated depending on relevant metabolic states 
(Gahete, Cordoba-Chacon, et al. 2010) and so it is possible that this difference in 
Mboat4 expression could lead to differences in coping with a metabolic challenge, but 
this remains to be determined. Ghrelin has also been shown to affect feeding not only 
via the ARC, but also via other extra-hypothalamic sites such as the paraventricular 
thalamus, amygdala and brainstem (Faulconbridge et al. 2003; Kanoski et al. 2013). 
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Further investigations are needed to define the role of neonatal overfeeding on extra-
hypothalamic influence of ghrelin long-term. Nonetheless, our results here further 
support those seen with the impact of neonatal overfeeding on leptin-mediated 
regulation of the hypothalamus in that many of the major effects resolve by 
adulthood. These findings are potentially encouraging for people having had poor 
diets in early life. 
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Introduction 
The early life nutritional environment can permanently affect homeostatic pathways, 
therefore programming an individual’s life-long health. Over- or under-nutrition in 
utero and during the neonatal period in male humans and rodents is associated with 
increased risks of developing metabolic disorders later in life (as reviewed in 
(Spencer 2012)). The nutritional environment in early life also alters sensitivity to the 
metabolic hormones leptin and ghrelin in males (Bouret 2010; Collden et al. 2015; 
Davidowa, Li, and Plagemann 2003; Plagemann 2006). We have seen that the 
nutritional environment during postnatal development in males leads to a permanent 
disruption of metabolic parameters such as body weight, circulating leptin and 
ghrelin, with central changes to the leptin and ghrelin systems (Sominsky, Ziko, et al. 
2017; Sominsky, Ziko, Nguyen, et al. 2016). However, whether similar effects are 
present in females is much less well known.  
 
Obesity affects women as much, if not more than men. Despite a great variability 
between and within countries, globally there are more obese women than men (Kanter 
and Caballero 2012). In boys the relation between body mass index (BMI) and 
puberty is non-linear. Being overweight in boys is associated with early puberty, 
whereas severe obesity is associated with late puberty. In girls, obesity is always 
associated with early puberty (Wang 2002; Rasmussen et al. 2015). Aside from the 
myriad diseases and disorders common to both sexes that are caused or precipitated 
by obesity, there are several obesity-related complications that are particular to 
females. Thus, it is established that being overweight and obese during childhood in 
girls leads to fertility problems including polycystic ovarian syndrome (Lee et al. 
2007; Maisonet et al. 2010; Teede, Deeks, and Moran 2010). Being overweight and 
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obese increases the risk of pregnancy complications such as gestational diabetes 
mellitus (Chu et al. 2007). Obesity also differentially affects circulating leptin levels 
in males and females with the latter having significantly increased leptin compared to 
males after controlling for BMI, age and percentage of body adiposity indicating that 
more leptin is released from the same adipose mass in women compared to men (Azar 
et al. 2002). In the context of mood, anxiety and depression there is a positive 
relationship between the above disorders and obesity (defined by BMI) in women but 
not in men (de Wit et al. 2010; Barry, Pietrzak, and Petry 2008).  
 
Early life events including nutrition or exposure to stress also affect females and 
males differently. Both male and female offspring born from mothers exposed to the 
Dutch Hunger Winter during pregnancy had increased BMI and adiposity, however 
females were affected to a greater extend compared to males (Stein et al. 2007). A 
number of animal studies have shown that maternal obesity is associated with 
hypothalamic gene dysregulation in both males and females, however this 
dysregulation in males is greater than in females (Dearden and Balthasar 2014). 
Likewise, male offspring overfed during the neonatal period develop higher 
hypothalamic inflammation compared to females (Argente-Arizon et al. 2018). Other 
early life perturbations, including stress, are associated with significantly increased 
risk of developing post-traumatic stress disorders, depression and anxiety in females 
compared to males (Pratchett, Pelcovitz, and Yehuda 2010; Olino et al. 2010; Breslau 
2009). As such it seems likely that females are equally if not more vulnerable than 
males to the early programming effects of diet on later metabolic function.  
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Unfortunately, most of the key animal studies elucidating the programming effects of 
early diet and the roles of hormones such as leptin have been performed in males 
without consideration of females. Bouret and colleagues have shown that large litter 
rearing in female rats bred to develop diet-induced obesity ameliorates central leptin 
sensitivity and protects from adverse metabolic effects of obesity in comparison to 
normal litter rearing females (Patterson et al. 2010). Furthermore, our group and 
others have shown that males that are neonatally overfed also have disruptions in both 
circulating ghrelin and the ability of ghrelin to act at the hypothalamus to regulate 
feeding circuitry (Sominsky, Ziko, Nguyen, et al. 2016; Collden et al. 2015); an effect 
that is present during the neonatal period but partly normalised by adulthood. Like 
males, neonatally overfed females are hyperleptinemic in juvenile and adult life 
(Stefanidis and Spencer 2012; Sominsky, Ziko, Soch, et al. 2016). Our group also 
shown that increased prepubertal weight and hyperleptinemia are associated with 
earlier puberty onset in female (Sominsky, Ziko, Soch, et al. 2016), but not male rats 
(Smith and Spencer 2012). However, it is currently unknown whether 
hyperleptinemia in females leads to disruptions in hypothalamic feeding circuitry as it 
does in males (Sominsky, Ziko, et al. 2017), and the precedent for major sex 
differences in hypothalamic outcomes after neonatal overfeeding (Spencer and 
Tilbrook 2009) suggests a similarity to male responses cannot be assumed for 
females. We therefore aimed to determine if neonatal overfeeding-induced 
hyperleptinemia would compromise hypothalamic connectivity and hypothalamic 
responsiveness to leptin in females as it does in males.  
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Materials and Methods  
4.1.1 Animals 
In these experiments time-mated pregnant Wistar rats were used, obtained from the 
Animal Resources Centre, WA, Australia. On arrival at the RMIT University Animal 
Facility at day 14-16 of gestation, they were housed at 22 °C, 12 hr light/dark cycle 
(0700 – 1900 hr). Ad libitum pelleted standard rat chow and water was provided to 
them. All procedures described here were conducted in accordance with National 
Health and Medical Research Council Australia Code of Practice for the Care of 
Experimental Animals and the RMIT University Animal Ethics Committee approval. 
 
4.1.2 Litter size manipulation  
As previously described in Chapter 2: Materials and Methods “Litter size 
Manipulation” and (Smith and Spencer 2012; Spencer and Tilbrook 2009; Stefanidis 
and Spencer 2012) manipulation of litter sizes was performed. Experimental animals 
were culled at P7, P12 or P14. Only females were used in the experiments described 
here. Data from the males of the same litters were used in other publications 
(Sominsky, Ziko, et al. 2017; Sominsky, Ziko, Nguyen, et al. 2016). All experimental 
groups were derived from three or more litters, using a maximum of two pups from 
the same litter for an experimental treatment to control for maternal effects (Spencer 
and Meyer 2017).  
 
4.1.3 Effects of neonatal overfeeding on neonatal circulating leptin and 
triglycerides  
On P7 or P14 the animals were rapidly decapitated and trunk blood was collected for 
later assessment of plasma leptin and triglycerides. Whole blood was collected in 
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EDTA-coated tubes, kept on ice and quickly centrifuged to separate the plasma. The 
plasma samples were aliquoted and stored at -20 °C avoiding freeze-thaw cycles until 
use.  
 
To determine leptin concentrations in our samples a standard commercial leptin 
ELISA was performed, following the manufacturer’s instructions (Millipore, 
Ballerica, MA, USA). Intra-assay variability was 1.9-2.5% CV, inter-assay variability 
3.0-3.9% CV, and lower limit of detection 0.04 ng/mL. All compared samples were 
assayed in duplicate and processed in the same assay.  
 
To determine triglyceride concentration in our samples a triglyceride assay (Cayman, 
Ann Arbor, MI, USA) was performed according to the manufacturer’s instructions. 
Intra-assay coefficient of variation was 1.34%, inter-assay coefficient of variation was 
3.17% and the lower limit of detection for this assay was 0.5 mg/dL. All samples 
were assessed in duplicate and under the same conditions. (This ELISA was 
conducted by Dr Simone De Luca from samples generated by me). 
 
4.1.4 Effects of neonatal overfeeding on hypothalamic gene expression 
Quantitative real-time PCR (qRT-PCR) was used in order to assess whether neonatal 
overfeeding alters hypothalamic gene expression of the neuropeptide Y (Npy), agouti 
related peptide (Agrp), proopiomelanocortin (Pomc) or leptin receptor (Lepr) in the 
arcuate nucleus of the hypothalamus (ARC) and hypothalamus from the animals 
described above (See Table 4.1 for primer details). These methods are extensively 
described in Chapter 2 (Materials and Methods: “Effects of neonatal overfeeding on 
hypothalamic gene expression”). Since POMC cell bodies are found exclusively in 
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two central nervous system (CNS) nuclei, the ARC and the nucleus tractus solitarius 
(Joseph, Pilcher, and Bennett-Clarke 1983; Cone 2005), POMC gene expression was 
not examined in the hypothalamic tissue that did not contain the ARC.  
 
Table 4.1 Primer details for quantitative real-time PCR. 
 
Primer name NCBI Reference Sequence TaqMan Assay ID Product size 
Actb NM_031144.2 4352340E 91 
Lepr NM_012596 Rn01433205_ml 94 
Npy NM_012614.2 Rn00561681_m1 63 
Agrp NM_033650.1 Rn01431703_g1 67 
Pomc NM_139326.2  Rn00595020_m1 92 
 
 
4.1.5 Neuronal activation in response to exogenous leptin  
To assess if neonatal overfeeding influences the ability of the hypothalamus to 
respond to circulating leptin, neuronal activation in response to 3 mg/kg i.p. leptin or 
an equivalent volume of 0.9% sterile saline at P12 was assessed. Pups were weighed 
immediately before and 45 min after injection. For immunohistochemistry and 
analysis of phosphorylated signal transducer and activator of transcription 3 
(pSTAT3) as a marker of leptin-induced neuronal activation, NPY, AgRP and POMC 
please see Chapter 2: Materials and Methods: “Brain collection” and 
“Immunohistochemistry”. pSTAT3 immunohistochemistry and cell counts were 
performed by Ms Thai Xinh Nguyen as part of her Honours project from sections 
generated by me and under my supervision and training. In order to exclude POMC 
cytoplasmic labelling from the fibre density analysis, area restriction was applied. 
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This allows for the NIS program to exclude labeling of any objects that were larger 
than the fibres.  
 
4.1.6 Data analysis 
All data were analysed using multi-factorial analyses of variance (ANOVA)s with 
neonatal nutritional environment (CL/SL) and age (P7/14) or leptin treatment 
(saline/leptin) as between factors. Where significant interactions were found, we then 
performed Tukey post hoc tests. Immunoreactivity results were analysed with 
Student’s unpaired t-tests. Data are presented as the mean ± SEM. Statistical 
significance was assumed when p ≤ 0.05. All data were tested for homogeneity of 
variance and normality, using the Levene’s test for Equality of Variance and the 
Shapiro-Wilks test, respectively, complemented by the assessment of skewness and 
kurtosis. These assessments and all other statistical analyses were conducted using 
SPSS. Outliers were determined using the Grubbs’ test (α = 0.05) in GraphPad Prism. 
 
Results  
4.1.7 Neonatal overfeeding leads to accelerated weight gain 
In this cohort of rats, neonatal overfeeding led to early weight gain. Neonatally 
overfed (SL) female rats were thus significantly heavier than controls (CL; significant 
age by litter size interaction: F(1, 32) = 30.37, p < 0.001; n = 8-10; Figure 4.1 A). Post 
hoc analyses indicated that by P14 the SL were significantly heavier than CL. These 
findings are similar to those in males (as in Chapter 2: Figure 2.1) and to our 
previously published data in females (Smith and Spencer 2012; Spencer and Tilbrook 
2009; Stefanidis and Spencer 2012).  
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4.1.8 Neonatal overfeeding effects on circulating leptin 
We have previously seen that circulating leptin levels are higher in neonatally overfed 
than in control female (and male) rats during the neonatal period, and into adulthood 
(Stefanidis and Spencer 2012; Sominsky, Ziko, et al. 2017; Sominsky, Ziko, Soch, et 
al. 2016) and we replicated the neonatal findings here (significant effect of litter size: 
F (1, 20) = 25.35, p < 0.001; significant effect of age: F (1, 20) = 6.01, p = 0.024, n = 6 per 
group, Figure 4.1 B). 
 
Figure 4.1 Effects of neonatal overfeeding on the neonatal leptin system.  
(A) Body weights of control (CL) and small litter (SL) rats at postnatal day (P) 7 and 
14. (B) Plasma leptin concentrations at P7 and P14. Data are mean ±S.E.M. n = 6 – 11 
per group. * Tukey’s post hoc. # significant main effect of litter size. $ significant 
main effect of age. p < 0.05.  
 
4.1.9 Neonatal overfeeding effects on neonatal hypothalamic feeding-
related gene expression  
Neonatal overfeeding did not affect the hypothalamic satiety-related genes measured 
here. However, significant age-related changes in these genes were observed. 
Expression of Lepr mRNA was significantly increased at P14 compared to P7 in the 
ARC (significant effect of age: F(1, 21) = 23.07, p < 0.001; n = 5-6; Figure 4.2 A) and 
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neonatal overfeeding, but it was significantly increased at P14 compared to P7 
(significant effect of age: F(1, 19) = 5.84, p = 0.026; n = 5-6; Figure 4.2 C). In the 
hypothalamus, neonatal overfeeding had no effect on Npy expression (Figure 4.2 D). 
Agrp mRNA expression in the ARC was not affected by neonatal overfeeding, 
however, like Npy, it was significantly increased at P14 compared to P7 (significant 
effect of age: F(1, 19) = 12.86, p = 0.002; n =5-6; Figure 4.2 E). Neonatal overfeeding 
also did not affect Pomc mRNA expression in the ARC. However, again, there was a 
significant increase of Pomc mRNA in P14 ARC compared to P7 (significant effect of 
age: F(1, 17) = 6.16, p = 0.024; n = 5-6; Figure 4.2 F).  
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Figure 4.2 Neonatal overfeeding effects on neonatal hypothalamic feeding-
related gene expression.  
(A) Leptin receptor expression in the arcuate nucleus of the hypothalamus (ARC) and 
(B) hypothalamus (HY) of control (CL) and small litter (SL) rats at postnatal day (P) 
7 and P14. (C) Neuropeptide Y (NPY) gene expression in the ARC and (D) in the 
HY. (E) Agouti-related peptide (AgRP) gene expression in the ARC. (F) Pro-
opiomelanocortin (POMC) gene expression in the ARC. Data are mean ± S.E.M. n = 
5 – 6 per group. $ significant main effect of age. p < 0.05. 
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4.1.10 Neonatal overfeeding effects on neonatal hypothalamic NPY, AgRP, 
POMC 
To determine if the elevated leptin in neonatally overfed females was associated with 
a disruption of hypothalamic NPY, AgRP and POMC as previously described in 
males (Sominsky, Ziko, et al. 2017), we examined NPY fibres (ARC: Figure 4.3 A, B, 
PVN: Figure 4.3 C, D), AgRP fibres (ARC: Figure 4.3 E, F, PVN: Figure 4.3 G, H), 
POMC positive cells in the ARC (Figure 4.3 I, J) and POMC fibres in the PVN 
(Figure 4.3 K, L) at P12. Neonatal overfeeding did not affect NPY, AgRP and POMC 
immunoreactive fibres or POMC immunoreactive cells in these regions (n = 5-6 per 
group).  
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Figure 4.3 Neonatal overfeeding effects on neonatal hypothalamic circuitry.  
(A, B) Neuropeptide Y (NPY) labelling in the arcuate nucleus of the hypothalamus 
(ARC) and (C, D) paraventricular nucleus of the hypothalamus (PVN) of control (CL) 
and small litter (SL) rats at postnatal day (P) 12. (E, F) Agouti-related peptide (AgRP) 
labelling in the ARC and (G, H) PVN. (I, J) Proopiomelanocortin (POMC) positive 
cells in the ARC. (K, L) POMC labelling in the PVN. Representative 
photomicrographs showing NPY labelling in the (B) ARC and (D) PVN, AgRP 
labelling in the (F) ARC and (H) PVN, POMC labelling in the (J) ARC and (L) PVN. 
Scale bars = 100 µm. Data are mean ± S.E.M. n = 5 – 6 per group. 
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4.1.11 Neonatal overfeeding effects on neonatal hypothalamic responses to 
leptin 
We next tested if neonatal overfeeding alters the ability of the neonatal hypothalamus 
to respond to a leptin signal by giving the pups a single injection of leptin or saline on 
P12 and measuring weight changes as well as hypothalamic pSTAT3 expression. 
Leptin stimulated an increase in the number of pStat3 positive cells in the ARC, as 
expected (F (1, 17) = 101.30, p < 0.001; n = 5-6). There was also a significant increase 
in the number of pStat3 positive cells in the ARC by litter size (main effect of litter 
size (F(1, 17) = 7.36, p = 0.015; Figure 4.4 A, D) but no interaction. In the ventromedial 
hypothalamus (VMH) however, leptin injection also induced a significant increase in 
pSTAT3 positive cells (main effect of leptin: F(1, 17) = 42.84, p < 0.001; n = 5-6; 
Figure 4.4 B, E).  
 
 
 
 
  99 
 
Figure 4.4 Neonatal overfeeding effects on neonatal hypothalamic responses to 
leptin.  
(A) Arcuate nucleus of the hypothalamus (ARC) and (B) ventromedial hypothalamus 
(VMH) neuronal activation in response to leptin injection at postnatal day (P) 12 in 
control (CL) and small litter (SL) rats as assessed by numbers of signal transducer and 
activator of transcription (pSTAT3) positive cells. The sum of cell counts in four 
sections was plotted. (C) Schematic diagram adapted from Paxinos and Watson 
illustrating the regions of interest (Paxinos and Watson 2009). Thick-line boxes are 
representative of analysed regions, dotted-line boxes are representative of the 
photomicrographs. Representative photomicrographs of pSTAT3 after a saline or 
leptin injection in the (D) ARC (scale bars = 100 µm) and (E) VMH (scale bars = 200 
µm). Data are mean ± S.E.M. n = 5 – 6 per group. # significant main effect of litter 
size. % significant main effect of leptin. p < 0.05. 
 
4.1.12 Neonatal overfeeding effects on neonatal circulating triglycerides 
Since neonatal overfeeding has minimal effects on hypothalamic feeding circuitry in 
female rats despite inducing pronounced neonatal hyperleptinemia we next examined 
circulating triglyceride levels. Triglycerides have been shown to mediate leptin 
transport to the brain (Banks et al. 2004). We therefore hypothesized neonatal 
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transport to the brain and thus reduce the effects of hyperleptinemia. In this regard, 
neonatal overfeeding led to an increase in circulating triglyceride levels (significant 
effect of litter size: F (1, 20) = 5.43, p = 0.030; n = 6 per group, Figure 4.5), without a 
main effect of age.  
 
Figure 4.5 Neonatal overfeeding effects on neonatal circulating triglycerides.  
Plasma triglyceride concentration at P7 and P14. Data are mean ± S.E.M. n = 6 – 10 
per group. # significant main effect of litter size. p < 0.05. 
 
Discussion 
The early life nutritional environment plays a crucial role in metabolism and 
neurodevelopment. Here, for the first time, we show that neonatal overfeeding in 
females, despite hyperleptinemia and a corresponding increased body weight, does 
not affect NPY, AgRP and POMC mRNA or protein in the hypothalamic circuitry 
responsible for feeding and metabolic control. These observations are different from 
findings previously shown in neonatally overfed males, where overfeeding leading to 
hyperleptinemia and increased body weight are associated with early life disruption of 
hypothalamic neuronal wiring responsible for metabolic regulation (Sominsky, Ziko, 
et al. 2017; Collden et al. 2015). 
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with a peak at P10 (Delahaye et al. 2008). They then decrease towards adult levels 
after weaning (Ahima, Prabakaran, and Flier 1998). Such an increase in leptin levels 
is not associated with acute changes in food intake, but is reflective of leptin’s 
neurodevelopmental role in stimulating the growth of hypothalamic connections 
between the ARC and other hypothalamic regions that are ultimately responsible for 
controlling energy balance (Bouret, Draper, and Simerly 2004b). Disruptions to this 
leptin surge can permanently impact upon the development of these hypothalamic 
connections and lead to aberrant feeding behaviour and metabolism throughout life 
(Bouret, Draper, and Simerly 2004a, 2004b). Being suckled in a small litter during the 
first three weeks of life in mice and rats can similarly disrupt hypothalamic circuitry. 
Thus, early life overfeeding increases body weight, fat mass, and circulating leptin in 
comparison to the normally-fed. In males, this hyperleptinemia is associated with a 
disruption in NPY and AgRP fibres and leads to an obese phenotype that is 
maintained throughout life (Stefanidis and Spencer 2012; Plagemann, Harder, Rake, 
et al. 1999; Plagemann et al. 2009; Lopez et al. 2007).  
 
It is important to note that most of the current knowledge in regards to the effects of 
postnatal overfeeding on hypothalamic neuronal development derives from 
observations in male rodents. However, changes in the neonatal leptin availability as a 
result of overfeeding appear to induce sex-dependent effects on the development of 
hypothalamic neuronal connectivity. We observe here that in females, similarly to 
males, neonatal overfeeding is associated with exacerbated hyperleptinemia during 
the neonatal leptin surge period, and this is followed by an increase in body weight. 
However, neonatally overfed females are still responsive to leptin and, importantly, 
there is no effect of female neonatal overfeeding on the mRNA levels of the leptin 
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receptor, or in gene or protein expression of NPY, AgRP, or POMC in the 
hypothalamus. The ARC of small litter animals showed decreased sensitivity to 
leptin, although there was no interaction between litter size and leptin. However, the 
magnitude of this difference is small, of the order of 15% of the response in the case 
of the leptin-treated. We also do not see this difference in the VMH. Is observed here 
that neonatally overfed females have increased circulating triglyceride levels relative 
to controls. It is thus possible that hyperleptinemia in females is compensated for by 
elevated blood triglycerides restricting leptin’s access to the brain in the neonatally 
overfed (Banks et al. 2004), which may also account for the minor reduction in the 
number of pSTAT3 positive cells in the ARC of these animals. However, this 
observation does not explain why males are not also resistant to the effects of excess 
leptin, since we would expect males to also have increased circulating triglyceride 
levels when neonatally overfed. There is some evidence of sex differences in 
triglyceride levels in adults after an early food restriction. For instance, there are 
elevated triglycerides in perinatally food-restricted females relative to males (Lee et 
al. 2013), while other perinatal insults, such as maternal deprivation, have been shown 
to increase circulating triglycerides in adult males, but decrease them in females 
(Mela et al. 2016). However, no direct sex comparison has yet been made during the 
neonatal phase. 
 
Previous results from our group have demonstrated sex differences in the way that 
neonatally overfed rats control energy expenditure. Female rats that are overfed as 
neonates remain obese into adulthood and they do this not by overeating, but by 
reducing energy expenditure, probably due to reduced activation of brown adipose 
tissue (BAT) during the first half of the dark phase (Stefanidis and Spencer 2012). 
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BAT is responsible for the conversion of energy from food into heat primarily via 
uncoupling protein in mitochondria (Commins et al. 1999), and neonatally overfed 
females are unable to optimally convert BAT into energy and show reduced energy 
consumption at the juvenile stage, with normalisation of function in adulthood. BAT 
uncoupling protein is capable of short-circuiting the electron transport chain and 
allowing for conversion of mitochondrial membrane potential to heat. This disruption 
of BAT function at the juvenile stage is not evident in the neonatally overfed males 
(Stefanidis and Spencer 2012). BAT thermogenesis is reduced in neonatally overfed 
females until P30 but by adulthood BAT thermogenesis normalises to controls levels 
(Stefanidis and Spencer 2012); a possible explanation for how these females retain an 
elevated body weight without any changes in their hypothalamic feeding networks.  
 
Another potential reason for these sex-dependent effects of neonatal overfeeding may 
lie in the way the male and female brain is wired. Sex steroid hormones such as 
estrogen and testosterone, in combination with neurotrophins, regulate formation of 
sexually dimorphic circuits by affecting axonal guidance and synaptogenesis 
(reviewed in (McCarthy and Arnold 2011)). Significant hormonal changes in the 
central nervous system in rodents happen partly due to the gonadal steroid hormones 
during sexual differentiation (Ikeda et al. 2003). For instance, sexually dimorphic 
nucleus, a cluster of cells in the preoptic area of the hypothalamus responsible for 
controlling sexual behaviour by affecting sex hormones such as testosterone and 
estrogens in rats, develops from as early as P1. By P8 this region is almost twice the 
size in males as that of females (reviewed in (He et al. 2013)). Conversely, the 
anteroventral periventricular nucleus, a region of the hypothalamus responsible for the 
pulsatile release of gonadotropin releasing hormone, covers a larger area and consists 
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of a larger number of neurons in females than in males (reviewed in (McCarthy and 
Arnold 2011)). Testosterone and estrogens influence energy homeostasis at least 
partially via hormone receptors, which are co-localised with hunger or satiety 
neuropeptides located in the hypothalamus (Frank, Brown, and Clegg 2014). This 
suggests that sexual dimorphism affects the development of hypothalamic regions that 
control energy balance, and thus may also be reflected in the differential effects of 
neonatal overfeeding on hypothalamic appetite-regulatory circuitry. 
 
Overall our results suggest females overfed during early life, despite being 
hyperleptinemic and experiencing an obesogenic phenotype, are not acutely affected 
in their central neuronal connectivity responsible for metabolic control. These results 
contrast with our and others’ previous findings in males. These findings are 
potentially reflective of differences in how females and males adapt to early life 
environmental dietary challenges. Our work further highlights that it is important not 
to assume female physiology from male data and that different physiological 
mechanisms may lead to a similar phenotypic outcome, in this case excess body 
weight. 
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Introduction 
In the previous chapters (Chapters 2-4) we showed that in males, an early life 
overnutritional environment was associated with peripheral and central alterations to 
the leptin and ghrelin systems. However, neonatally overfed females despite their 
obese phenotype, were not affected in terms of the central neuronal connectivity 
responsible for metabolic control. Despite these findings, the female hypothalamus is 
still likely to be vulnerable to early life challenge since we have previously shown 
that females exposed to an over-nutritional environment during the first weeks of life 
have exacerbated responses to psychological stress later in life. Notably, such 
responses are unaffected in males (Spencer and Tilbrook 2009).  
 
Both physical and psychological stressors rapidly activate the hypothalamic-pituitary-
adrenal (HPA) axis by stimulating release of corticotropin releasing hormone (CRH) 
from the paraventricular nucleus of the hypothalamus (PVN; the apex of the HPA 
axis). CRH stimulates the anterior pituitary into synthesizing adrenocorticotropic 
hormone (ACTH), which in return acts via melanocortin 2 receptors in the adrenal 
cortex to stimulate and secrete glucocorticoids such as corticosterone and cortisol in 
rodents and humans, respectively. Glucocorticoids negatively feed back at the 
hypothalamus, hippocampus and pituitary to inhibit secretion of CRH and ACTH and 
therefore stop further activation of the HPA axis (Papadimitriou and Priftis 2009). 
Human studies have shown that dysregulation of the HPA axis, especially during 
development, has been strongly linked to long-term disease risk (Reynolds 2013; 
Edwards et al. 1993). For instance, low birth weight due to an adverse prenatal 
environment is associated with increased HPA axis reactivity including increased 
morning cortisol levels, increased cortisol responses to ACTH challenge, 
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cardiovascular, metabolic and cognitive disorders long-term (Reynolds 2013; 
Reynolds et al. 2001). Moreover, girls and women are more likely to display greater 
stress reactivity than boys and men. As such, preterm females have higher morning 
cortisol levels compared to preterm and full-term males (Quesada et al. 2014). 
Likewise, in a study from Yong Ping et al, prenatal maternal stress programs greater 
stress responsivity, as evidenced by increased salivary cortisol after a brief maternal 
separation in female toddlers compared to male toddlers (Yong Ping et al. 2015). 
These findings indicate that it is particularly important to consider sex differences in 
HPA axis responses to stress. 
 
Ghrelin, along with its roles in regulating energy balance and neurodevelopment, has 
recently been shown to be involved in HPA axis regulation (as reviewed in (Spencer 
et al. 2015)). Ghrelin is modulated by exposure to stressful situations (Lutter et al. 
2008; Zheng et al. 2009). Under stress, circulating ghrelin levels are highly increased, 
possibly via sympathetic activation of gut ghrelin cells (Mundinger, Cummings, and 
Taborsky 2006). High ghrelin levels due to ghrelin subcutaneous injection or calorie 
restriction are associated with anxiolytic-like behaviours, which in turn may help the 
animals to cope with stress (Lutter et al. 2008; Spencer et al. 2012). Furthermore, 
ghrelin affects the HPA axis at all its levels. In the hypothalamus, ghrelin indirectly 
activates the PVN (Cabral et al. 2012); in the anterior pituitary we have shown that 
ghrelin stimulates ACTH release by recruiting the growth hormone secretagogue 
receptor (GHSR) (Spencer et al. 2012); and in the adrenal gland ghrelin enhances 
adrenal cortical cell proliferation (Andreis et al. 2003). 
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It remains largely unknown how the postnatal nutritional environment affects 
ghrelin’s ability to regulate the HPA axis during development and long-term and 
whether these effects are sex-dependent. We ((Sominsky, Ziko, Nguyen, et al. 2016) 
and Chapter 2) and others (Collden et al. 2015) have previously shown that neonatal 
overfeeding disrupts the ghrelin system in males. However, the effects of early life 
overnutrition on the ghrelin system and ghrelin’s ability to control the HPA axis in 
females are currently unknown. Here we hypothesised that neonatal overfeeding 
affects ghrelin’s ability to regulate the HPA axis in females and consequently their 
responses to stress. To test this hypothesis we assessed ghrelin’s ability to signal the 
hypothalamus and the pituitary gland in neonatally overfed female rats. We observed 
that neonatal overfeeding had no effect on ghrelin signaling in the hypothalamus, 
however it significantly suppressed the ability of ghrelin to stimulate the pituitary 
gland, which may be a contributing factor to the exacerbated HPA axis responses to 
stress we see in these females. 
 
Materials and methods  
5.1.1 Animals 
As described in Chapter 2, we obtained timed pregnant Wistar rats from the Animal 
Resources Centre, WA, Australia. On arrival at the RMIT University Animal Facility, 
we housed them at 22°C on a 12 hr light/dark cycle (07:00–19:00 h) and provided 
them with standard pelleted rat chow and water ad libitum. We conducted all 
procedures in accordance with the National Health and Medical Research Council 
Australia Code of Practice for the Care of Experimental Animals and RMIT 
University Animal Ethics Committee approval.  
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5.1.2 Litter size manipulation  
To derive our neonatally overfed animal model we performed manipulation of litter 
sizes as previously described in Chapter 2 (Materials and methods: “Litter size 
manipulation”). In this study, the animals were culled at postnatal day (P) 7, 12, 14 
and at ~P70. The animals that were allowed to grow to adulthood were separated into 
same sex littermate pairs at weaning (P21) and were fed a standard chow diet until 
experimentation. The experimental groups were derived from 3 or more litters. 
Females only were used in these experiments, results collected from males were 
published in (Sominsky, Ziko, Nguyen, et al. 2016) and reported in Chapters 2 and 3.   
 
5.1.3 Ghrelin assays  
Female animals were used in these experiments on P7, P14 and ~P70. Animals were 
euthanised and blood was collected and processed as previously described in Chapter 
3 (Materials and Methods: “Neonatal overfeeding effects on circulating ghrelin”).  
 
5.1.4 Real-time qPCR analysis  
To assess neonatal overfeeding effects on genes involved in ghrelin-sensitive central 
pathways we collected pituitaries and brains from which hypothalami were dissected. 
Samples were processed as previously described in Chapter 2 (Materials and 
Methods: “Effects of neonatal overfeeding on hypothalamic gene expression”) using 
the primers described in Table 5.1. 
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Table 5.1 Primer details for qRT-PCR 
 
Primer name NCBI Reference Sequence TaqMan Assay ID Product size 
18s X03205.1 4319413E 187 
Ghsr NM_032075.3 Rn00821417_m1 61 
Mboat4 NM_001107317.2 Rn02079102_s1 93 
 
 
5.1.5 Hypothalamic responsiveness to exogenous ghrelin  
To assess if neonatal overfeeding affects hypothalamic responsiveness to exogenous 
ghrelin, we injected 1 mg/kg of acyl ghrelin (AG), des-acyl ghrelin (DAG) or saline 
to control (CL) and small litter (SL) animals on P12. 2 hr post-injection the animals 
were deeply anaesthetized then transcardially perfused as previously described in 
Chapter 2 (Materials and methods: “Brain collection”) and the tissue was processed 
for c-Fos immunohistochemistry as described in Chapter 3 (Materials and Methods: 
“Neonatal overfeeding effects on neuronal activation in response to ghrelin c-Fos 
immunohistochemistry”).  
 
5.1.6 Neonatal overfeeding affects pituitary responses to AG and CRH in 
vitro 
To assess the in vitro effects of AG and CRH on the anterior pituitary release of GH 
and ACTH, we excised the anterior pituitaries from CL and SL adult female rats and 
stored them in ice-cold Dulbecco’s modified Eagle’s medium/Nutrient mixture F-12 
(DMEM/F-12; Thermo Fisher Scientific, Scoresby, Victoria, Australia) containing 
0.1% bovine serum albumin (BSA) until all tissues were collected. Each anterior 
pituitary was bisected, weighed and pre-incubated for two x 1 hr incubations in 1 mL 
of DMEM/F-12 at 37 °C in a 95% O2/5% CO2 atmosphere. After the pre-incubation 
period, we refreshed the medium and collected samples every 15 min for 1 hr to 
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obtain basal release profiles of growth hormone (GH) and ACTH from the anterior 
pituitary. To assess the pituitary responsiveness to secretagogue stimuli, AG (10-6 M) 
and CRH (100 ng/mL)-containing media were added in the second fraction. After 
each 15 min interval, the medium was collected and stored at -20 °C until assayed. 
GH and ACTH levels were assessed by ELISAs following the manufacturers’ 
instructions. Intra assay variability for the GH ELISA (Millipore, Ballerica, MA, 
USA) was 1.7 - 4.3% coefficient of variation (CV), inter assay variability was 3.2 – 
4.9% CV and the lowest level of detection was 0.07 ng/mL. For the ACTH ELISA 
(MD Biosciences, St. Paul, MN, USA), intra-assay variability was 3.1 - 4.2% CV, 
inter-assay variability, 5.8 - 6.2% CV, and lowest limit of detection, 0.46 pg/mL. 
Samples from all treatment groups were assayed together in duplicate. Data are 
expressed as percentage of the basal ACTH or GH secretion as measured at the end of 
the first 15 min period, and set to 100% as previously described in (Cai et al. 2016) 
and Figure 5.1 (Dr Luba Sominsky assisted me with running the in vitro studies and 
she conducted the ELISAs, which were analysed by me).  
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Figure 5.1 Study design.  
At postnatal day (P) 0 litter size manipulation was conducted and 12 pups (6 males 
and 6 females) were allocated to dams to form a control litter and 4 pups (2 males and 
2 females) to serve as a small litter. Only female offspring were used in this study. At 
P7, P14 and ~P70 circulating ghrelin concentration, hypothalamic and pituitary 
mRNA expression of growth hormone secretagogue receptor (Ghsr) and ghrelin O-
acyl transferase (Goat) were measured in CL and SL animals. At P12, hypothalamic 
responsiveness to exogenous acyl ghrelin (AG), des acyl ghrelin (DAG) or saline was 
assessed. Another cohort of CL and SL adult animals was used for the in vitro study. 
After collection of fraction 1 (0 min), pituitaries were either stimulated with 
corticotropin releasing hormone (CRH: 10-10 M) or AG (10-6 M); or left unstimulated 
with media only being refreshed and collected every 15 min. Pituitary growth 
hormone (GH) and adrenocorticotropic hormone (ACTH) secretion were measured in 
the media collected every 15 min (for 45 min). 
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5.1.7 Data analysis  
Neonatal and adult data were analysed separately in this study. Neonatal overfeeding 
effects on ghrelin, gene expression and hypothalamic responses to ghrelin in early life 
were analysed using multifactorial analysis of variance (ANOVA)s with litter size 
(CL/SL), age (P7/P14) or treatment (saline/ghrelin) as between factors where 
appropriate. At P12 data analysis was conducted using Student’s unpaired t-tests. For 
adults we used Student’s unpaired t-tests or two-way ANOVAs. When significant 
interactions were found, Tukey post hoc tests were performed. p values of less than 
0.05 were considered to be statistically significant. We used repeated measures 
ANOVAs to analyse in vitro pituitary GH and ACTH with AG/CRH and litter size as 
between factors, and time as the repeated measure. When the assumption of sphericity 
was violated, we used the Greenhouse-Geisser correction. A Bonferroni correction 
was applied to adjust for multiple comparisons. We followed this analysis by two-way 
ANOVA and Tukey post hoc tests, where significant interactions were found (p < 
0.05). Data are presented as the mean ± SEM. All data were tested for homogeneity of 
variance and normality, using the Levene’s test for Equality of Variance and the 
Shapiro-Wilks test, respectively, complemented by the assessment of skewness and 
kurtosis. These assessments and all other statistical analyses were conducted using 
SPSS. Outliers were determined using the Grubbs’ test (α = 0.05) in GraphPad Prism. 
 
Results  
5.1.8 Neonatal overfeeding effects on the female ghrelin system in early life 
It has been previously demonstrated in females and males ((Spencer and Tilbrook 
2009; Stefanidis and Spencer 2012; Sominsky, Ziko, Soch, et al. 2016) and Chapter 2, 
3 and 4), and here that neonatal overfeeding is associated with significantly increased 
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body weight at P12 (t(9) = 3.89, p = 0.004, Figure 5.2 A). However, no effects of 
neonatal overfeeding on circulating total, AG or DAG levels were observed in P7 or 
P14 female pups. There was a significant litter size by age interaction so that P14 
control, but not neonatally overfed animals had increased DAG levels compared to P7 
(significant litter size by age interaction, F(1,26) = 4.48, p = 0.044, Figure 5.2 D). 
Neonatal overfeeding did not affect the hypothalamic gene expression of growth 
hormone secretagogue receptor (Ghsr) or ghrelin O-acyl transferase (Goat; Figure 5.2 
F). However, there was an increase in Ghsr expression on P14 compared to P7, 
irrespective of litter size (significant effect of age; F(1,27) = 42.82, p < 0.001, Figure 
5.2 E).  
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Figure 5.2 Neonatal overfeeding effects on ghrelin system short-term.  
(A) Body weights in control (CL) and small litter (SL) female animals at P12. (B) 
Circulating total ghrelin, (C) acyl ghrelin and (D) des-acyl ghrelin at postnatal day (P) 
7 and P14 in CL and SL animals. Hypothalamic gene expression of (E) growth 
hormone secretagogue receptor (Ghsr) and (F) ghrelin O-acyl transferase (Goat) in 
CL and SL animals at P7 and P14. Data are mean ± SEM. * p < 0.05. n = 5 – 8 per 
group. 
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ARC neuronal activation as shown by similar numbers of c-Fos positive cells 
activated in the ARC of CL and SL animals in response to exogenous ghrelin (Figure 
5.3 A). In the PVN, neonatal overfeeding also failed to affect hypothalamic 
responsiveness to exogenous ghrelin, however AG (significant effect of ghrelin; F(2,31) 
= 16.45, p < 0.001), but not DAG, induced a significant increase in neuronal 
activation compared to saline and DAG injected animals, irrespective of litter size 
(Figure 5.3 B, C). It is important to note that here was used the same AG dosage that 
induced a significant increase in PVN neuronal activation in SL males compared to 
CL males (Chapter 3, Figure 3.3 B).  
 
 
Figure 5.3 Early life overfeeding effects on hypothalamic responsiveness to 
exogenous acyl ghrelin (AG), des-acyl ghrelin (DAG) or saline.  
Number of c-Fos positive cells activated by AG, DAG or saline in control (CL) and 
small litter (SL) females at postnatal day (P) 12 in the (A) arcuate nucleus of the 
hypothalamus (ARC) and (B) paraventricular nucleus of the hypothalamus (PVN). 
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(C) Photomicrographs of the PVN. Scale bar = 100 μm. Data are mean ± SEM. * p < 
0.05. 
 
5.1.9 Long-term effects of neonatal overfeeding on the ghrelin system in 
females 
To assess peripheral and central effects of neonatal overfeeding on the ghrelin system 
long-term we measured circulating ghrelin, hypothalamic gene expression of Ghsr 
and Goat, as well as body weights. Neonatal overfeeding did not affect circulating 
ghrelin levels in adult females (Figure 5.4 A) or hypothalamic Ghsr and Goat gene 
expression (Figure 5.4 B, C). However, the body weight of neonatally overfed 
animals remained significantly increased in adulthood relative to controls (t(10) = 4.36, 
p = 0.001; Figure 5.4 D). These results indicate that long-term increased body weight 
with neonatal overfeeding is not likely due to the central ghrelin effects.  
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Figure 5.4 Long-term effects of neonatal overfeeding on the ghrelin system.  
(A) Circulating total, acyl and des-acyl ghrelin in control (CL) and small litter (SL) 
female adult rats. Gene expression of hypothalamic (B) growth hormone secretagogue 
receptor (Ghsr) and (C) ghrelin O-acyl transferase (Goat) of CL and SL animals. (D) 
Body weights of CL and SL adult females. Data are mean ± SEM. * p < 0.05. n = 5 – 
7 per group. 
 
5.1.10 Acute and long-term effects of neonatal overfeeding on pituitary 
ghrelin signaling  
To assess overfeeding effects on ghrelin signaling at the pituitary level we measured 
gene expression of pituitary Ghsr and Goat. In the juveniles, was observed that 
neonatal overfeeding significantly increased pituitary Ghsr at P14 relative to normal 
feeding (significant effect of litter; F(1,25) = 6.89, p = 0.015, Figure 5.5 A). There was 
no effect of overfeeding on pituitary Goat gene expression in juveniles (Figure 5.5 B). 
In the adults, neonatal overfeeding significantly suppressed pituitary Ghsr (t(12) = 
2.29, p = 0.041, Figure 5.5 C) and Goat (t(12) = 2.61, p = 0.023, Figure 5.5 D) gene 
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expression. These results indicate that females that are overfed during the neonatal 
period may have a suppressed ability to respond to ghrelin at the pituitary level in 
adulthood. 
 
 
Figure 5.5 Acute and long-term effects of neonatal overfeeding on potential for 
pituitary ghrelin signaling.  
Pituitary (A) growth hormone secretagogue receptor (Ghsr) and (B) ghrelin O-acyl 
transferase (Goat) gene expression at postnatal day (P) 7 and P14 of control (CL) and 
small litter (SL) female rats. Adult Ghsr (C) and Goat (D) gene expression at the 
pituitary of CL and SL rats. Data are mean ± SEM. * p < 0.05. n = 5 – 8 per group. 
 
5.1.11 Pituitary responses to AG and CRH stimulation in vitro  
To test whether neonatal overfeeding affects the ability of the pituitary to release GH 
and ACTH, we first measured GH and ACTH release from CL and SL non-stimulated 
adult anterior pituitaries. Under basal conditions both control and neonatally overfed 
pituitaries released similar levels of GH (Figure 5.6 A) and ACTH (Figure 5.6 B). 
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When stimulated with AG, CL and SL pituitaries again released similar levels of GH 
(Figure 5.6 C). However, pituitaries from neonatally overfed rats that were stimulated 
with AG showed significantly suppressed levels of ACTH secretion at 15 and 30 min 
time-points relative to controls given AG (Figure 5.6 D), a suppression that was not 
observed after stimulation with CRH (Figure 5.6 E). The above results indicate that 
neonatal overfeeding affects the pituitary’s ability to respond to AG without affecting 
its responses to CRH.  
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Figure 5.6 Neonatal overfeeding effects on adult female pituitary responsiveness 
to acyl ghrelin (AG) and corticotropic-releasing hormone (CRH).  
(A) Pituitary growth hormone (GH) release under basal conditions from control litter 
(CL) and small litter (SL) animals. (B) Basal adrenocorticotropic hormone (ACTH) 
release from pituitaries of CL and SL animals. (C) AG-induced GH release from CL 
and SL pituitaries. (D) AG-induced ACTH release from CL and SL pituitaries. (E) 
CRH-induced ACTH release from CL and SL pituitaries. Data are mean ± SEM. * p < 
0.05. n = 4 – 11 per group. 
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Discussion 
We have shown in this study that neonatal overfeeding in females, in contrast to 
findings previously shown in males, did not affect circulating ghrelin or the 
hypothalamic responsiveness to exogenous ghrelin in the neonatal or adult periods. 
However it alters long-term pituitary Ghsr and Goat expression. In an in vitro setting, 
neonatal overfeeding did not affect basal or AG-stimulated GH secretion from the 
pituitary. It also did not affect basal or CRH-induced ACTH secretion. However, 
neonatal overfeeding significantly suppressed pituitary ACTH’s responsiveness to 
AG indicating that early life nutritional environment permanently affects the female 
pituitary ghrelin system and consequently ghrelin-induced HPA axis function.  
 
Ghrelin, traditionally known for its role in centrally controlling energy metabolism, is 
the only peripherally produced peptide that induces feeding (Nakazato et al. 2001; 
Wren et al. 2001). It does this, in part, by centrally activating ARC NPY/AgRP 
neurons via GHSR expressed by these neurons, and inactivating POMC/CART by 
initiating gamma-aminobutyric acid (GABA) release from NPY/AgRP/GABA 
neurons. GABA directly inhibits nearby POMC/CART neurons (reviewed in 
(Edwards and Abizaid 2017)). Ghrelin also induces feeding by acting at the PVN, 
where it initiates AgRP secretion, which antagonizes α-melanocyte-stimulating 
hormone (α-MSH) and β-MSH at melanocortin receptors to abolish anorectic effects 
from this region (Aponte, Atasoy, and Sternson 2011). Cabral et al. have 
demonstrated that ghrelin indirectly activates PVN CRH neurons, which lack GHSR, 
consequently activating the HPA axis (Cabral et al. 2012). The mechanism by which 
ghrelin activates PVN CRH neurons does not necessarily require an intact ARC 
(Cabral et al. 2016). Studies from our group and others have shown that neonatal 
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overfeeding at least in males is associated with a disruption of hypothalamic Ghsr 
expression (Soares et al. 2012; Collden et al. 2015; Sominsky, Ziko, Nguyen, et al. 
2016). In the present study we show that neonatally overfed females however, in 
contrast to males, display similar hypothalamic Ghsr and Goat expression compared 
to normally fed animals, further emphasizing that there are sex-dependent effects of 
neonatal overfeeding on the ghrelin system and that females are resistant to the 
ghrelin-perturbing effects of this early life diet, at least in terms of the hypothalamic 
appetite regulatory circuitry.  
 
The early life nutritional environment is crucial not only for regulating metabolic 
programming but, also anxiety and stress responses later in life (Delpierre et al. 
2016). We have previously observed that neonatal overfeeding affects anxiety and 
stress responses with overfed females exhibiting reduced anxiety and increased 
responses to restraint stress compared to normally fed counterparts (Spencer and 
Tilbrook 2009). We have also shown that under stress conditions ghrelin specifically 
stimulates pituitary ACTH release in order to activate HPA axis to consequently 
suppress stress and anxiety (Spencer et al. 2012). Ghrelin’s role in the HPA axis 
regulation, including after exposure to stress, implies that any abnormality in the 
ghrelin system may be a contributor to the abnormal functioning of the HPA axis 
(Spencer et al. 2012; Patterson et al. 2013). Ghrelin stimulates secretion of hormones 
involved in the stress response, including ACTH and glucocorticoids. In humans and 
rodents, ghrelin stimulates ACTH and glucocorticoid release, indicating it has effects 
on both the pituitary (Spencer et al. 2012; Shimon, Yan, and Melmed 1998) and 
adrenal glands (Barreiro et al. 2002; Rucinski et al. 2009; Andreis et al. 2003). The 
mechanisms by which ghrelin affects stress, anxiety and mood disorders remain to be 
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fully elucidated. In this regard, recent work from Goosens’ laboratory demonstrates 
that ghrelin and its stress-induced increased circulating levels are involved in stress-
associated fear learning. Interestingly, stress-induced increase in ghrelin, specifically 
AG, persists long after the cessation of the stress exposure, in both rodents and 
humans. These elevated AG levels in turn mediate prolonged susceptibility to 
exhibiting stress-enhanced fear behaviours (Yousufzai et al. 2018). These fear-
enhancing actions of AG are likely to occur in the amygdala and are independent of 
the traditional HPA axis activation (Meyer et al. 2014). Another possible mechanism 
through which ghrelin is likely to modulate stress-related behaviours is through its 
potential dual role in promoting neophobia under conditions of positive energy 
balance (i.e. under low ghrelin levels), and anxiolytic effects at high concentrations 
(Spencer et al. 2012; Lutter et al. 2008). This adaptation might occur in order to 
promote food-seeking behaviour when food is scarce and minimize exploratory 
behaviour when not necessary. In the current study we observe that neonatal 
overfeeding significantly alters pituitary Ghsr and Goat expression. It exacerbates 
Ghsr during the second week after birth, and then significantly suppresses both 
pituitary Ghsr and Goat expression in adulthood. While we have not assessed stress-
induced changes in ghrelin or stress responsivity in the current study, these findings 
suggest that our previously reported exacerbated PVN responses to restraint stress in 
neonatally overfed females (Spencer and Tilbrook 2009) could at least partly be due 
to the suppressed ability of the pituitary to respond to stress-induced ghrelin and 
hence diminished HPA axis negative feedback.  
 
A number of studies have demonstrated sexual dimorphism in circulating ghrelin 
levels, with females having higher ghrelin than males and ghrelin levels being 
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inversely related to body mass index (BMI) in girls/women, but not in boys/men 
(Soriano-Guillen et al. 2016; Makovey et al. 2007). In animal studies, fasting induces 
higher ghrelin levels in female adult rats compared to males (Gayle et al. 2006). In 
terms of the impact of the early life environment on the ghrelin system, little is known 
about the influences of sex. In male rats, studies have revealed that early life 
overnutrition greatly affects circulating ghrelin (Soares et al. 2012; Collden et al. 
2015; Sominsky, Ziko, Nguyen, et al. 2016), but such studies have not been reported 
in females. Interestingly, we observe here that neonatal overfeeding in females has no 
effect on the levels of any of the forms of circulating ghrelin (AG or DAG).  
 
Exposure to nutritional challenges during early life development is associated with 
long-term complications including metabolic diseases in both sexes (reviewed in 
(Dearden, Bouret, and Ozanne 2018)). However, females in particular are more likely 
to experience increased adiposity as well as anxiety behaviours compared to males 
(Sullivan et al. 2010; Samuelsson et al. 2013; Oostvogels et al. 2017). As reviewed in 
(Carpenter, Grecian, and Reynolds 2017), not only nutrition but also stress during 
prenatal life in humans is associated with altered HPA axis responses to stress in a 
sex-specific manner, with females being more vulnerable than males to stressors later 
in life. As such, there are sex-differences in depression and major depressive 
disorders (MDD) with women being more vulnerable to depressive disorders 
compared to men (Goldstein et al. 2016; Kessler et al. 1993), corresponding with our 
previous findings indicating increased stress responsivity in neonatally overfed 
female, but not male rats.  
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In conclusion, our current results suggest that neonatal overfeeding in females, unlike 
in males, does not affect hypothalamic ghrelin system, however it suppresses the 
pituitary’s ability to respond to ghrelin long-term. These results are important in 
further understanding the role of ghrelin in the regulation of HPA axis responses to 
stress in a sex-specific manner.  
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Acylated ghrelin suppresses the cytokine 
response to lipopolysaccharide and does so 
independently of the hypothalamic-pituitary-
adrenal axis 
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Introduction 
In Chapter 5 we looked at the effects of ghrelin in the regulation of the hypothalamic-
pituitary-adrenal (HPA) axis in females. Very recently, additional functions for the 
peptide have come to light, including its anti-inflammatory properties (reviewed in 
(Baatar, Patel, and Taub 2011)). Thus, ghrelin decreases mortality in septic shock 
(Chang, Zhao, et al. 2003; Chang, Du, et al. 2003) and morbidity in models of colitis 
(Gonzalez-Rey, Chorny, and Delgado 2006; Konturek et al. 2009) and other 
inflammatory challenges (Collden, Tschop, and Muller 2017). Ghrelin likely does 
this, at least in part, by acting directly on immune cells, including microglia, 
macrophages and T-cells, to reduce the pro-inflammatory cytokine response to 
immune challenge (Waseern et al. 2008; Dixit et al. 2004; Moon et al. 2009). 
 
Ghrelin also regulates HPA axis responses to stress and may thus modify cytokine 
responses to immune challenge via this mechanism. During acute physical or 
psychological stress, cells in the paraventricular nucleus of the hypothalamus (PVN) 
secrete corticotropin-releasing hormone (CRH), which acts on the anterior pituitary to 
stimulate adrenocorticotropic hormone (ACTH) release. Increased circulating ACTH 
levels stimulate the adrenal cortex to synthesise and secrete glucocorticoids, which 
then initiate a series of events to aid the organism to cope with the stress (Nicolaides 
et al. 2015). In addition to its other roles, glucocorticoids also act to suppress nuclear 
factor (NF)κB-mediated cytokine transcription in immune cells (Auphan et al. 1995; 
Scheinman et al. 1995). Ghrelin’s role in regulating the HPA axis is still imprecisely 
described. However, exogenous ghrelin strongly activates CRH neurons in the PVN 
and increases circulating glucocorticoid levels without affecting growth hormone 
secretagogue receptors (GHSR) expression on these neurons, suggestive of ghrelin’s 
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indirect effect on the apex of the HPA axis (Cabral et al. 2012). Thus, stress induces 
high levels of glucocorticoid release in proportion with increased circulating ghrelin 
(Lutter et al. 2008; Azzam et al. 2017). We have shown that ghrelin stimulates the 
HPA axis at the level of the pituitary by targeting the GHSR to facilitate ACTH 
release (Spencer et al. 2012). Ghrelin can also directly activate pituitary ACTH 
expressing cells (Stevanovic et al. 2007). Therefore, we hypothesized here that 
ghrelin’s anti-inflammatory actions on the cytokine response to an immune challenge 
(with lipopolysaccharide (LPS)) may be mediated by activation of the HPA axis. 
 
As discussed in previous chapters, ghrelin exists in at least two biologically active 
isoforms: acylated ghrelin (AG), which is the result of ghrelin-o-acyl-transferase 
(GOAT)-mediated acylation of pro-ghrelin at serine-3; and des-acylated ghrelin 
(DAG), which is the unacylated and most abundant form. AG confers its activity via 
GHSR, and is now known to have important roles in feeding, reward, memory, 
immune responses, cardiovascular activity, reproduction, and a host of other 
physiological functions and behaviours, including in regulating the stress response 
(Spencer et al. 2012; Spencer et al. 2015; Sominsky, Hodgson, et al. 2017). AG 
appears to have a dual role in stress and anxiety (Spencer et al. 2015; Spencer et al. 
2012). It likely promotes neophobia and timely responses to stress at low 
concentrations, such as occur under conditions of positive energy balance, but 
suppresses anxiety and stress at high concentrations, as occur with negative energy 
balance (Lutter et al. 2008; Spencer et al. 2012). This fine interplay would ensure that 
food-seeking behaviour is promoted when necessary, without encouraging 
unnecessary exploration and risk under high stress conditions if food is not scarce. 
DAG has been less well investigated, and its receptor(s) has not yet been identified. 
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However, our own work has recently suggested DAG also contributes to stress 
responses and can promote anxiety (Stark et al. 2016a). With these studies, we have 
shown AG and DAG may have opposing roles in regulating hypothalamic circuitry in 
response to stress. Since DAG is the most abundant form of ghrelin and AG is quickly 
metabolized to DAG in vivo (Bayliss et al. 2016; Chen et al. 2015), elucidating DAG 
and AG’s relative roles in HPA axis function is crucial. Here we hypothesized that 
AG and DAG would differentially modulate the HPA axis response to an immune 
challenge with LPS. 
 
To test this, we gave adult male Wistar rats a concomitant injection of LPS and either 
AG or DAG and assessed circulating cytokine and HPA axis responses. Circulating 
pro- and anti-inflammatory cytokines stimulated by LPS were significantly 
suppressed in the presence of AG, but not DAG. DAG also had no effect on any HPA 
axis component assessed. In vitro, high AG stimulated the release of ACTH from the 
anterior pituitary and, in vivo, AG stimulated HPA axis activation, but the in vivo 
ACTH, glucocorticoid, and PVN responses to LPS were not influenced by AG. These 
data suggest that AG markedly suppresses the circulating cytokine response to LPS 
but probably does not do this by modulating the HPA axis response. 
 
Materials and methods 
6.1.1 Animals 
In these experiments, we used adult male Wistar rats obtained from the Animal 
Resources Centre, WA, Australia. After arrival at the RMIT University Animal 
Facility, at approximately postnatal day (P) 63, they were housed at 22 °C on a 12 hr 
light/dark cycle (0700 – 1900 hr) and acclimatised for approximately one week prior 
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to the experiment. We provided them with ad libitum pelleted rat chow and water. All 
procedures were conducted in accordance with the National Health and Medical 
Research Council Australia Code of Practice for the care of experimental animals and 
RMIT University Animal Ethics Committee approval.   
 
6.1.2 Responses to exogenous AG and DAG after an immune challenge with 
LPS  
To assess how exogenous AG and DAG alter the hypothalamic and extra-
hypothalamic components of the HPA axis after an immune challenge with LPS in 
vivo, we gave the rats a single injection of AG or DAG (1 mg/kg s.c.; PolyPeptide 
Group, Strasbourg, France), combined with a concomitant injection of LPS (E. coli, 
serotype 0127:B8; Sigma, St Louis, MO, USA; 100 μg/kg i.p.) or pyrogen-free saline 
(0.9% NaCl Figure 6.1). Immediately after lights on (0700), rats were singly housed 
and fasted for 2.5 hr prior to ghrelin injection in order to allow for endogenous ghrelin 
levels to normalise without inducing negative energy balance. A pre-weighed amount 
of rat pelleted chow was given to the animals immediately after AG, DAG or saline 
injection. At 2 hr post-injection the weight of the remaining food was recorded and 
the difference between remaining and received taken as the amount consumed. Body 
weights were also recorded immediately before and 2 hr after injections. All the 
experiments were conducted between 0900 and 1300 to limit the potential effects of 
circadian rhythms on any parameters measured. 
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Figure 6.1 Study design 
Male adult rats were concomitantly injected with LPS and acyl ghrelin (AG), des-acyl 
ghrelin (DAG) and/or saline and after 2 hr blood and brains were collected. Pituitaries 
and adrenals from saline and AG injected animals were collected to be stimulated in 
vitro with corticotropin-releasing hormone (CRH; 10-10 M) and adrenocorticotropic 
hormone (ACTH; 10-7 M) accordingly. After collection of fraction 1, AG/DAG (10-6 
M) alone, the stimulus alone (CRH/ACTH) or the combination of the two were added 
to the media and samples were collected every 15 min up to 1 hr to test ACTH and 
corticosterone (CORT) responses of pituitaries and adrenals respectively. 
 
6.1.3 Effects of AG and DAG on circulating cytokine responses to LPS  
To assess the effects of ghrelin on peripheral markers of inflammation in response to 
LPS, we collected cardiac blood into ethylenediaminetetraacetic acid (EDTA) coated 
tubes, which were kept on ice until the end of the experiment, then centrifuged at 
1000 g for 15 min at 4 °C. Plasma was collected, aliquoted and stored at -20 °C until 
processed for cytokine analysis. Relative concentrations of granulocyte-macrophage 
colony-stimulating factor (GM-CSF), interferon gamma (IFN-γ), interleukin-1α (IL1-
α), IL1-β, IL-2, IL-4, IL5, IL-6, IL-10, IL-12, IL-13 and tumor necrosis factor-α 
(TNFα) in plasma samples were quantified using a 12-plex rat cytokine Bio-Plex 
Th1/Th2 assay (#171K1002M; Bio-Rad California, USA) and a Bio-Plex MAGPIXTM 
instrument (Bio-Rad) according to the manufacturer’s instructions. Results from 
samples (in duplicate), blank and standards (in triplicate) were extracted using Bio-
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Plex Manager software and analysed by asymmetric sigmoidal, 5PL, X log 
concentration of mean fluorescence intensity values minus background in Prism 
(GraphPad Software, Inc.). GM-CSF, IFN-γ, IL-4, IL-12 and IL-13 values are not 
reported due to their levels being undetectable in this assay.  
 
6.1.4 Effects of AG and DAG on pituitary and adrenal gland responses to 
stimulation in vitro  
To assess the in vitro effects of AG and DAG on the anterior pituitary release of 
ACTH and adrenal gland release of corticosterone (CORT), we excised the anterior 
pituitaries and the adrenal glands from the AG- and DAG-treated rats that had been 
given saline only and treated as previously described in Chapter 5 (Materials and 
methods: Neonatal overfeeding affects pituitary responses to AG and CRH). To assess 
the pituitary responsiveness to secretagogue stimuli, AG or DAG (10-6 M) and CRH 
(10-10 M)-containing media were added in the second fraction. To assess the adrenal 
gland responsiveness to secretagogue stimuli AG or DAG (10-6 M) and ACTH (10-7 
M)-containing media were added in the second fraction. CORT levels were measured 
with a standard CORT assay (Abnova Corp., Taipei, Taiwan) with intra-assay 
variability 5.5% CV and inter-assay variability of 10.4% CV. The lower limit of 
detection for this assay was 0.35 ng/mL. Samples from all treatment groups were 
assayed together in duplicate. Data are expressed as percentage of the basal ACTH or 
CORT secretion as measured at the end of the first 15 min period, and set to 100% as 
previously described in (Cai et al. 2016; Sominsky, Ziko, and Spencer 2017). 
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6.1.5 Effects of exogenous AG and DAG on circulating ghrelin after LPS 
To assess if exogenous AG or DAG had an effect on circulating ghrelin after an 
immune challenge with LPS we collected cardiac blood for later assessment of serum 
ghrelin, as well as for plasma CORT and ACTH (assayed as for the media, above). 
For ghrelin, blood was treated with Pefabloc as previously described in Chapter 3 
(Materials and methods: Neonatal overfeeding effects on circulating ghrelin).  
 
6.1.6 c-Fos immunohistochemistry  
To assess the effects of AG and DAG on hypothalamic neuronal activation after an 
immune challenge with LPS we examined PVN c-Fos expression. Brains were 
hemisected into left and right-hand sides. From the left-hand sides, the hypothalami 
were dissected and immediately snap-frozen in liquid nitrogen to be further processed 
for mRNA expression analysis. The right-hand side of each brain was immersion-
fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS; 4 °C, pH 
7.4). These brains were then processed as previously described in Chapter 2, 
Materials and methods: “Brain collection”. Sections throughout the PVN were 
immunolabelled for c-Fos. Immunofluorescently labeled c-Fos sections were 
incubated in (1:5 000; ABE 457, MERK Millipore) in a solution of 3% BSA, 0.3% 
Triton X-100 in PBS with 0.1% Tween-20 for 2 days at 4 °C, after an antigen 
retrieval (10 mM sodium citrate solution, pH 6.0, 70°C for 10 min) and blocking step 
(3% BSA, 0.3% Triton X-100, PBS Tween-20, 3 hr at room temperature). Sections 
were further incubated with secondary antibody (1:500, Alexa-fluor 488 goat anti-
rabbit; Thermo Scientific, Rockford, IL, USA) in a solution of 3% BSA, 0.3% Triton 
X-100, PBS Tween-20 for 2 hr at room temperature. After five washes at 5 min 
intervals, sections were mounted on slides and coverslipped with DAPI anti-fading 
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mounting medium (Sigma-Aldrich, St Louis, MS, USA) to be later examined with a 
confocal microscope. Brain sections were visualised under a 488 nm laser and a 
515/30 filter set for c-Fos labeling and under a 408 nm laser for DAPI on an A1 
upright confocal laser microscope (Nikon, Tokyo, Japan).  
 
6.1.6.1 Cell counts 
An experimenter blinded to treatment groups assessed PVN sections for the numbers 
of cells positive for c-Fos. Through-focus series (z-stacks) of PVN images were taken 
under 20x magnification lenses and one cumulative image of all the z-planes was 
analysed for each section. c-Fos positive cells were manually counted using ImageJ 
(National Institutes of Health, Bethesda, MD, USA), which places a number over 
each counted cell to prevent over- or under- counting. Positive cells were determined 
by eye, based on the size and round shape, allowing for exclusion of blood vessel 
staining, which is distinctive (continuous lines of positive staining). Magnocellular 
(MG) and parvocellular (MP) regions were delineated by overlaying one of two 
dotted line templates adapted from (Buller, Dayas, and Day 2003) to the images to be 
analysed, according to the rostrocaudal level. We analysed four sections 120 μm apart 
between 1.56 and 1.92 mm caudal to the bregma (according to the Paxinos and 
Watson Rat Brain Atlas (Paxinos and Watson 2009)) for each animal and recorded a 
mean of c-Fos positive cells from these four sections.  
 
6.1.7 Real-time quantitative PCR array 
We used a custom RT2 profiler PCR array (Qiagen, Carlsbad, CA, USA) to examine 
the mRNA expression from the dissected hypothalami of four genes as in Table 6.1, 
according to manufacturer’s instructions. The RNA (400 ng) was transcribed to 
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complimentary DNA using an RT2 First Strand Kit (Qiagen). Samples were diluted in 
RT2 SYBR Green Mastermix, loaded onto 384-well PCR array plates and amplified 
on an Applied BiosystemsTM QuantStudioTM 7 Flex qPCR System instrument (Life 
Technologies, Carlsbad, Ca, USA). The relative quantitative measure of the target 
gene expression was compared with an endogenous control, β-actin. RNA expression 
was determined using the double delta (C(t)) equation 2-ΔΔC(t), where threshold 
cycle (C(t)) values were the values at which fluorescence was first detected 
significantly above background, as previously described (Sominsky, Ziko, et al. 
2017).  
 
Table 6.1 Gene details for RT-PCR array. 
 
Gene 
symbol 
Gene name NCBI Assay catalog # 
Actb Actin beta PPR06570 
Nr3c1 Nuclear receptor subfamily 3 group C member 
1 
PPR52805 
Nr3c2 Nuclear receptor subfamily 3 group C member 
2 
PPR44413 
Crhr1 Corticotropin-releasing hormone receptor 1 PPR44886 
 
 
 
6.1.8 Statistical Analyses 
Data were analysed using multi factorial analyses of variance (ANOVA)s with 
immune challenge (saline, LPS) and ghrelin (saline, AG or DAG) treatment as 
between factors. We used repeated measures ANOVAs to analyse in vitro pituitary 
and adrenal responses to stimulation, with stress hormones (CRH or ACTH, 
respectively) and AG or DAG treatment as between factors, and time as the repeated 
measure. When the assumption of sphericity was violated, we used the Greenhouse-
Geisser correction. A Bonferroni correction was applied to adjust for multiple 
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comparisons. We followed the analysis by two-way ANOVAs and Tukey post hoc 
tests, where significant interactions were found. Data are presented as the mean ± 
SEM. Statistical significance was assumed when p < 0.05. All data were tested for 
homogeneity of variance and normality, using the Levene’s test for Equality of 
Variance and the Shapiro-Wilks test, respectively, complemented by the assessment 
of skewness and kurtosis. These assessments and all other statistical analyses were 
conducted using SPSS. Outliers were determined using the Grubbs’ test (α = 0.05) in 
GraphPad Prism. 
 
Results 
6.1.9 Effects of AG on pituitary and adrenal responses to stimulation 
As previously reported from our group AG stimulates pituitary ACTH release in 
female rats (Sominsky, Ziko, and Spencer 2017) and in psychologically stressed male 
mice (Spencer et al. 2012) so we tested if the pituitary ACTH and adrenal CORT 
response to AG is sensitized in the presence of stress signals CRH and ACTH, 
respectively. Consistent with our mouse and female rat data, AG treatment robustly 
affected pituitary ACTH production. CRH at the dose used in these experiments was 
insufficient to stimulate an increase in pituitary ACTH in the media-alone group. 
Similarly, there was no effect of CRH and AG combined on ACTH release. However, 
AG alone stimulated significant ACTH secretion within 15 min. As such, repeated 
measures ANOVA indicated there were significant fraction x CRH treatment and 
fraction x AG treatment interactions (F(3,72) = 5.46, p = 0.002; F(3,72) = 4.19, p = 
0.009), as well as a significant main effect of CRH (F(1,24) = 6.56, p = 0.017; Figure 
6.2 A; n = 6-8). Post hoc tests revealed ACTH was increased in the AG-alone group 
in the 15 min (second) fraction compared with the other groups at this time-point.  
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ACTH at this dose stimulated an increase in CORT released from the adrenal gland in 
AG-treated tissue. Repeated measures ANOVA indicated there was a significant 
fraction x AG treatment interaction (F(3,66) = 8.08, p < 0.001) and a significant main 
effect of AG (F(1,22) = 12.14, p = 0.002; Figure 6.2 B; n = 6-7). Post hoc tests revealed 
CORT was specifically increased in the AG-ACTH group in the 30 and 45 min (third 
and fourth) fractions compared with the AG-alone group. These data suggest that AG 
has the capacity to stimulate pituitary ACTH release and to potentiate the effect of 
ACTH on CORT in male rats but has minimal direct effect on adrenal CORT release. 
 
 
 
Figure 6.2 Acyl ghrelin (AG) effects on pituitary and adrenal responses to 
stimulation in vitro. 
(A) AG’s effect on corticotropin-releasing hormone (CRH)-induced 
adrenocorticotropic hormone (ACTH) release from anterior pituitaries of adult male 
rats. AG (10-6 M) and CRH (10-10 M) were added to the media after collection of 
fraction 1. B) AG’s effect on ACTH-induced corticosterone release from adrenals. 
Data are mean ± SEM. A) * AG compared with the other groups; p < 0.05 (n = 6-8 
per group). (B) * ACTH group compared with AG-alone group. p < 0.05 (n = 6-7). 
 
6.1.10 Effects of exogenous AG on LPS-induced anorexia and circulating 
cytokines 
To test how AG affects HPA axis responses to immune challenge in vivo, we next 
tested if the pro- and anti-inflammatory cytokine responses to LPS were affected by 
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elevated AG. Exogenous AG did not significantly affect 2 hr food intake or the 
anorexic response to LPS (Figure 6.3 A; n = 6-8 per group). However, AG did 
decrease the levels of several circulating cytokines induced by LPS (n = 5-8 per 
group). Thus, LPS increased the concentrations of TNF, IL-1, IL-1, and IL-10 
under otherwise-untreated conditions, but not when the rats were concomitantly 
treated with AG. There was a significant interaction between immune challenge and 
AG on TNF (F(1,24) = 11.15, p = 0.003; Figure 6.3 B), IL-1 (F(1,23) = 4.31, p = 
0.049; Figure 6.3 C) and IL-10 (F(1,27) = 8.55, p = 0.007; Figure 6.3 H) and a 
significant effect of immune challenge on IL-1 (F(1,22) = 6.34, p = 0.02; Figure 6.3 
D). There was no effect of either immune challenge or AG on IL-2 (Figure 6.3 E), IL-
5 (Figure 6.3 F) or IL-6 (Figure 6.3 G). The latter were compared using a t-test 
between the Sal-LPS and AG-LPS groups since no IL-6 was detectable in the saline-
treated rats. IL-4, IL-12, IL-13, GM-CSF and IFN were not detectable in any groups 
with this assay.  
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Figure 6.3 Effects of exogenous acyl ghrelin (AG) on lipopolysaccharide (LPS)-
induced anorexia and circulating cytokines 
(A) AG did not affect 2 hr food intake or the anorexigenic effect of LPS. LPS induced 
a significant increase in circulating cytokines: (B) tumor necrosis factor  (TNF), 
(C) interleukin (IL)-1, (D) IL-1 and (H) IL-10. AG significantly suppressed the 
response of TNF (B) and (H) IL-10 to LPS. There was no effect of immune 
challenge or AG on (E) IL-2, (F) IL-5 or (G) IL-6. # main effect of immune 
challenge. * significant differences with post hoc tests. Data are mean ± SEM, p < 
0.05 (n = 5-8 per group). 
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6.1.11 Effects of exogenous AG on PVN responses to LPS in vivo 
AG is able to indirectly modulate PVN activation in response to psychological stress 
(Spencer et al. 2012), in mice, so we next sought to identify if it could influence PVN 
responses to immune challenge with LPS in rats (Figure 6.4 A-D). As expected, LPS 
increased neuronal activation in the MP region (significant effect of LPS: F(1, 20) = 
7.14, p = 0.015; Figure 6.4 B; n = 5-7 per group), but there was no significant effect 
of AG. Treatment with AG significantly activated the MG region of the PVN 
(significant effect of AG: F(1, 22) = 10.97, p = 0.003; Figure 6.4 C; n = 5-8 per group) 
and did not affect the MG response to LPS. Total PVN neuronal activation was driven 
by the effect of AG (significant effect of AG: F(1, 21) = 5.83, p = 0.025; Figure 6.4 D; n 
= 5-8 per group). Exogenous AG, or LPS, also did not affect Crhr1 mRNA in the 
hypothalamus (Figure 6.4 E; n = 4-8) together indicating AG does not affect the 
central HPA axis response to LPS.  
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Figure 6.4 Exogenous acyl ghrelin (AG) does not affect central hypothalamic 
pituitary adrenal (HPA) axis responses to immune challenge in vivo. 
(A) Representative photomicrographs of Fos-positive cells in the paraventricular 
nucleus of the hypothalamus (PVN). (B) Lipopolysaccharide (LPS) increased 
numbers of Fos-positive cells in the medial parvocellular (MP) region of the PVN 
without any effect of AG. C) AG significantly activated the magnocellular (MG) 
region of the PVN without any effect of LPS. D) Total PVN neuronal activation was 
driven by the effect of AG. E) Hypothalamic mRNA expression of corticotropin-
releasing hormone Crhr1 receptor. # main effect of immune challenge, $ main effect 
of AG. Data are mean ± SEM, p < 0.05. n = 4-8 per group. 
 
6.1.12 Effects of exogenous AG on ACTH responses to LPS in vivo 
Since the ACTH response to AG was elevated in vitro, indicating AG has the capacity 
to regulate at least part of the HPA axis in male rats, we next tested if AG could 
influence HPA axis responses to LPS in vivo at the level of the pituitary. There was a 
significant interaction between time and both LPS (F(2, 65) = 8.03, p = 0.001) and AG 
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(F(2, 65) = 5.34, p = 0.007; Figure 6.5 A; n = 5 - 7 per group), but the only relevant 
effect revealed with the post hoc tests was a reduction in ACTH at 2 hr compared 
with 15 min in the saline-saline group. There was no indication at any time point that 
AG was suppressing the ACTH response to LPS.  
 
 
Figure 6.5 Effects of exogenous acyl ghrelin (AG) on adrenocorticotropic 
hormone (ACTH), corticosterone (CORT), glucocorticoid receptor (Nr3c1) and 
mineralocorticoid receptor (Nr3c2) expression in vivo. 
(A) AG’s effects on circulating ACTH responses to lipopolysaccharide (LPS) at 15 
min, 30 min and 120 min. (B) AG’s effects on CORT responses to LPS at 15 min, 30 
min and 120 min. (C) Hypothalamic Nr3c1 and Nr3c2 gene expression. * significant 
differences with post hoc tests. Data are mean ± SEM, p < 0.05. n = 4-8 per group. 
 
6.1.13 Effects of exogenous AG on CORT responses to LPS in vivo 
Any effect of AG on the HPA axis that mitigates the inflammatory effects of immune 
challenge would necessarily involve CORT-mediated suppression of NFκB-induced 
cytokine transcription (Goujon et al. 1997; Auphan et al. 1995). We therefore next 
assessed if AG could influence the CORT response to LPS, potentially by-passing 
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both the PVN and pituitary to do so directly. There was a significant interaction 
between time and LPS on circulating CORT (F(2, 71) = 13.37, p < 0.001; Figure 6.5 B; 
n = 5 - 9 per group), but no indication that AG could suppress the response to LPS. 
Post hoc tests revealed CORT was significantly elevated by LPS at 2 hr compared 
with the LPS-treated groups at 15 min and compared with the saline-treated groups at 
2 hr, irrespective of AG treatment. AG and LPS also did not affect expression of 
Nr3c1 (glucocorticoid receptor) or Nr3cr2 (mineralocorticoid receptor) mRNA in the 
hypothalamus at 2 hr (Figure 6.5 C; n = 4-8). Together these data suggest that the 
AG-induced cytokine suppression we see after LPS stimulation is not likely due to 
AG’s effects on the HPA axis.  
 
6.1.14 Effects of exogenous AG and LPS on circulating ghrelin 
AG has a relatively short half-life of 30 min (De Vriese et al. 2004). Our analyses of 
the in vitro and acute ACTH and CORT responses to AG and LPS were therefore 
likely to be in the context of high circulating AG whereas the AG concentrations were 
likely to have dissipated at 2 hr, the time at which we measured cytokine levels. We 
therefore next tested if there was significant circulating AG still present at 2 hr after 
AG and LPS administration, to account for the cytokine suppression at this time. 
Treatment with AG led to a significant increase in circulating total ghrelin levels even 
at 2 hr after injection in both the saline and LPS-injected groups (significant effect of 
AG: F(1,27) = 463.3, p < 0.001; Figure 6.6 A; n = 7-8), with no notable effect of LPS 
on ghrelin either under basal or AG-injected conditions. Unexpectedly, this increase 
in total ghrelin was accounted for by DAG, with elevated DAG after AG irrespective 
of LPS treatment (significant effect of AG: F(1,24) = 586.0, p < 0.001; Figure 6.6 C; n 
= 6-8). Circulating AG was even suppressed in those rats that had been given AG 
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(significant effect of AG: F(1,25) = 8.50, p = 0.007; Figure 6.6 B; n = 6-8), indicating 
that exogenous AG is metabolized to DAG and DAG can inhibit AG release (Inhoff 
et al. 2008). 
 
 
Figure 6.6 Effects of acyl ghrelin (AG) and lipopolysaccharide (LPS) on 
circulating ghrelin.  
Exogenous AG is readily metabolized to des-acyl ghrelin (DAG) at 2 hr post-
injection. (A) Exogenous AG significantly increased circulating total ghrelin, due to 
increased circulating DAG levels (C). (B) Exogenous AG significantly suppressed 
circulating AG without any effect of LPS. # main effect of AG. Data are mean ± 
SEM, p < 0.05. n = 6-8 per group. 
 
6.1.15 Effects of exogenous DAG and LPS on circulating ghrelin 
As our results showed exogenous AG is fully metabolized to DAG by 2 hr after 
injection, it seemed possible that the suppressive effect of AG on the circulating 
cytokine response to LPS is actually due to an acute effect of DAG at or before the 2 
hr time point. As with AG, treatment with DAG also led to a significant increase in 
circulating total ghrelin levels in both the saline and LPS-injected groups (significant 
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effect of DAG: F(1,28) = 3283.4, p < 0.001; Figure 6.7 A; n = 8 per group), with, again, 
no notable effect of LPS on ghrelin either under basal or DAG-injected conditions. 
This increase in total ghrelin was again exclusively due to DAG, with elevated 
circulating DAG after exogenous DAG irrespective of LPS treatment (significant 
effect of DAG: F(1,27) = 3135.22, p < 0.001; Figure 6.7 C; n = 7-8). Circulating AG 
was suppressed to undetectable levels after exogenous DAG in both saline and LPS-
treated rats. Since these levels were undetectable, the comparison of the effects of 
LPS on AG levels under otherwise untreated conditions (Sal-Sal versus Sal-LPS) was 
assessed for significance using Student t-test and there was a resultant suppression of 
AG with LPS alone (t(13) = 3.37, p = 0.005; Figure 6.7 B; n = 7-8), consistent with the 
trend seen in the exogenous AG experiment.  
 
6.1.16 Effects of exogenous DAG on LPS-induced anorexia  
There was no effect of DAG on food intake, but there was a significant main effect of 
LPS in this experiment such that those exposed to LPS consumed less than the saline-
treated rats, consistent with the expected anorexigenic effect of LPS (F(1,22) = 7.30, p 
= 0.013; Figure 6.7 D; n = 6-8).  
 
6.1.17 Effects of DAG on pituitary and adrenal responses to stimulation  
Neither CRH nor DAG had a significant effect on ACTH release from the pituitary 
gland (Figure 6.7 E; n = 7-8). In the adrenal gland, there was a significant interaction 
between fraction, DAG, and ACTH treatments (F(3,69) = 2.816, p = 0.045; Figure 6.7 
F; n = 5-8) on CORT levels. The effect of ACTH on CORT release was not 
statistically significant with post hoc tests, but the magnitude of the difference 
between the ACTH-alone and media-alone groups was similar to that seen in the AG 
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experiment. In the presence of DAG, however, ACTH markedly and significantly 
increased CORT in the 30 and 45 min (second and third) fraction with no effect of 
DAG alone. Together these results indicate AG has some minimal effect on CORT 
release from the adrenal gland, slightly potentiating it in the presence of ACTH, while 
DAG is able to strongly potentiate the effects of ACTH.  
 
6.1.18 Effects of exogenous DAG on HPA axis responses to LPS 
Despite this strong in vitro effect of DAG on ACTH-induced CORT release, there 
was no effect of DAG on the central HPA axis response to LPS in vivo. LPS 
significantly increased neuronal activation in the MP (significant effect of LPS: F(1,24) 
= 24.42, p < 0.001; Figure 6.7 G; n = 5-8) and MG regions (significant effect of LPS: 
F(1,24) = 10.24, p = 0.004; Figure 6.7 H; n = 6-8) of the PVN, as well as in both 
regions combined (significant effect of LPS: F(1,24) = 23.20, p < 0.001; Figure 6.7 I; n 
= 6-8), both under otherwise-untreated conditions and after concomitant treatment 
with DAG, with no further effect of DAG. Exogenous DAG, or LPS, did not change 
expression of Crhr1 (Figure 6.7 J). CORT was elevated at 2 hr in response to LPS, 
but this was not affected by DAG (significant effect of LPS: F(1,28) = 46.92, p < 0.001; 
Figure 6.7 K; n = 8) and neither DAG nor LPS altered Nr3c1 or Nr3cr2 mRNA in the 
hypothalamus (Figure 6.7 L; n = 5-6), except that there was a significant main effect 
of immune challenge on Nr3c1 (F(1,20) = 4.90, p = 0.039) with LPS suppressing 
expression of this gene.  
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Figure 6.7 Effect of exogenous des-acyl ghrelin (DAG) and lipopolysaccharide 
(LPS) in vivo and in vitro.  
(A) Circulating total ghrelin. (B) Circulating acyl ghrelin (AG). (C) Circulating DAG. 
(n = 7-8 per group). (D) Food intake. (E) Neither corticotropin-releasing hormone 
(CRH) nor DAG had an effect on the in vitro adrenocorticotropic hormone (ACTH) 
release from the anterior pituitary. (F) In the presence of DAG, ACTH significantly 
increased CORT in the 30 min and 45 min fractions without any effects of DAG or 
ACTH alone. (G) Centrally, LPS induced a significant increase in numbers of Fos-
positive cells in the G) medial parvocellular (MP) and (H) magnocellular (MG) 
regions of the paraventricular nucleus of the hypothalamus (PVN) as well as in both 
regions combined (I). Neither DAG nor LPS had any effect on hypothalamic (J) 
corticotropin-releasing hormone receptor (Crhr1), (L) glucocorticoid receptor (Nr3c1) 
or mineralocorticoid receptor (Nr3cr2) mRNA expression. (K) LPS significantly 
increased circulating CORT in vivo without any further effects of DAG. # main effect 
of immune challenge, $ main effect of DAG, Data are mean ± SEM, p < 0.05. (n = 5-
8 per group. 
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6.1.19 Effects of exogenous DAG on circulating cytokine responses to LPS 
Finally, we tested if the ability of DAG to potentiate the CORT response to ACTH, 
observed in vitro, would lead to a suppression of the cytokine response to LPS such as 
we saw with AG. As expected, LPS lead to elevated circulating cytokines at 2 hr (n = 
5-7), but there were no effects of DAG on this response. There was a significant main 
effect of immune challenge on TNF (F(1,24) = 6.33, p = 0.019; Figure 6.8 A) and IL-
1 (F(1,24) = 16.81, p < 0.001; Figure 6.8 C). There was also a significant effect of 
DAG on IL-5 (F(1,25) = 7.08, p = 0.013; Figure 6.8 E), but no effects on IL-1, (Figure 
6.8 B), IL-2 (Figure 6.8 D), or IL-6 (t-test; Figure 6.8 F). The p value for IL-10 was p 
= 0.058 (Figure 6.8 G). There were no detectable levels of IL-4, IL-12, IL-13, GM-
CSF or IFN. Although we saw a significant effect of LPS on IL-1 in the AG 
experiment (C) and not here (Figure 6.8 B), this effect was small in the former and the 
absolute IL-1 levels were very similar between experiments. Together these data 
suggest that AG, but not DAG, can suppress cytokine secretion and can influence 
HPA axis function, and that the AG-induced cytokine suppression we see after LPS is 
not due to AG’s HPA axis effects but is also not due to a predominant role for DAG.  
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Figure 6.8 Effects of des-acyl ghrelin (DAG) on circulating cytokine responses to 
lipopolysaccharide (LPS) in vivo.  
LPS significantly increased circulating (A) tumor necrosis factor  (TNF) and (C) 
interleukin (IL)-1, without any further effects of DAG. (E) DAG significantly 
suppressed IL-5 without any effects of LPS. No effect of LPS or DAG was observed 
on (B) IL-1, (D) IL-2, (F) IL-6, or (G) IL-10. # main effect of DAG, $ main effect of 
immune challenge. Data are mean ± SEM, p < 0.05. n = 5-7 per group. 
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Discussion 
Ghrelin’s role in the HPA axis response to psychological stress is well-reported 
(Lutter et al. 2008; Spencer et al. 2015; Spencer et al. 2012). However, its impact on 
the HPA axis responses to an immune challenge is less well-characterized. Similarly, 
research has been lacking into DAG’s function in the neuroimmune response. Here 
we show that AG, but not DAG suppresses LPS-induced pro- and anti-inflammatory 
circulating cytokines at 2 hr after injection, despite AG being fully metabolized to 
DAG by this time. However, although AG can clearly stimulate HPA axis activation, 
this suppressive effect of AG on cytokine release is not likely to be due to its HPA 
axis effects.  
 
LPS induces a pro-inflammatory response by interacting with cell surface receptors of 
immune cells such as monocytes/macrophages, neutrophils and lymphocytes 
(reviewed in (Newton and Dixit 2012)). LPS is transported to pattern recognition 
receptors toll-like receptor (TLR) 4 and 2 (Kawai and Akira 2011). TLR4 activation 
initiates a cascade of cell processes including activation of myeloid differentiation 
primary response gene 88 (MyD88), MyD88 adaptor-like (Mal) and toll-like receptor 
(TRIF) -related adaptor molecule (TRAM)), which further activate pro-inflammatory 
transcription factors such as NFκB and extracellular signal-regulated kinase (ERK), 
initiating transcription of pro- and anti-inflammatory genes, resulting in production of 
pro- and anti-inflammatory cytokines (Newton and Dixit 2012). This cytokine 
response then leads to the cyclo-oxygenase 2-mediated conversion of arachidonic acid 
into prostaglandins, including PGE2 that then act at E-prostanoid receptors 
throughout the brain to activate the HPA axis (reviewed in (Ricciotti and FitzGerald 
2011)). CRH and arginine vasopressin (AVP) cells in the parvocellular region of the 
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PVN are stimulated to secrete CRH, which reaches the anterior pituitary through the 
hypothalamo-hypophysial portal blood vessel system from the median eminence and 
stimulates the release of ACTH. ACTH acts at melanocortin 2 receptors in the adrenal 
cortex to stimulate release of glucocorticoids that negatively feed back onto 
glucocorticoid and mineralocorticoid receptors to suppress further activation of the 
HPA axis (Jacobson and Sapolsky 1991). Glucocorticoids also act to inhibit NFκB-
mediated cytokine transcription (Auphan et al. 1995).  
 
At least in psychological stress, AG is known to interact with the HPA axis in order to 
regulate stress-related behaviours, making this a candidate mechanism for cytokine 
suppression (Spencer et al. 2015). It has been documented that ghrelin activates the 
HPA axis at the hypothalamic level, activating hypothalamic explants in vitro (Wren 
et al. 2002; Mozid et al. 2003). Ghrelin also indirectly activates the HPA axis via 
brainstem inputs to the PVN (reviewed in (Spencer and Tilbrook 2011)) and via 
indirect activation of CRH neurons of the PVN (Cabral et al. 2012). In humans, 
ghrelin administration increases ACTH and cortisol release (Arvat et al. 2001; Takaya 
et al. 2000; Locatelli et al. 2010). Similarly, in rodents ghrelin also stimulates 
increases in circulating ACTH and CORT (Spencer et al. 2012). As was seen 
previously (Sominsky, Ziko, and Spencer 2017), we here again show that AG alone is 
able to stimulate robust ACTH production from the pituitary in an in vitro setting. 
However, in the case of an immune challenge with LPS it seems AG’s effects on the 
HPA axis are insufficient to affect cytokine release.  
 
In support of the idea that AG influences the cytokine response independently of the 
HPA axis, we saw no significant effects of AG on LPS-induced ACTH levels in vivo. 
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There was even an apparent reduction in ACTH over time. It is likely this is due to a 
mild effect of the stress associated with handling and injection (Viau et al. 1993) but 
it is notable that there was no significant effect of LPS or AG on ACTH release. AG 
also lacked suppressive effects on LPS-induced CORT. Interestingly, an earlier study 
showed that a much lower dose of ghrelin (0.1 mg/kg) could potentiate the CORT 
response to LPS (Soriano et al. 2011). In our study, LPS gradually increased CORT 
release over time, as expected, inducing the highest CORT levels at 120 min, but no 
AG effects were observed at any time. Centrally, AG alone stimulated a significant 
increase in neuronal activation in the PVN, including in the magnocellular region of 
the PVN. Magnocellular neurons are mainly responsible for secretion of oxytocin and 
AVP into the peripheral circulation via the posterior pituitary. AVP and CRH are both 
produced in the parvocellular neurons projecting to the anterior pituitary and other 
brain regions (Ludwig and Leng 2006). Levels of both AVP and CRH are inversely 
related to glucocorticoid levels, with a role in feedback regulation (Ludwig et al. 
2002). AVP, as an ACTH secretagogue, potentiates CRH’s effects on ACTH release 
from the anterior pituitary. However, AG neither significantly attenuated the LPS-
induced activation of the PVN, nor significantly stimulated in vivo stress hormone 
secretion despite this PVN activation.    
 
It thus seems clear that AG’s suppressive effects on the cytokine response to LPS are 
independent of its influence on the HPA axis. However, AG clearly suppressed this 
component of the immune response. Limited literature suggests AG is able to 
suppress immune activation via the vagus nerve in animal models of traumatic brain 
injury, sepsis or stroke where ghrelin administration suppressed serum TNF and IL-
6 (Wu, Dong, et al. 2007; Cheyuo et al. 2011; Bansal et al. 2012). However, these 
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studies did not account for the fluctuation of ghrelin levels based on feeding status or 
any potential anti-inflammatory role of DAG. Also, the exact neuronal connectivity 
and involved neurotransmitters that mediate communication between ghrelin and 
vagus nerve remain to be determined (Veedfald et al. 2018). Another possible 
mechanism by which ghrelin suppresses inflammatory cytokines is by inhibiting high-
mobility group box 1 (HMGB1) release. HMGB1 is an important protein in initiating 
inflammation in a number of inflammatory diseases including sepsis. It is expressed 
in almost all cell types, however ghrelin greatly inhibits HMGB1 secretion from 
macrophages by blocking its cytoplasmic translocation (Chorny et al. 2008). This 
study, however, tested the delayed effect of ghrelin after endotoxemia was established 
for a period of more than 2 hr. Whether ghrelin plays an acute role in this regard 
remains to be tested. Ghrelin can also directly suppress the inflammatory response of 
a number of immune cells including peripheral macrophages, T-cells and activated 
microglia (as reviewed in (Hattori 2009)). It is proposed that it does this via a dual 
effect in reducing pro-inflammatory mediators but also enhancing activation of the 
anti-inflammatory p38 MAPK pathway through GHSR in order to mediate Th1 and 
Th2 responses simultaneously (Waseem et al. 2008). The exact cell mechanisms via 
which ghrelin suppresses inflammation however, need further elucidation.  
 
In the present study, we have shown that unlike AG, DAG does not suppress LPS-
induced cytokine activation. It also has limited effect on the HPA axis. These findings 
are particularly notable given AG is completely metabolized to DAG within 2 hr after 
injection and suggest that the anti-inflammatory effects of AG on the LPS response 
are indeed due to an acute AG action and not to excessive accumulation of DAG over 
the 2 hr. Studies have shown that in the arcuate nucleus DAG exerts its biological 
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effects via a non-GHSR receptor by impairing AG’s orexigenic effect (Fernandez et 
al. 2016). Here we show that the involvement of DAG in the HPA axis is limited to a 
potentiating effect on ACTH in vitro, resulting in high CORT levels at 30 and 45 min. 
Otherwise DAG was unable to suppress any LPS-induced effects in vivo at any level 
of the HPA axis. Mozid et al (Mozid et al. 2003) have also shown that DAG has no 
effect on the HPA axis. We did see a suppressive effect of DAG on IL-5, but this was 
independent of LPS and not seen with any other tested cytokine. DAG, but not AG, 
can exert anti-apoptotic effects in cultured neuronal cells (Hwang et al. 2009) and can 
suppress IL-6 secretion from amyloid- stimulated microglia (Bulgarelli et al. 2009). 
Taken together these results indicate that DAG has limited anti-inflammatory effects 
and, again, does not influence circulating cytokines via the HPA axis. Our findings 
suggest AG’s anti-inflammatory effects are independent of its actions on the HPA 
axis and are not due to excessive accumulation of DAG. While the exact mechanisms 
by which ghrelin influences the immune response remain to be determined, the 
apparent separation between ghrelin’s effects on HPA axis responses to psychological 
versus immune challenges raise the possibility of targeting this peptide for treatments 
of inflammatory conditions without compromising HPA axis activity. 
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General discussion   
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In this thesis I investigated the effects of neonatal overfeeding on the metabolic 
hormones leptin and ghrelin and their role in brain development and long-term 
function. In terms of developmental programming, it is well established that the early 
life nutritional environment is crucial in shaping long-term health in humans (Barker 
2003). However, the importance of nutrition in programming the developing brain 
with regards to the metabolic hormones leptin and ghrelin has only recently been 
addressed and has been largely ignored for females. In this thesis I examined the 
importance of the early life nutritional environment in establishing optimal neuronal 
connections in the developing brain, particularly in those regions that are responsible 
for controlling metabolism. 
 
An over- or under-nutritional environment during important developmental periods 
leads to metabolic and emotional disorders such as obesity and stress in a sex specific 
manner, with females having a tendency to experience more stress-related disorders 
than males (Dearden, Bouret, and Ozanne 2018). However, the effects of an altered 
nutritional environment during early life development and its impact on the 
hypothalamic pituitary adrenal (HPA) axis and stress responses remain to be further 
studied. Along with its role in metabolism, ghrelin is involved, in the adult animal, in 
modulating stress and anxiety as well as immunity and inflammation (Spencer et al. 
2015; Spencer et al. 2012; Pereira, da Silva, and de Moraes-Vieira 2017). However, 
ghrelin’s effects in modulating responses to early life adverse nutrition, its effects in 
programming the HPA axis, and whether these effects vary in males and females 
remain largely unstudied. Furthermore, the mechanisms involved in ghrelin’s anti-
inflammatory roles are not well defined. Leptin, similarly to ghrelin, has been 
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implicated in the early regulation of neuronal connectivity in hypothalamic regions 
responsible for feeding and metabolism (Bouret, Draper, and Simerly 2004b). 
However, there are significant gaps in our knowledge with regards to an altered early 
life nutritional environment and leptin’s role in programming the brain long-term.  
 
To study the effects of nutritional environmental adversity in early life, we used an 
animal model of litter size manipulation where pups on the day of birth were 
redistributed into control litters of 12 pups and small litters of 4 pups, with small litter 
pups having greater access to the dam’s milk and consequently having an increased 
body weight compared to controls. The animal model used in this thesis leads to a 
long-lasting moderately overweight phenotype, which significantly differs from other 
animal models of genetic or adult diet-induced obesity. In our model, neonatally 
overfed animals, when adults, have increased body weight compared to controls 
despite consuming the same standard diet for most of their lives. 
 
In Chapter 2, is demonstrated for the first time that neonatal overfeeding, along with 
the obese phenotype characterised by elevated body weight, increased the magnitude 
of the leptin surge and elevated leptin levels long-term. These effects were associated 
with early life disruptions to hypothalamic neuropeptide Y (NPY) and agouti related 
peptide (AgRP) fibre density as well as acute hypothalamic insensitivity to leptin. 
However, in adulthood, central control of appetite regulation was normalised even 
though the body weight and circulating leptin levels remained elevated in neonatally 
overfed rats (Sominsky, Ziko, et al. 2017). This persistently elevated leptin and 
increased body weight in neonatally overfed adult animals could be due to other 
permanently altered metabolic factors that we have not measured here. For instance, 
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disturbances to the nutritional environment during development, is associated with 
disruptions in circulating insulin levels in parallel this with a prolonged leptin surge 
(Kirk et al. 2009). Furthermore, it has been shown that maternal high fat diet impairs 
hypothalamic neurocircuitry formation due to affected neonatal insulin levels (Vogt et 
al. 2014). When in elevated levels, during perinatal life, insulin may program the 
development of obesity. Similarly to neonatal leptin, malprogramming of neonatal 
insulin system especially ARC resistance to the insulin satiety signals may explain 
acquired long-term metabolic problems, including obesity (Plagemann 2008).  
 
Obesity causes a form of low-grade inflammation involving elevated adipocytokines 
such as leptin, interleukin (IL)-1, IL-6 and tumor necrosis factor alpha (TNFα) 
secretion from adipocytes (Pereira and Alvarez-Leite 2014). Our group has previously 
shown that neonatal overfeeding permanently affects the hypothalamic 
neuroinflammatory profile manifested in increased numbers of microglia, one of the 
primary immune cells of the central nervous system (CNS), indicating increased 
central inflammation long-term (Ziko et al. 2014). Douglass et al have shown that 
increased hypothalamic inflammation is associated with weight gain (Douglass et al. 
2017). It is also important to note that metabolic inflammation in the peripheral 
tissues can be independent of the CNS, as was demonstrated by Valderacos and 
colleagues in a model of diet induced obesity and microglia ablation, potentially 
explaining the long-lasting peripheral metabolic disturbances despite the fact that 
there were no differences in gene expression in central leptin sensitivity in adulthood 
(Valdearcos et al. 2018). 
 
  161 
It has been previously shown that there is a high interrelation between leptin and 
ghrelin during early life neurodevelopment with ghrelin suppressing the overgrowth 
of hypothalamic neuronal connections stimulated by leptin in order to fine-tune 
metabolic central control (Steculorum et al. 2015). In this chapter we examined 
whether an early life overnutritional environment, in addition to alterations to the 
leptin system (Chapter 2), would affect the ghrelin system in male rats. Indeed, 
neonatal overfeeding altered the peripheral and central ghrelin system short-term and 
this effect was partially ameliorated by adulthood (Chapter 3) (Sominsky, Ziko, 
Nguyen, et al. 2016). We have largely focused here on the metabolic hormones leptin 
and ghrelin however it should be noted that some of the effects could be mediated by 
insulin and glucose. Plagemann’s studies, for instance, in newborn rats injected with 
insulin from P8-P11, demonstrate life-long increased body weight, impaired glucose 
tolerance and increased vulnerability to a sub-diabetogenic dose of streptozotocin 
(Harder et al. 1999). In another study from the same group, gestational diabetes (GD) 
was induced in mothers on the day of conception with the hypothesis that prenatal 
hyperleptinemia would affect hypothalamic regulators of body weight and 
metabolism. It was demonstrated that on P21 offspring of GD mothers were 
overweight, hyperinsulinemic and they had disrupted differentiation of nuclei within 
the paraventricular nucleus of the hypothalamus (PVN) and ventromedial 
hypothalamus (VMH) (Plagemann, Harder, Janert, et al. 1999). These results 
emphasise the importance of optimal insulin levels during critical periods of postnatal 
life in hypothalamic regulation of body weight and metabolism and susceptibility to 
diabetes in later life due to temporary early life hyperinsulinemia. 
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As observed in Chapter 2, neonatal overfeeding in males was associated with acute 
disruption to hypothalamic metabolic control, changes that had not been studied in 
females in relation to the early life nutritional environment. Therefore, in Chapter 4 
we aimed to examine whether the same metabolic changes accompanying the early 
life nutritional status in males would be observed in females; given the importance of 
sex differences in many aspects. We observed in this chapter that neonatally overfed 
females, experiencing long-term increased body weight and circulating leptin, had no 
changes in the central control of feeding circuitry compared to normally fed 
counterparts (Ziko et al. 2017). Sex-differences in brain structures between males and 
females have been observed from before birth, with males having larger brain mass 
than females (Dean et al. 2018). The hypothalamus, being the main energy-regulating 
brain region, is highly sexually dimorphic. It has been suggested that female sex 
hormones are responsible for regulating neurogenesis and cell death during the 
development of the hypothalamus and the absence or overexpression of these 
hormones during key developmental periods is associated with permanent neuronal 
changes (Budefeld et al. 2008). Sex hormones are also responsible for regulation of 
feeding. For instance, male mice have decreased numbers of proopiomelanocortin 
(POMC) neurons within the arcuate nucleus of the hypothalamus (ARC), which may 
explain their higher calorie intake and increased body weight when compared to 
females (Nohara et al. 2011). These changes are at least partially mediated by 
testosterone during hypothalamic development and, as shown by Nohara and 
colleagues, female mice injected with testosterone have decreased number and density 
of POMC neurons within the ARC relative to control females (Nohara et al. 2011). 
We have previously mentioned that males and females also differ in the location of fat 
deposition, with males being characterised by abdominal fat deposition whereas 
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females preferentially deposit subcutaneous fat (Karastergiou et al. 2012). This 
phenomenon could be explained by the sexually dimorphic way in which the 
sympathetic nervous system innervates peripheral adipose tissues, with males having 
more afferent projections to abdominal fat and females having more projections to 
subcutaneous fat (Frank, Palmer, and Clegg 2018). The above findings suggest that 
males and females are differently wired not only centrally, but also peripherally, 
explaining the changes in responses to nutritional challenges in early life. 
Furthermore, these findings suggest that peripheral factors, including innervation of 
adipose tissue, may aid the fact that males and females behave differently in the way 
they centrally control appetite.  
 
In Chapter 4 we observed that neonatal overfeeding in females, in contrast to males, 
was not associated with any changes in the central control of energy intake. However, 
we have previously reported that neonatally overfed females, but not males, display 
exacerbated HPA axis responses to restraint stress (Spencer and Tilbrook 2009). We 
have also demonstrated that ghrelin directly affects the anterior pituitary in secreting 
adrenocorticotropic hormone (ACTH) in order to aid the stress response and help the 
organism cope with stress (Spencer et al. 2012). In Chapter 5 we observed that 
neonatally overfed females have altered ghrelin receptor and Goat expression in the 
pituitary as well as a suppressed ability of the anterior pituitary to respond to ghrelin 
when stimulated in an in vitro setting, indicating that neonatal overnutrition affects at 
least partly the HPA axis responses to stress in females (Sominsky, Ziko, and Spencer 
2017). It has long been shown that the HPA and hypothalamic-pituitary-gonadal 
(HPG) axis are closely connected (as reviewed in (Goel et al. 2014; Sominsky, 
Hodgson, et al. 2017)). It has been suggested that sex-specific changes to HPA axis 
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activity are affected by sex hormones (estrogen, progesterone and testosterone), the 
end products of the HPG axis, that are produced in significant quantities after the 
onset of puberty (Panagiotakopoulos and Neigh 2014). However, differences between 
boys and girls in HPA axis activity are already observed in early childhood, with boys 
under the age of eight having high salivary cortisol compared to girls of the same age. 
This pattern is reversed after the age of eight years (van der Voorn et al. 2017). The 
early life environment including maternal exposure to medications used to treat 
postpartum stress is an important factor in the neurodevelopmental outcomes of 
children. For instance, postpartum maternal exposure to fluoxetine (a pharmacological 
antidepressant used to treat postpartum depression) differently affects male and 
female offspring in adulthood. Maternal postpartum exposure to fluoxetine induces 
HPA axis negative feedback in adult male but not female rats, whereas maternal 
exposure to exercising is associated with increased hippocampal neurogenesis in both 
sexes, however maternal exposure to exercising impairs HPA axis activity in female 
offspring (Gobinath et al. 2018). In humans, early life stress, such as with child abuse 
and neglect, is also associated with impairments in neuronal development and may be 
one of the leading causes of psychiatric disorders in adulthood (Lajud et al. 2012). 
There are clear patterns for sex-specific prevalence rates of mental disorders, with 
conditions such as post-traumatic stress disorder (PTSD) and major depressive 
disorder (MDD) being more common among women, whereas aggressive behaviour 
and drug abuse are more common among men (Lundberg 2005; Keane, Marshall, and 
Taft 2006; Nestler et al. 2002).  
 
The human brain undergoes immense functional and structural transformations 
between week 24 and 44 after conception (Pomeroy 2004) and also during neonatal 
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life, early childhood and adolescence (as reviewed in (Karatsoreos and McEwen 
2013)). Any alteration to the nutrient state during these times not only affects brain 
neuroanatomical features, but also its chemistry and physiology, and this can be 
associated with long-term detrimental effects on physical and mental health (Anda et 
al. 2010). Having said this, the young brain is also extremely plastic and therefore it 
may optimise some repair after nutrient alterations. Nutritional insults result in brain 
dysfunction only when they outbalance brain plasticity. It has been shown that not 
only the young brain, but also the adult brain has considerable capacity for resilience 
(Karatsoreos and McEwen 2011). The adult brain has the ability for long-term change 
and in humans it is altered by behavioural interventions such as cognitive behavioural 
therapy, which reduces amygdala volume in anxiety disorders and increases grey 
matter in the prefrontal cortex in chronic fatigue patients (Seminowicz et al. 2013; 
Mansson et al. 2016). Furthermore, physical activity increases hippocampal volume in 
elderly people (Erickson et al. 2011). Similarly, in this thesis we observed that adult 
brain, in our rat model that had been challenged with early life poor nutrition, 
demonstrates resilience.  
 
Ghrelin, along with its neurotrophic role in regulating neuronal connectivity within 
energy-controlling hypothalamic centres at early times after birth, has shown a major 
involvement in regulation of the immune system in adulthood. Acute or chronic 
inflammatory complications influence ghrelin levels. Increased circulating ghrelin 
levels have been correlated not only with disease severity, but also with expression of 
pro-inflammatory cytokines (as reviewed in (Baatar, Patel, and Taub 2011)). In 
Chapter 6 we looked at ghrelin’s involvement in the endocrine regulation of the 
immune system as an anti-inflammatory agent. Ghrelin has shown its anti-
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inflammatory properties in a number of conditions such as sepsis, inflammatory 
bowel disease, rheumatoid arthritis and, experimentally, with high dose 
lipopolysaccharide (LPS) (Baatar, Patel, and Taub 2011; Pereira, da Silva, and de 
Moraes-Vieira 2017)). Ghrelin’s presence in all of the above conditions leads to 
reduction of serum levels of TNFα and a number of interleukins including IL-6 and 
IL-8. However, the mechanisms by which ghrelin exerts its anti-inflammatory 
properties remain to be further elucidated. In Chapter 6 we aimed to define the 
mechanism by which ghrelin is suppresses LPS-induced circulating pro- and anti-
inflammatory cytokines, hypothesising that ghrelin exerts these effects via the HPA 
axis (Ziko et al. 2018). Examining the effects of both forms of ghrelin, acylated (AG) 
and desacylated (DAG) at all of the levels of the HPA axis we observed that des-acyl 
ghrelin (DAG) was unable to suppress any LPS-induced effects in vivo at any level of 
the HPA axis. Despite AG’s ability to stimulate HPA axis activation, our study 
showed that its suppressive effect on cytokine release was clearly not due to its HPA 
axis effects.  
 
Some of the mechanisms by which ghrelin suppresses inflammation have been 
discussed below, however, further studies are crucial in understanding beneficial 
effects of ghrelin as an anti-inflammatory agent. Initial work suggested that ghrelin 
may exert its anti-inflammatory effects via the vagus nerve. It is well recognized that 
ghrelin stimulates the vagus nerve (Okada et al. 2018; Date 2012) and such 
stimulation has shown to be beneficial in anti-inflammatory complications including 
sepsis and traumatic brain injury (Jacob, Wu, et al. 2010; Bansal et al. 2012). In 
support of this, Shah and colleagues have shown that in a rat model of radiation-
combined injury and sepsis ghrelin administration significantly reduced plasma TNFα 
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and IL-6 levels only in non-vagotomized, but not in vagotomized animals (Shah et al. 
2009). These studies, however, did not account for fluctuation of ghrelin levels based 
on feeding status or any effects of desacyl ghrelin on the anti-inflammatory role. 
Ghrelin has also shown anti-inflammatory effects by suppressing the sympathetic 
nervous system. Increased cytokine levels, at least partly, are mediated by 
norepinephrine (NE) release from the gut during sepsis and ghrelin suppresses gut-
derived NE release (Jacob, Rajan, et al. 2010). Furthermore, ghrelin has been shown 
to inhibit activation of nuclear factor-κB (NF-κB), a well-known transcription factor 
involved in production of pro-inflammatory cytokines during inflammatory insults 
(Newton and Dixit 2012).  
 
Another potential mechanism by which ghrelin may suppress inflammation is via 
recruitment of P38 mitogen-activated protein kinase (MAPK). LPS is one of the most 
well-known stimulators of toll-like receptor (TLR) 4 and TLR4 activation initiates a 
series of intracellular processes including stimulation of myeloid differentiation 
primary response (MYD) 88, which further triggers activation of the P38 MAPK 
cascade (Lamon et al. 2010). MKP-1, the first identified MAPK phosphatase, 
deactivates P38 MAPK after LPS stimulation (Chen et al. 2002). Increased activation 
of P38 MAPK leads to overproduction of inflammatory cytokines from the liver and 
ghrelin upregulates MKP-1 to suppress inflammation (Jacob, Rajan, et al. 2010). In 
addition, in a study from Slomiany and colleagues, LPS induced increased 
phosphorylation of P38 in gastric mucosal cells, whereas ghrelin significantly 
suppressed this LPS effect, indicating that ghrelin counteracts the pro-inflammatory 
consequences of Helicobacter pylori derived LPS (Slomiany and Slomiany 2013).  
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Ghrelin receptors are largely expressed by macrophages and ghrelin’s presence 
suppresses inflammatory cytokine expression (Chowen and Argente 2017). In 
contradiction with what previous studies have shown, work from Wu et al, 
demonstrated that LPS treatment alone of Kupffer cells (the resident macrophages of 
the liver) and peritoneal macrophages, dramatically increases TNFα and IL-6 levels. 
Ghrelin co-incubation with LPS, however, was unable to further affect the elevated 
LPS-induced cytokine levels, suggesting that the anti-inflammatory effects of ghrelin 
may not be due to its direct effect on ghrelin receptors expressed on macrophages 
(Wu, Dong, et al. 2007). Despite the above-proposed anti-inflammatory mechanisms 
of ghrelin, its role in the HPA axis responses to an immune challenge has been less 
well characterised, indicating that further research is necessary to define ghrelin’s 
mechanisms in inflammatory complications as a promising anti-inflammatory agent.  
 
Future directions  
In this thesis we have contributed to the existing knowledge of the importance of the 
metabolic hormones ghrelin and leptin in the development of hypothalamic feeding 
circuits (Steculorum and Bouret 2011; Bouret and Simerly 2006; Bouret, Draper, and 
Simerly 2004a; Steculorum et al. 2015). We further expanded on the effects of an 
early life over-nutritional environment on such development considering the 
observations that males and females respond differently to early life nutritional 
challenges. It is important to note that a direct comparison between sexes of the 
parameters measured in this thesis needs to be considered for future studies. Despite 
the work described here, there are considerable gaps in our knowledge with regards to 
the effects of early life nutritional disturbances centrally; in long-life stress, cognition 
and whether other extra-hypothalamic regions are involved in such systems. Postnatal 
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overfeeding and consequently altered leptin and ghrelin levels, are involved in 
regulation of many systems including endocrine system, reproductive function, HPA 
axis, adipose tissue, glucose and insulin homeostasis, modification of plasma lipids 
and proteins, adipocytokines, oxidative stress, kidney and cardiovascular function (as 
reviewed in (Habbout et al. 2013; Lean and Malkova 2016)).  
 
Of particular interest would be to determine the role of neonatal nutritional insults on 
the structure and function of adipose tissue. In Chapters 2, 3, 4 and 5 we saw that 
early life overnutrition was associated with long-term weight gain consisting of 
excess adipose tissue. Excessive caloric intake and positive energy imbalance related 
to the obese phenotype are associated with not only over-accumulation of adipose 
tissue either as subcutaneous or intra-abdominal, but also with adipose tissue 
dysfunction including increased cell density, lipolysis and inflammatory cytokine 
production (from adipocytes and immune cells) and decreased adipose sensitivity to 
insulin as well as decreased lipogenesis (Ortega and Fernandez-Real 2013)). 
Inflammation and oxidative stress on the other hand further influences fat 
accumulation, leading to a continuous positive feedback (Fresno, Alvarez, and Cuesta 
2011). Many studies have shown a close relationship between immune and metabolic 
systems (Schaeffler et al. 2009; Wolowczuk et al. 2008) and leptin, one of the most 
studied adipokines, exerts both metabolic and anti-inflammatory properties (Fresno, 
Alvarez, and Cuesta 2011; DiAngelo et al. 2009). However, it is not known whether 
early life development in combination with nutritional challenges influences this low-
grade inflammation by affecting leptin levels. In this thesis we observed that neonatal 
overfeeding was associated with elevated leptin levels throughout life. Therefore, it 
will be important in future studies to measure molecular markers of inflammation 
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including IL-6, IL-1β, c-reactive protein, serum amyloid A and fibrinogen in the 
metabolically active organs such as adipose tissue, liver and muscle in the neonatally 
overfed and control animals during development and in adulthood. The presence of 
these markers has been shown in association with obesity and insulin resistance in the 
following rodents and human studies (Chou et al. 2014; Shoelson, Lee, and Goldfine 
2006; Kwon and Pessin 2013). Furthermore, since recent studies have been 
suggesting that peripheral inflammation is a result of central inflammation in obesity 
(Weisberg et al. 2003; Thaler et al. 2012; Mori et al. 2010), it will be important to 
measure inflammatory markers centrally in the hypothalamus.    
 
Ghrelin and leptin receptors are expressed in extra-hypothalamic regions, including in 
the hippocampus, and adult rodent studies have demonstrated a direct effect of both 
these hormones on synaptic plasticity and cognitive function (Beck and Pourie 2013; 
Harvey 2013). Previous studies have shown that early life exposure to imbalanced 
nutritional environment or stress can lead to long-life cognitive dysfunctions (as 
reviewed in (Spencer 2017). Alterations in leptin levels for instance, are associated 
with emotional and cognitive disorders as observed in pre-clinical and clinical studies 
(Guo et al. 2013; Milaneschi et al. 2016). Similarly, a reduced ability for local brain 
ghrelin production, especially in the temporal lobe, has been observed in Alzheimer’s 
Disease (AD) patients (Gahete, Rubio, et al. 2010). In contrast, in animal studies, 
ghrelin administration in a mouse model of AD is associated with enhanced 
hippocampal synaptic plasticity and consequently improved learning and memory 
(Diano et al. 2006). However, the effects of an imbalanced nutrition during early life 
with regards to ghrelin and leptin’s influence on cognitive development long-term 
remain to be further elucidated. We observed in Chapter 3 that neonatal overfeeding 
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was associated with suppressed circulating ghrelin levels, and increased ghrelin 
receptor expression in the ARC during the first week after birth in male pups. If 
perturbations to the ghrelin system extend to higher order brain regions involved in 
cognitive processing this may suggest insufficient ghrelin levels to be associated with 
increased chances of the offspring developing AD later in life. We indeed have 
previously seen that neonatally overfed adult rats perform poorly in cognitive 
behavioural tests and demonstrate impaired sensitivity to learning (De Luca et al. 
2016). This is important even if ghrelin levels resolve since the insults have occurred 
during an important developmental window and may potentially be associated with 
long-term detrimental effects.  
 
As mentioned in Chapter 6 and here in Chapter 7, ghrelin suppresses inflammation 
via a number of mechanisms including inhibiting NF-κB pathway (Wu, Zhou, et al. 
2007; Tsubouchi et al. 2014), directly suppressing pro-inflammatory cytokines in 
monocytes and T-cells (Dixit et al. 2004) and through other suggested pathways 
mentioned in this thesis. Recent research has shown DAG’s ability to reverse the pro-
inflammatory effects of chronic high fat diet (Gortan Cappellari et al. 2016). Also, 
DAG is involved in adipose lipid accumulation and suppression of adipose tissue 
inflammation (Pereira, da Silva, and de Moraes-Vieira 2017). A mechanism via which 
DAG exerts these effects has been suggested by Au et al.. They examined the effects 
of DAG on breast adipose tissue inflammation in obesity, where the capacity of 
human adipose tissue macrophages in stimulating aromatase (the enzyme involved in 
the biosynthesis of estrogens) expression in primary human breast cells (ASCs) was 
measured. Breast adipose tissue inflammation in obesity is associated with elevated 
expression of aromatase. DAG treatment significantly suppressed macrophage-
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dependent induction of aromatase in ASCs, identifying a new mechanism for DAG in 
modulating inflammation. However, these studies have not taken into account the 
expression of the enzymes that hydrolase AG to DAG, such as butyrylcholinesterase, 
in order to rule out which form of ghrelin is exerting the effects. Altered levels of 
butyrylcholinesterase are observed in obesity, insulin resistance, hypertension (Chen 
et al. 2017) and inflammatory diseases (Xu et al. 2018). Understanding the 
mechanisms via which AG and DAG exert their anti-inflammatory properties would 
be very important extending to the effects of both forms of ghrelin as promising 
therapeutic strategies for treatment of inflammatory conditions. 
 
Based on our results we conclude that leptin and ghrelin are two metabolic hormones 
with great importance in the developmental origins of adult diseases. Nutritional 
disturbances during early life development alter the levels of these hormones and the 
systems they control long-term and are associated with long-life metabolic 
disturbances such as a permanent increase in body weight, despite at least partial 
central resilience in orexigenic/anorexigenic circuitry as measured here.  
 
Here we also emphasise the importance of studying sex differences. Cellular and 
molecular changes triggered by steroid hormones and sex chromosomes throughout 
development define specific physiological functions and behaviours in males and 
females. Therefore, is very important to consider both sexes to avoid assumption of 
equal behaviours between sexes without specific assessment.  
 
Important developmental windows that can alter metabolism long-term in humans are 
the prenatal period, early infancy, 5-7 years of age (known as adiposity rebound 
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period) and puberty (Power, Kuh, and Morton 2013). Our findings provide further 
insight into how leptin and ghrelin can affect central and peripheral feeding circuitry 
during development, which in humans corresponds approximately to the third 
trimester (Semple et al. 2013), under nutritional challenges. This information could be 
used to inform the public of the importance of the nutritional environment during 
important developmental windows in humans in order to minimize the risk of 
childhood obesity and associated metabolic and cognitive disorders. Therefore, the 
early life developmental period studied here is not only a period of high vulnerability, 
but also a very important window for therapeutic interventions. 
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